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 localized on DNA reduces hydrogen peroxide to form 
hydroxyl radical (
•
OH), resulting in oxidative DNA damage. This DNA damage causes 





arteriosclerosis. Sulfur and selenium antioxidants have been investigated for the 
prevention and treatment of these diseases, and studies have shown that
 
sulfur- and 
selenium-containing antioxidants prevent DNA damage from copper-generated hydroxyl 
radical and that metal coordination is required for the observed antioxidant activity.  
 To determine how copper coordination results in DNA damage inhibition, Cu
+
 
complexes with selone and thione ligands were synthesized with the aim of studying their 
electrochemistry and reactivity with H2O2. Tris(pyrazolyl)methane and -borate ligands 
are used to synthesize the target metal complexes, since they mimic metal coordination 
environments in biological systems. N,N’-1,3-dimethyl-imidazole thione (dmit), and 
selone (dmise) ligands are used since they resemble ergothioneine and selenoneine, sulfur 
and selenium-containing antioxidants naturally found in plants and animals. Selone 
coordination to Cu
+
 significantly stabilizes Cu
2+
 more effectively than thione 





 and Tp*Cu(dmise) (Tpm
R
 = tris(pyrazolyl)methane, R = H; Tpm, R = 
Me; Tpm*, R = iPr; Tpm
iPr
; Tp* = tris(1,3-dimethylpyrazolyl)borate) have potentials 





Tp*Cu(dmit)) have potentials ranging from 70 mV to -232 mV. If similar Cu-Se 
iii 
 
complexes are formed in vivo, these potentials may be low enough to inhibit Cu
2+
 
reduction by NADH and prevent copper redox cycling.  
 The reactivity of dmise, dmit, and their tris(3,5-dimethylpyrazolyl)methane 
copper complexes [Tpm*Cu(L) (L = dmise or dmit) with H2O2 was explored. Dmise and 
dmit are both reactive towards H2O2 and may be effective scavengers of H2O2. Treatment 
of [Tpm*Cu(dmise/dmit)]
+
 with H2O2 showed sacrificial oxidation of the chalcogenone 
without oxidation of the Cu
+
 metal center, and if similar copper-selenium or –sulfur 
complexes form in vivo, these complexes may scavenge H2O2 and inhibit copper-
mediated oxidative damage.  
 A comparative coordination chemistry and density functional theory study of 
selone and thione with cuprous halides was also performed, and the resulting complexes 
have varied geometries and stochiometries depending on the type of halide and 
chalcogenone ligand used, intramolecular π-π interactions, and degree of short contact 
interactions between X-H (X = I, Br, Cl, Se or S) atoms in the solid state structures. Cu
+
 
complexes of the bidentate thio- and seleno-imidazolyl ligands 
bis(thioimidazolyl)methane, bis(selenoimidazolyl)methane, bis(thioimidazolyl)ethane, 
and bis(selenoimidazolyl)ethane were synthesized, and these complexes preferentially 
formed dinuclear, three- and four-coordinate Cu
+
 complexes. The Cu
2+/+
 reduction 
potentials of these copper complexes with bidentate chalcogenone ligands vary within a 
range of 471 mV, a difference that would have significant effects in redox-mediated 
reactions. The results presented give more insight on the antioxidant activity of selone 
and thione compounds in the prevention of copper-mediated oxidative damage. These 
iv 
 
results also reveal the diverse coordination chemistry of Cu
+
 with selone and thione and 
elucidates the effects of this coordination on Cu
2+/+
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ANTIOXIDANT AND METAL COORDINATION PROPERTIES OF BIOLOGICAL 
CHALCOGENONES 
Antioxidant and biological effects of selenium and sulfur. 
Selenium is an essential micronutrient for both humans and animals with a RDA 
(recommended dietary allowance) ranging from 55-350 g/day for humans.
1
 It is 
incorporated as selenocysteine in the active site of many antioxidant proteins, including 
glutathione peroxidases, thioredoxin reductases, and thyroid hormone deiodinases.
2-3
 In 
humans, selenium deficiency can lead to Keshan, Kashin-Beck, and neurodegenerative 
diseases, whereas selenium overload may lead to garlic breath, poisoning, and selenosis.
4
 
Selenocysteine coordinates nickel in Ni-Fe-Se hydrogenase, a microbial enzyme that 












 respectively. Metal coordination of selenium 




-mediated oxidative DNA damage,
9-11
 and 
selenium antioxidants play protective roles against heart disease, as well as prostate, lung, 
and colon cancer.
12,13
 Recently, the selenium containing compound selenoneine (Figure 




Sulfur is found in numerous proteins and low molecular weight compounds in 





 Major sulfur-containing compounds in the body include methioneine, 
cysteine, taurine, glutathione, N-acetylcysteine, and ergothioneine, and these compounds 
are involved in protein synthesis and antioxidant defense mechanisms. In biological 














 and zinc fingers.
24





-mediated DNA oxidative damage through metal coordination.
25,26
 Sulfur-
containing compounds such as N-acetyl-L-cysteine and D-penicillamine are used to treat 
heavy metal poisoning, whereas allicin and other sulfur containing compounds from 
garlic exhibit antimicrobial, antibacterial and antifungal properties.
27-30
 The thione 



















E = Se, selenoneine




















E = Se, selenoneine diselenide
E = S, ergothioneine disulfide




Antioxidant and metal binding properties of biological chalcogenones.  
Selenoneine (2-selenohistidine trimethylbetaine or 2-selenyl-Nα,Nα,Nα-trimethyl-L-
histidine) is a seleno-histidine first identified by Yamashita and Yamashita in 2010 after 
isolation from the blood of blue tuna, Thunnus orientalis.
14
 Selenoneine is also the 
primary source of selenium in chicken gizzard, liver, and heart as well as in squid 
hepatopancreas. The highest concentration of selenoneine (430-437 nmol of selenium/g) 
are found in tuna and mackerel blood.
14
 Selenoneine was first isolated in its oxidized 
diselenide form that was then reduced to the monomeric selone form by treatment with 
dithiothreitol or glutathione. In solution, selenoneine exhibits selenol-selone tautomerism 
and exists primarily in the selone form under physiological conditions.
14
  
As an antioxidant, selenoneine is a potent radical scavenger and has shown 
greater antioxidant activity than the analogous sulfur antioxidant ergothioneine in 
scavenging the 1-diphenyl-2-picrylhydrazyl (DPPH) radical in vitro.
14
 The high 
concentrations of selenoneine found in animal tissues suggest that this molecule may play 
an important role in physiological redox and antioxidant processes.
14
 Because selenium 






 and because 
selenoneine likely coordinates metal ions through the selenium and nitrogen atoms of the 
five-membered ring, the coordination chemistry of selenoneine may contribute to its 
antioxidant behavior. Thus, understanding the binding properties of similar selone 




Ergothioneine (2-mecarptohistidine trimethylbetaine) is a thiohistidine first 
isolated in 1909 from ergot, and it is also found in plants, animals, and humans.
34
 Similar 
to selenoneine, ergothioneine exhibits thione-thiol tautomerism, but exists primarily in 
the thione form under physiological conditions.
27
 Ergothioneine binds divalent metals 
ions such as Cu
2+
 without undergoing autooxidation to the disulfide dimer due to its more 
negative reduction potential relative to other thiols.
27
 
 The antioxidant abilities of ergothioneine inhibition of peroxynitrite-dependent 
nitration of nitrotyrosine,
35
 and prevention of xanthine and hypoxanthine formation, 
compounds implicated in inflammatory conditions such as gout.
36
 Similar to selenoneine, 
ergothioneine also scavenges DPPH radical but it is less potent compared to 
selenoneine.
14
 Several studies have shown that ergothioneine can neutralize reactive 
oxygen species such as hydroxyl radical and peroxynitrite,
37,38
 and that ergothioneine 
protects rat kidneys and livers from oxidative damage by Fe/H2O2,
34
 despite studies 
showing that the reaction of ergothioneine with H2O2 is very sluggish.
39,40
  









, by binding through sulfur or nitrogen atoms. To determine how this metal 
coordination ability may be related to its observed antioxidant activity, it is necessary to 
investigate the coordination chemistry of ergothioneine analogs.  
The thione methimazole is the most common drug used in the treatment of 
hyperthyroidism.
41
 The mechanism of inhibition of hyperthyroidism using thiourea drugs 
such as methimazole is not fully understood, but these compounds are proposed to block 
5 
 
thyroid hormone biosynthesis by inhibiting thyroid peroxidases catalyzed iodination of 
tyrosine residues in thyroglobulin.
41,42
 Numerous studies have also shown that 
methimazole is a potent scavenger of hydroxyl radical and peroxynitrite and that it 
prevents thyroperoxidase and DNA damage.
43-45
 Medicinal studies of methimazole have 
shown its ability to prevent oxidative stress and chemical-induced gastropathy in rats,
46
 to 
inhibit melanin synthesis in cultured B16 melanocytes,
47




The rich coordination chemistry of transition metals with methimazole has 
previously been investigated in detail.
49-52
 The coordination of methimazole to Cu
+
 
results in diverse architectures ranging from mononuclear complexes to polynuclear 
networks with several methimazole binding modes, including monodentate and bridging 
via coordination of the sulfur and non-alkylated nitrogen atom.
53-55
  
The research presented in this dissertation involves understanding the antioxidant 
mechanisms of chalcogenone compounds similar to selenoneine, ergothioneine, and 





 and methimazole (Figure 1.1).
41
 The work presented in 
Chapter 2 investigates the effects of N,N’-1,3-dimethylimidazole selone (dmise) and 





Tris(pyrazolyl)methane and -borate ligands are used to synthesize the target Cu
+
 
complexes, since they mimic metal coordination environments in biological systems.
58
 
Research described in Chapter 3 focuses on the reactivity of dmise, dmit, and their 
tris(pyrazolyl)methane Cu
+
 complexes with H2O2. Work outlined in Chapter 4 
6 
 




 as well as the 
coordination and electrochemistry of bis(1-methylimidazolyl) diselenide with Cu
2+
. The 
work presented in Chapters 2, 3, and 4 enhances further understanding of selenium and 
sulfur antioxidant activity through their ability to alter Cu
2+/+
 reduction potential upon 
coordination to Cu
+
 or through the ability of selenium and sulfur antioxidant compounds 
to scavenge reactive oxygen species such as H2O2. 
Work described in Chapter 5 investigates the comparative coordination chemistry 
of dmise and dmit with Cu
+
 halides, resulting in complexes with varied geometries and 
stochiometries. Tetrameric and monomeric copper complexes were synthesized and 
compared using density functional theory calculations to determine ligand effects as well 
as the effects of inter- and intramolecular forces on solid state geometries of the 
complexes.
59
 The research described in Chapter 6 focuses on the coordination and 
electrochemistry studies of the bidentate thio- and seleno-imidazolyl ligands 
bis(thioimidazolyl)methane, bis(selenoimidazolyl)methane, bis(thioimidazolyl)ethane, 
and bis(selenoimidazolyl)ethane ligands with Cu
+
. Overall the work presented in this 
dissertation reveals the diverse coordination chemistry of Cu
+
 with selone and thione 
ligands and elucidates the effect of this coordination on Cu
2+/+
 reduction potentials and 
reactivity with H2O2. It also sheds light on the mechanisms of antioxidant activity of 
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PROBING THE ANTIOXIDANT ACTION OF SELENIUM AND SULFUR USING 
Cu(I)-CHALCOGENONE TRIS(PYRAZOLYL) METHANE AND -BORATE 
COMPLEXES 
Introduction 
Reactive oxygen species, (ROS) which include superoxide (O2
•-
), hydrogen 
peroxide (H2O2), hydroxyl radical (
•
OH), singlet oxygen (
1
O2
•) and peroxyl radical 
(RO2
•
), are involved in oxidative damage to lipids, proteins and DNA.
1
 Copper(I) 
participates in the Fenton-like reaction (reaction 1) in which hydroxyl radical is generated 




This copper-mediated hydroxyl 





. Numerous studies have linked damage from copper-generated 











   (1) 
Selenium- and sulfur-containing compounds have been widely studied as 
potential antioxidants for the prevention or reduction of oxidative DNA damage.
5
 
Selenium is an essential micronutrient for both humans and animals, with a 
recommended dietary allowance ranging from 55-350 g/day.
6
 Organoselenium 
compounds are of particular interest because they appear to be more bioavailable relative 
to inorganic selenium compounds.
7
   
12 
 
Using copper-mediated DNA damage studies and UV-vis spectroscopy, our group 
has identified copper coordination as an explanation for selenium and sulfur antioxidant 
activity.
5,8-10
 This novel metal binding antioxidant hypothesis is separate from the 
traditional explanation that focuses on the ability of selenium compounds to decompose 








As part of our efforts to understand the role of Se/S-Cu coordination in the 
prevention of metal-mediated DNA damage, biologically relevant Cu
+
 selone and thione 
Figure 2.1. A) Tris(pyrazolyl) and heterocyclic thione and selone 
ligands used in this study. Numbering scheme is shown for dmit. B) 
Structures of naturally-occurring selone and thione antioxidants and the 
drug methimazole. 




complexes with tris(pyrazolyl)methane or tris(pyrazolyl)borate ligands have been 
synthesized, with the aim of studying their copper coordination and electrochemistry. 
Scorpionate nitrogen donor ligands first introduced by Trofimenko
12
 (Figure 2.1A) were 
employed, since they mimic biological coordination.
13
 The heterocyclic selones and 
thiones used in this study (Figure 2.1A) resemble methimazole, a drug currently used in 
the treatment of hyperthyroidism (Figure 2.1B).
14





 respectively, antioxidant compounds widely 
found in plant and animal tissues (Figure 2.1B). 
The heterocyclic chalcogenones used in this study are good σ- and π-donors, and 
similar compounds, such as imidazoline-2-thiones, display a diversity of bonding 
modes.
17
 The coordination chemistry of selones and thiones with transition metals and 









 as well as studied by Devillanova, et al.,
22
 Williams, et al.,
23-27
 Rabinovich, et 
al.,
28,29
 and Parkin, et al.
30,31





 but reports of analogous selone complexes are few.
35-37
 Herein, we report 





 where (L = N,N’-dimethylimidazole selone, dmise; N,N’-
dimethylimidazole thione, dmit; Tp* = hydrotris(3,5-dimethylpyrazolyl)borate; Tpm
R
 = 
tris(pyrazolyl)methane, R = H; Tpm, R = Me; Tpm*, R = iPr; Tpm
iPr





 have determined that the antioxidant activities of analogous 
selenium and sulfur compounds can be very distinct. Thus, we have investigated the 
geometries and spectroscopic properties of both copper-selone and -thione complexes. 
14 
 
Because selenium and sulfur coordination to copper is necessary for prevention of copper 
mediated DNA damage, comparative electrochemical studies of selone and thione 
complexes will help determine changes in the reduction potentials of Cu
2+/+
 upon 
coordination. These comparative studies will provide insights into the effects of selenium 
and sulfur coordination and antioxidant activity in vivo. "This work is reproduced from 
Kimani, et al. Inorg. Chem. 2010, 49, 9200-9211. Copyright 2010 American Chemical 
Society." The copyright permission is in Appendix A, page 221. 
 
Results and Discussion 
Synthesis of Cu(I) selone and thione complexes. The target copper(I) complexes 
with the BF4
-
 counterion were synthesized using two different routes. Method 1 involves 
a two-step, one-pot procedure via the treatment of equimolar amounts of 
[Cu(NCCH3)4][BF4] and N,N’-dimethylimidazole selone (dmise) or N,N’-
dimethylimidazole thione (dmit) in acetonitrile followed by cannula addition of the 
desired tripodal ligand in acetonitrile. Method 2 involves treating 
[Tpm
R
Cu(NCCH3][BF4] with one molar equivalent of dmise or dmit in dichloromethane 
(Scheme 2.1). Compared to method 1, method 2 generally results in slightly higher yields 
with shorter reaction times. Copper complexes with the chloride counterion were 
synthesized by reaction of equimolar amounts of CuCl and the chalcogenone in a mixed 
solvent system of methanol and acetonitrile, followed by cannula addition of the tripodal 
ligand in acetonitrile (Scheme 2.1).  
15 
 
The neutral copper complexes were synthesized by combining CuCl and 
dmise/dmit in methanol and acetonitrile, respectively, followed by cannula addition of 
tris(3,5-dimethylpyrazolyl)borate (Tp*) in acetonitrile (Scheme 2.1). These neutral 
complexes can also be synthesized by reaction of Tp*Cu(NCCH3) with molar equivalent 
of dmit or dmise in dichloromethane (Scheme 2.1). All of the target metal complexes are 















H NMR spectra 
of [Tpm
R
Cu(L)][X] (R = H; Tpm, R = Me; Tpm*, R = iPr; Tpm
iPr
; L = NCCH3, dmise, or 




), the apical CH proton resonance of the tris(pyrazolyl)methane 
ligand bound to copper is shifted upfield by  0.1 to 0.5 from its position in the free 







 All other proton signals of both the tripodal ligand 
(Tpm
R
) and the chalcogenone (dmise and dmit) are shifted downfield upon Cu
+
 
complexation. This downfield shift of the ligand resonance upon copper coordination is a 
result of increased deshielding effects on the protons upon metal binding. For copper 
complexes with tris(pyrazolyl)borate ligands, the resonance for the BH proton is not 








H} NMR spectroscopy data for the complexed and uncomplexed 
selone and thione ligands are given in Table 2.1 (ligand numbering scheme in Figure 
2.1A). A substantial shift of the C-2 resonance of the dmise and dmit ligands, are 
observed upon complexation to copper. Shifts of  3 to 8 for both the C=Se and C=S 
carbons are also observed upon copper binding, attributed to the shift of the electron 
density from the selenocarbonyl or thiocarbonyl group to the neighboring N-C bond. This 
electron density shift reduces the double bond character of the C=Se or C=S bond while 
increasing that of the C-N single bond, resulting in an upfield shift for the C-2 
resonance.
32,41-43
 This upfield shift is characteristic of selone or thione bound to copper 
via the selenium and sulfur atoms. The increased electron density of the C-N bond upon 
copper complexation results in a minor increases in deshielding effects on C-4 and C-5, 
17 
 






H} NMR spectra, H-4/5 and are shifted downfield and C-2 resonances are shifted 
upfield for the selone copper complexes (δ 6.93 - 7.18 and δ 120.3 - 122.2, respectively) 
and thione copper complexes (δ 6.82 - 7.04 and δ 118.6 - 119.9, respectively) relative to 
the free selone (δ 6.77 and δ 119.7) and thione (δ 6.64 and δ 117.6) compounds (Table 
2.1). These NMR shifts upon selone and thione complexation are consistent with copper 
binding stabilizing the resonance form that places the positive charge into the 







H} NMR resonances for the tris(pyrazolyl) copper selone complexes 1, 
3, 6, and 8 are shifted upfield (δ -31.5 to -95.6) upon selone coordination to copper 
relative to the free dmise ligand (δ -6). The charge of the ligand of the tri(pyrazolyl) 




H} NMR resonance upon 




H} NMR resonance in the neutral 





 (R = H; Tpm; 3, R = Me; Tpm*; 1, R = iPr; 6) show an 
average upfield shift of δ 86.8.  
Notably, the copper complexes with Cl
-









on the methyl and olefinic protons and smaller upfield C-2 resonance shifts of the 









 counterion may compete 




 The presence of mononuclear 
copper complexes with dmise and dmit ligands can be clearly seen from their ESI-mass 
spectra. The fragmentation patterns found for all the complexes are consistent with their 





H} shift ( ) 
1




H} shift (δ) 









Dmise 155.57 119.71 3.53 6.77 -6 
[TpmCu(dmise)][BF4]     (3) 148.90 122.24 3.73 7.15 -95.6 
[Tpm*Cu(dmise)][BF4]   (1) 147.61 121.60 3.88 7.17 -87.5 
[Tpm
iPr
Cu(dmise)][BF4]  (6) 148.12 121.47 3.85 7.18 -95.6 
[Tpm*Cu(dmise)][Cl]     (9) 153.22 119.98 3.75 6.97  
[Tpm
iPr
Cu(dmise)][Cl]   
(12) 
152.03 120.54 3.79 6.98  
Tp*Cu(dmise)                  
(8) 
151.63 120.27 3.75 6.93 -31.5 
dmit  162.42 117.60 3.53 6.64  
[TpmCu(dmit)][BF4]       (4) 154.66 119.90 3.82 7.04  
[Tpm*Cu(dmit)][BF4]     (2) 155.96 119.70 3.80 7.00  
[Tpm
iPr
Cu(dmit)][BF4]    (5) 155.49 119.80 3.77 7.03  
[Tpm*Cu(dmit)][Cl]      
(10) 
156.54 119.42 3.73 6.86  
[Tpm
iPr
Cu(dmit)][Cl]     
(11) 
159.52 118.58 3.70 6.82  
Tp*Cu(dmit)                    (7) 157.45 119.33 3.68 6.83  
 
 
 Molar conductivities of the neutral complexes Tpm
iPr
CuCl and Tpm*CuCl are 















H} NMR  chemical shifts of selone and thione 




contrast, molar conductivities of the cationic complexes 1, 2, 5, and 6 with non-
coordinating BF4
-





1:1 ionic complexes. Conductivities of compounds with Cl
-
 anions (9, 10, 11, and 12) 




, indicating that the Cl
-
 anions compete with thione 
and selone for copper binding. The 
1
H NMR resonances for the H-4/5 protons of the 
copper chloride complexes 9, 10, 11, and 12 (δ 6.82 - 6.98) are closer to the unbound 
ligands compared to complexes 1, 2, 5, and 6 with non-coordinating BF4
-
 counterions (δ 
7.00 – 7.18), corroborating the conductivity measurements.  
 IR Spectroscopy. The acetonitrile copper complexes used as starting materials, 
[Tpm*Cu(NCCH3)][BF4] and [Tpm
iPr
Cu(NCCH3)][BF4] have N≡C stretching 
frequencies of 2272 and 2275 cm
-1
 respectively, comparable to literature reports.
46
 The 
N≡C stretches in these copper acetonitrile complexes are shifted to higher wavenumbers 
relative to free acetonitrile (2250 cm
-1
), indicating an increased N≡C bond strength due to 




 The IR spectrum of dmit shows a C=S 
stretching vibration at ~ 1181 cm
-1
, whereas dmise has a C=Se stretching vibration at 
~1148 cm
-1
, consistent with previous reports for dmit, 1-mesitylimidazole selone, mbit = 
1,1'-methylenebis(1,3-dihydro-3-methyl-2H-imidazole-2-thione), and mbis = 1,1'-
methylene-bis(1,3-dihydro-3-methyl-2H-imidazole-2-selone).
48-50
 Upon copper-dmit 
binding in complexes 2, 4, 5, and 7 this C=S stretch shifts to lower energy, 1172-1178 
cm
-1
, indicative of weak backbonding to the thione ligand. Coordination of dmise to 
copper in Tpm
R
 complexes 1, 3, and 6 results in a slight shift of C=Se stretch to higher 
energy, 1150-1151 cm
-1
, indicating that backbonding interactions with this ligand are not 
20 
 
significant. In contrast, the IR spectrum of Tp*Cu(dmise) (8) shows a slight shift to lower 
energy region for C=Se stretch (1145 cm
-1
) upon coordination of dmise to copper. 
Structural analysis of copper selone and thione complexes. Single crystal X-ray 
diffraction data were collected for [Tpm*Cu(dmise)][BF4] (1), [Tpm*Cu(dmit)][BF4] (2), 
[TpmCu(dmit)][BF4] (4), [Tpm
iPr
Cu(dmise)][BF4] (6), Tp*Cu(dmit) (7) and 
Tp*Cu(dmise) (8) which crystallized as colorless prisms, and for [TpmCu(dmise)][BF4] 
(3), which crystallized as colorless rods. Their structural parameters are summarized in 
Tables 2.5 to 2.11, and their structures are shown in Figures 2.3 to 2.5 and 2.7 to 2.10 
while their packing diagrams are depicted in Figures 2.6, and 2.14 to 2.19. All the Cu
+
 
centers adopt distorted tetrahedral coordination geometry, bound to three nitrogen atoms 
from the tridentate ligand in a κ
3
-fashion, and terminally bound to the heterocyclic 
chalcogenones. The distorted tetrahedral geometries can be seen in the N-Cu-N angles, 
ranging from 84.6 to 92.1º and arise from pinning back of Tpm
R
 and KTp* nitrogen 
atoms due to the small bite angles of these ligands.
51
      
The crystal structure of [TpmCu(dmise)][BF4] (3) is composed of two 
crystallographically-independent molecules in the same unit cell (Figure 2.3; Table 2.5). 
Each copper atom adopts a distorted tetrahedral coordination environment with average 
Cu-N distances of 2.12 Å for Cu(1)-N and 2.13 Å for Cu(1A)-N(A). Mean N-Cu-N 
angles are 87.2º for N-Cu(1)-N and 86.9º for N(A)-Cu(1A)-N(A), respectively. The Cu-
Se bond lengths and Cu-Se-C bond angles are the major differences between the 
molecular geometry of these independent molecules, with the Cu(1A) molecule 
21 
 
exhibiting a bond length of 2.314 Å and an angle of 110.3º and the Cu(1) molecule a 
slightly shorter bond length of 2.294 Å and a much smaller angle of  100.4º.  
Structures of the Tpm, Tpm*, Tpm
iPr
, and Tp* copper selone complexes (1, 3, 6 
and 8; (Figures 2.3, 2.4, 2.5, and 2 7; Table 2.2, 2.3, 2.4 and 2.5) are very similar despite 
the differences in steric bulk of their tris(pyrazolyl)methane ligands and overall charge of 
the ligands. In 1, 3, 6, and 8 the dmise ligand is bound to the copper center with an 
average angle of 105.2º due to the presence of the lone pairs on the selenium atom. The 
Cu-Se bond lengths for 1 (2.30 Å), 3 (2.29 Å and 2.31 Å), and 6 (2.31 Å) are comparable, 
whereas the Cu-Se bond in 8 (2.33 Å) is slightly longer. The Cu-Se bond distances in 1, 
3, 6, and 8 are comparable to the Cu-Se bond distance of  2.30 Å in the 
Cu
III
-bis-diselenolene complex reported by Ribas et al.,
52
 but shorter than most reported 
copper-selenium complexes such as the selone [Cu(1,10-phen)2(C5H10N2Se)][2ClO4] 
(2.49 Å);
36
 the selenolate [CuSe(2,4,6-iPr3C6H2)]2[bipy]2 (2.45 Å);
53
 the selenoether 
[Cu(o- C6H4(SeMe)2)2][PF6] (2.42 Å);
54
and the selenium macrocycle 
[Cu(C11H14Se2)2][BF4] (avg. 2.41 Å).
55
 Short Cu-Se bond distances for 1, 3, 6, and 8 
imply stronger donor interactions between the soft selenium ligand and the soft copper 
metal ion, but only a limited number of non-bridging copper selone complexes are 
available for structural comparison.  
Short interactions of 3.59 Å between selenium atoms are found within the unit 
cell of [Tpm
iPr
Cu(dmise)][BF4] (6), and these interactions are shorter than the sum of 







Cu(1)-N(3) 2.188(6) N(4)-Cu(1)-N(5) 88.8(2) 
Cu(1)-N(4) 2.111(6) N(4)-Cu(1)-N(3) 86.6(2) 
Cu(1)-N(5) 2.053(6) N(5)-Cu(1)-N(3) 86.1(2) 
Cu(1)-Se(1) 2.2941(13) N(3)-Cu(1)-Se(1) 122.35(17) 
C(1)-Se(1)  N(4)-Cu(1)-Se(1) 132.94(17) 
  N(5)-Cu(1)-Se(1) 125.80(17) 
Cu(1A)-N(3A) 2.111(6) N(4A)-Cu(1A)-N(5A) 86.20(3) 
Cu(1A)-N(4A) 2.094(7) N(4A)-Cu(1A)-N(3A) 87.4(3) 
Cu(1A)-N(5A) 2.184(7) N(5A)-Cu(1A)-N(3A) 87.0(3) 
Cu(1A)-Se(1A) 2.3120(13) N(3A)-Cu(1A)-Se(1A) 114.74(17) 
C(1A)-Se(1A)  N(4A)-Cu(1A)-Se(1A) 145.41(18) 
  N(5A)-Cu(1A)-Se(1A) 119.49(18) 
Figure 2.3. Crystal structure diagram (50% probability ellipsoids) of 
[TpmCu(dmise)][BF4] (3) showing the two crystallographically independent 
molecules. Counterion and hydrogen atoms are omitted for clarity. 
Table 2.2. Selected bond lengths (Å) and angles (°) for the two 








Cu(1)-N(3)            2.126(2) N(4)-Cu(1)-
N(5)            
88.66(10) 
Cu(1)-N(4)            2.063(3) N(4)-Cu(1)-
N(3)            
87.66(10) 
Cu(1)-N(5)            2.089(2) (5)-Cu(1)-
N(3)            
85.67(9) 
Cu(1)-Se(1)           2.2981(6) ( )-Cu(1)-
Se(1)           
125.46(7) 
Se(1)-C(1)             1.868(3) N(4)-Cu(1)-
Se(1)           
132.37(7) 
  N(5)-Cu(1)-






Figure 2.4. Crystal structure diagram of [Tpm*Cu(dmise)][BF4] (1) displaying 
50% probability density ellipsoids. Hydrogen atoms and counterion are 
omitted for clarity. 
 









Cu(1)-N(3)            2.058(4) N(4)-Cu(1)-N(5)            84.62(16) 
Cu(1)-N(4)            2.095(4) N(4)-Cu(1)-N(3)            88.44(16) 
Cu(1)-N(5)            2.189(4) N(5)-Cu(1)-N(3)            85.43(16) 
Cu(1)-Se(1)           2.3126(8) N(3)-Cu(1)-Se(1)           130.52(11) 
Se(1)-C(1)             1.858(5) N(4)-Cu(1)-Se(1)           124.40(11) 
  N(5)-Cu(1)-Se(1)           128.71(10) 
  C(1)-Se(1)-Cu(1) 104.62(13) 
Figure 2.5. Crystal structure diagram of [Tpm
iPr
Cu(dmise)][BF4] (6) 
displaying 50% probability density ellipsoids. Hydrogen atoms and counterion 
are omitted for clarity.  
 









The copper(I) thione complexes 2, 4, and 7 are tetrahedrally coordinated via the 
three nitrogen atoms of the Tpm* (2), Tpm (4), or Tp* (7), ligands and the sulfur atom of 
dmit (Figures 2.9, 2.10, and 2.11; Tables 2.8, 2.9, and 2.10). The average Cu-N distance 
of 2.10 Å in complex 7 is similar to complex 2, but shorter compared to Cu-N distances 
of 2.12 Å in complex 4. 
Figure 2.6. Crystal packing diagram of [Tpm
iPr
Cu(dmise)][BF4] (6) at 50% 
probability density ellipsoids displaying short Se-Se interactiona along the a-









Cu(1)-N(2)        2.033(4) N(2)-Cu(1)-N(3)    92.05(10) 
Cu(1)-N(3)      2.120(2) N(2)-Cu(1)-N(3A ) 92.05(10) 
Cu(1)-N(3A)         2.120(2) N(3)-Cu(1)-N(3A)     87.53(13) 
Cu(1)-Se(1) 2.3299(9) N(2)-Cu(1)-Se(1)          135.23(10) 
Se(1)-C(1)              1.864(4) N(3)-Cu(1)-Se(1)   118.86(7) 
  N(3A)-Cu(1)-Se(1)          118.86(7) 
  C(1)-Se(1)-Cu(1)          103.63(13) 
Figure 2.7. Crystal structure diagram of Tp*Cu(dmise) (8) displaying 50% 
probability density ellipsoids. Hydrogen atoms are omitted for clarity. 
 
Table 2.5. Selected bond lengths (Å) and angles (°) for complex 8. 
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The thione ligand is bound to the copper ion at almost identical C-S-Cu angles in 
complexes 4 (106.9º) and 7 (105.6º), but the angle increases to 111.3º in complex 2. 
Complex 7 has a Cu-S bond distance of 2.22 Å, slightly longer than the observed bond 
length of 2.19 Å for complex 2 and 2.20 Å for complex 4. The Cu-S bond lengths of 
complexes 2, 4, and 7 are shorter than previously-reported copper thione complexes such 
as [Cu(PPh3)2(bzimH2)Cl] (2.38 Å),
34









 however, the 
Cu-S bond lengths of complexes 2, 4, and 7 are longer than those copper thiolate 






Changing the alkyl substituents on the 3 and 5 positions of the pyrazole ring has 
minor effects on Cu-Se/S bond distances and Cu-Se/S-C(1) bond angles. In addition, the 
overall charge of the tris(pyrazolyl) ligand has very little effect on the structure of copper 
thione complexes. Complex 7 with the negatively charged Tp* ligand has slightly larger 
N-Cu-N angles (avg. 90.5º) compared to the neutral Tpm and Tpm* ligands (avg. 87.2º). 
The Cu-S bond distance of 2.19 Å in [Tpm*Cu(dmit)][BF4] (2) is slightly shorter relative 
to 2.22 Å in the neutral complex Tp*Cu(dmit) (7).  
The average Cu-N bond lengths and N-Cu-N angles in complexes 1, 2, 3, 4, and 6 
are comparable to other tris(pyrazolyl)methane copper(I) complexes such as 







Cu(NCCH3)][PF6] (2.06-2.14 Å, 89.2º),
51







Cu-N(3)        2.095(2) N(3)-Cu-N(4)    88.49(8) 
Cu-N(4)         2.077(2) N(3)-Cu-N(5)     85.23(8) 
Cu-N(5)         2.1334(19) N(4)-Cu-N(5)     87.40(8) 
Cu-S              2.191(8) N(3)-Cu-S          125.20(6) 
S-C(1)           1.709(3) N(4)-Cu-S          130.45(6) 
  N(5)-Cu-S          126.07(6) 
  C(1)-S-Cu          111.30(9) 
 
Figure 2.8. Crystal structure diagram of [Tpm*Cu(dmit)][BF4] (2) 
showing 50% probability density ellipsoids. Hydrogen atoms and 
counterion are omitted for clarity. 
 








Cu-N(3)        2.128(2) N(3)-Cu-N(4)    88.73(9) 
Cu-N(4)         2.121(2) N(3)-Cu-N(5)     87.82(9) 
Cu-N(5)         2.117(2) N(4)-Cu-N(5)     85.5(10) 
Cu-S              2.202(7) N(3)-Cu-S          111.8(6) 
S-C(1)           1.711(3) N(4)-Cu-S          133.15 
  N(5)-Cu-S          134.51 
  C(1)-S-Cu          106.8(9) 
Figure 2.9. Crystal structure diagram of [TpmCu(dmit)][BF4] (4) 
showing 50% probability density ellipsoids. Hydrogen atoms and 
counterion are omitted for clarity. 
 






Cu-N(3)        2.1248(16) N(3)-Cu-N(4)    92.09(7) 
Cu-N(3A)      2.1248(16) N(3A)-Cu-N(5)  92.09(7) 
Cu-N(4)         2.039(2) N(4)-Cu-N(5)     87.23(9) 
Cu-S              2.219(9) N(3)-Cu-S          119.14(5) 
S-C(1)           1.708(3) N(3A)-Cu-S       119.14(5) 
  N(4)-Cu-S          134.84(7) 
  C(1)-S-Cu          105.62(10) 
Figure 2.10. Crystal structure diagram of Tp*Cu(dmit) (7) showing 50% 
probability density ellipsoids. Hydrogen atoms are omitted for clarity. 
 






Cu(CO)][PF6] (avg. 2.05 Å,88.1º).
40
 The neutral Tp* complexes 7 and 8 have 
average N-Cu-N bond angles of 90.5º, larger than those of complexes 1 (87.3º), 2 (87.1º), 
3 (87.3º and 86.9º), 4 (87.4º), 6 (86.2°) and K[Tp*Cu(SC6H4NO2)]·2C3H6O (88.9º),
61
 but 
similar to or slightly smaller than the previously reported Tp
iPr





 complexes.  
Coordination of the dmise ligand to copper results in slightly shorter Se-C(1) 
bond lengths of 1.87 Å  in complex 1 and 1.86 Å in complexes 6 and 8 relative to that of 
the uncoordinated ligand (1.89 Å),
27
 whereas for complex 3, this bond length is relatively 
unchanged compared to unbound dmise (1.89, Se(1)-C(1A) and 1.87 Å, Se(1A)-C(1A)). 
This slight shortening of the C=Se bond may be a result of donor bond formation 
between dmise and copper. Coordination of the thione ligand to copper in complexes 2, 
4, and 7 results in almost identical S-C(1) bond distances (1.71 Å), longer than the S-C(1) 
bond distance (1.68 Å) in the free thione ligand.
62
 Thus, the C=S bond is weakened due 
to back bonding from the copper. Based upon IR data and C=S/Se bond distances of the 
ligands before and after coordination, dmit is a better pi-acceptor than dmise but is a 
weak pi-acceptor relative to ligands such as CO that show slight elongation of the CO 
bond distance and a large shift of the C-O bond stretch to lower wavenumbers (~50 cm
-1
) 
in the IR spectrum upon copper coordination.
40
 
It has been reported that the strength of the metal-chalcogenone bond can be 




H} NMR shift difference for the C-2 resonance upon 
complexation of selone or thione ligands.
42,63,64
 Popovic, et al.,
42







H} NMR resonance shifts vs. Hg-S bond lengths for three complexes, 
but this reported trend does not correlate with a shift of ν(C=S) to lower energies in the 
reported IR spectra. Isab and coworkers,
63,64





NMR data with no corresponding structural data. To determine whether our data 






C-2 resonance shifts for our 
complexes (Table 4) with their Cu-S/Se bond lengths from the X-ray crystallographic 
data. For the copper selone complexes, the largest C-2 resonance shift of  8 compared to 
unbound dmise was found for [Tpm*Cu(dmise)][BF4] (1), but its Cu-Se bond length of 
2.298 Å is not statistically different from the average bond length of 2.303 Å for 
[TpmCu(dmise)][BF4] (3) with a C-2 resonance shift of  6. [Tpm
iPr
Cu(dmise)][BF4] (6) 
and Tp*Cu(dmise) (8) have C-2 resonance shifts of δ 7 and δ 4, respectively, compared 
to unbound dmise and slightly longer Cu-Se bond lengths of 2.313 Å and 2.330 Å, 
respectively. For the copper thione complexes, the largest C-2 resonance shift of  8 
relative to the unbound dmit was found for [TpmCu(dmit)][BF4] (4) with the 
second-shortest Cu-S bond distance of 2.20 Å. [Tpm*Cu(dmit)][BF4] (2) has the shortest 
Cu-S bond distance of  2.19 Å and a C-2 resonance shift of  7. The neutral complex 
Tp*Cu(dmit) (7) has a C-2 resonance shift of  5 compared to the unbound dmit and a 
slightly longer Cu-S bond distance of 2.22 Å. Thus, although we observed consistent 




H} NMR spectra of complexes 1 to 12 
upon dmise and dmit coordination to copper, no specific correlation is observed between 




Electrochemical studies of selone and thione ligands and their copper complexes. 
The electrochemical behavior of the chalcogenone ligands and their copper(I) complexes 
were examined by cyclic voltammetry to determine the difference in redox potentials 
between dmise and dmit as well as the change in the Cu
2+/+
 redox potential upon Cu-
selone or Cu-thione coordination. The free selone has a more negative reduction potential 
(E ) compared to the thione: E1/2 = -367 mV and -169 mV, respectively, versus normal 
hydrogen electrode (NHE), and both ligands exhibit quasi-reversible electrochemical 
behavior (Figure 2.11). The lower reduction potential of the selone relative to that of the 
thione implies that selone is a better reducing agent, thus it may possess greater 








 redox potentials of the copper selone and thione complexes versus 
NHE are given in Table 2.12. The cyclic voltammograms (CV) of these complexes 
Figure 2.11. Cyclic voltammetry (CV) scans for dmise (A) and dmit (B). All 










 reduction and oxidation processes, as shown in Figure 2.12 (CV spectra for all 
complexes are provided in Figures 2.13). At negative potentials, a peak corresponding to 
the Cu
+/0 
reduction commences at potentials more negative than -1242 mV. After 
switching the scan direction, the Cu
0




The acetonitrile complexes [Tpm
iPr
Cu(NCCH3)][BF4], [Tpm*Cu(NCCH3)][BF4], 
and [TpmCu(NCCH3)][BF4] show large peak separations between the cathodic and 
anodic waves for the Cu
2+/+
 oxidation and reduction potentials compared to the copper 
selone and thione complexes, suggesting quasi-reversible electrochemical behavior. This 
large separation may indicate that the oxidized or reduced products are not stable enough 
to remain intact, due to slow electron transfer kinetics during the voltammetry sweep,
69
 or 
may indicate a large reorganization energy upon shifting from a distorted tetrahedral Cu
+
 





The redox potentials of the copper selone complexes decrease significantly 
compared to those of the thione copper complexes. Complexation of selone and thione 
ligand to [Tpm*Cu(NCCH3)][BF4] lowers the Cu
2+/+
 redox potential by 635 mV and 374 





redox potential is reduced by 847 mV and 617 mV, respectively. Thus, dmise 
coordination stabilizes the Cu
2+
 metal center more effectively than dmit coordination by 






Effect of ligands and counterions on the Cu
+/2 
redox potential. For the copper 
selone and thione complexes (1, 2, 3, 4, 5, and 6) the bulkier the tris(pyrazolyl)methane 
ligand on the 3 and 5 positions of the pyrazole rings, the more negative the Cu
2+/+
 redox 
potentials. The electron donating ability of the alkyl substituents is: iPr > Me > H. For the 
copper selone complexes, the redox potentials are shifted to lower voltages in the 
following order: [TpmCu(dmise)][BF4] (3) (-283 mV) > [Tpm*Cu(dmise)][BF4] (1) (-
366 mV) > [Tpm
iPr
Cu(dmise)][BF4] (6) (-0.390 mV). Despite the analogous copper 
thione complexes having higher positive potentials, the same trend is observed: 
[TpmCu(dmit)][BF4] (4) (70 mV) > [Tpm*Cu(dmit)BF4] (2) (-105 mV) > 
[Tpm
iPr
Cu(dmit)][BF4] (5) (-160 mV). The partially-negatively-charged chalcogenone 





Figure 2.12. Cyclic voltammetry (CV) scan for Tp*Cu(dmise) (dashed line) 




results in a more negative Cu
2+/+
 redox potential. In contrast, for the acetonitrile 
complexes [Tpm
R
Cu(NCCH3)][BF4]  (R = H, Me, iPr), increased steric bulk of the alkyl 
substituents on the 3 and 5 position of the pyrazole rings results in a more positive Cu
2+/+
 
potential: [TpmCu(NCCH3)][BF4] (-219 mV) < [Tpm*Cu(NCCH3)][BF4] (269 mV) < 
[Tpm
iPr
Cu(NCCH3)][BF4] (457 mV). Thus, increasing the steric bulk on the 3 and 5 
positions of the pyrazole rings results in increased thermodynamic stability of the 
copper(I) acetonitrile complexes, due to increased electron donating ability of the alkyl 
groups on the 3 and 5 positions of the pyrazole ring. The same increase to more positive 
Cu
2+/+
 potentials with increased steric bulk and electron donating ability on the 3 position 
of the pyrazole ring in copper acetonitrile complexes with tris(pyrazolyl)methane type 
ligands was observed by Fujisawa et al.
40
 
 The selone compound 1 with the neutral Tpm* ligand has slightly more negative 
Cu
2+/+
 potentials (-366 mV) relative to the complex 8 with anionic Tp* ligand (-346 mV).  
For the copper thione complexes, complex 7 with the anionic Tp* ligand has significantly 
more negative potential (-232 vs. -105 mV) compared to complex 2 with the neutral 
Tpm* ligand, an effect similarly observed for Tp*Cu(NCCH3) (-349 mV) vs. 
[Tpm*Cu(NCCH3)][BF4] (269 mV). Fujisawa et al. also observed more negative 
potentials for Tp
iPr
Cu(NCCH3) relative to [Tpm
iPr
Cu(NCCH3)][PF6] and determined that 
the borate ligands are more electron donating than the methane ligands.
40
 It is expected 
that the negatively-charged borate ligands coupled with the partially-negatively-charged 
chalcogenone will stabilize Cu
2+
 relative to Cu
+
 vs. the neutral Tpm* ligand, resulting in 





Biological significance of selenium coordination. Although dmit and dmise are 





respectively, which are sulfur and selenium containing antioxidants found in plants and 
animals. Yamashita, et al.
16
 found that selenoneine is the major selenium compound 
found in tuna and mackerel blood (~0.45 M concentration) and is a very potent radical 
scavenger. Dmit is also structurally similar to methimazole,
14
 a thione drug currently used 
for treatment of hyperthyrodism. Mugesh, et al. has demonstrated the abilities of dmit 
and dmise to protect against peroxynitrite-mediated protein tyrosine nitration
71
 and 
similar compounds such as selenoneine have been shown to be very potent radical 
   Cu
2+/+ 
   Cu
+/0 
  
















[TpmCu(dmise)][BF4]          (3) -30 -536 506 -283 -915 -1303 324 -760 
[Tpm*Cu(dmise)][BF4]        (1) -88 -644 556 -366 -905 -1494 589 -1199 
[Tpm
iPr
Cu(dmise)][BF4]         (6) -49 -729 680 -390 -888 1257 370 -1070 
Tp*Cu(dmise)                      (8) -122 -570 448 -346 -1072 -1444 372 -1258 
[Tpm*Cu(dmise)][Cl]           (9) -30 -752 722 -376 -803 -1305 502 -1053 
[Tpm
iPr
Cu(dmise)][Cl]         (12) 11 -643 654 -316 -920 -1448 525 -1184 
[TpmCu(NCCH3)][BF4]  203 -641 844 -219 -598 -922 324 -760 
[Tpm*Cu(NCCH3)][BF4]  1158 -620 1778 269 -363 -1297 934 -830 
Tp*Cu(NCCH3)  -51 -647 596 -349 -824 -1247 423 -1036 
Tpm*CuCl  46 -450 496 -202 -723 -1645 922 -1184 
dmise
a
  39 -773 812 -367     
[TpmCu(dmit)][BF4]             (4) 392 -252 644 70 -932 -1295 363 -1113 
[Tpm*Cu(dmit)][BF4]           (2) 307 -518 825 -105 -789 -1371 582 -1080 
[Tpm
iPr
Cu(dmit)][ BF4]         (5) 187 -507 694 -160 -967 -1181 214 -1074 
Tp*Cu(dmit)                        (7) 147 -611 758 -232 -980 -1566 586 -1273 
[Tpm*Cu(dmit)][Cl]            (10) -15 -341 326 -163 -785 -1349 564 -1067 
[Tpm
iPr
Cu(dmit)][Cl]           (11) 9 -291 300 -141 -908 -1442 534 -1175 
[Tpm
iPr
Cu(NCCH3)][BF4]  1254 -340 1594 457 -332 -1248 916 -790 
Tpm
iPr
CuCl                        280 -18 298 131 -467 -1370 903 -918 
dmit
a
  424 -761 1158 -167     




 potentials of synthesized 
copper complexes vs. NHE. 






 Dmise and dmit also prevent copper-mediated DNA damage.
72
 The 
electrochemical data obtained from the target metal complexes provides insight as to 
whether similar Se-Cu complexes formed in vivo could cycle between the Cu
2+/+
 forms. 
Complexes with reduction potentials lower than -324 mV (versus NHE) cannot be 
reduced by cellular reductants such as NADH.
73
 The copper selone complexes have a 
reduction potential range of -283 to -390 mV, whereas copper thione complex potentials 
range from 70 to -232 mV versus NHE. Thus, copper selenium complexes have 
significantly lower potentials than analogous copper-sulfur complexes, and most are 
more negative than that of NADH. Therefore, if similar complexes are formed in vivo, 
these potentials may be low enough to prevent Cu
2+
 reduction by NADH, making the 
Fenton-like reaction of copper non-catalytic, and inhibiting generation of hydroxyl 





 selone and thione complexes with 
tris(pyrazolyl)methane and tris(pyrazolyl)borate ligands have been synthesized and 
characterized, and their electrochemistry has been investigated and compared. The 
copper-selone complexes [Tpm*Cu(dmise)][BF4] (1), [TpmCu(dmise)][BF4] (3), 
[Tpm
iPr
Cu(dmise)][BF4] (6), and Tp*Cu(dmise) (8) possess the shortest copper-selone 
bond distances reported. The copper-thione complexes [Tpm*Cu(dmit)][BF4] (2), 
[TpmCu(dmit)][BF4] (4), and Tp*Cu(dmit) (7) have Cu-S bond lengths ranging from 
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2.19 - 2.22 Å. Changing the alkyl groups on the 3 and 5 positions of the pyrazole ring has 
little effect on the Cu-Se or Cu-S bond lengths, but has dramatic effects on the Cu
2+/+
 




H} NMR data predicts stronger Cu-Se bonding 
in [Tpm*Cu(dmise)][BF4] (1) relative to [TpmCu(dmise)][BF4]  (3) and 
[Tpm
iPr
Cu(dmise)][BF4]  (6), although little variation is observed in the Cu-Se bond 
distances. The dmise ligand coordination stabilizes the Cu
2+
 center more effectively than 
dmit coordination by an average of 224 mV. The results obtained in this study give us 
insight into possible alternative explanation about the antioxidant abilities of selenium 
and sulfur compounds. Since reduction potentials of the copper selone complexes are 
more negative than the copper thione complexes, if similar complexes are formed in vivo, 
these potentials may be low enough to inhibit Cu
2+
 reduction by NADH and prevent 
copper redox cycling. 
 
Experimental section 
Materials. The synthesis and manipulation of all copper complexes was 
performed under an inert atmosphere of argon or nitrogen using standard Schlenk 
techniques. Acetonitrile, methanol, and ether were purified using standard procedures and 
freshly distilled under argon atmosphere prior to use. The following compounds were 

































 The following reagents were used as received: 
cuprous chloride (Aldrich), 3,5-dimethyl-1-pyrazole (Aldrich), tetra-n-butylammonium 
bromide (Aldrich), sodium carbonate (VWR), selenium powder, sulfur powder, cuprous 
oxide (stabilized; Aldrich), diisobutyrylmethane (VWR), hydrazine monohydrate (VWR), 















H} NMR spectra were obtained 




H} NMR spectra 






H} NMR chemical 








H} NMR spectra were externally referenced to CCl3F (  0)
78
 






H} NMR chemical shifts were 
externally referenced to diphenyl diselenide (δ 461),
80
 and reported relative to dimethyl 
selenide (δ 0). 
Electrochemical experiments were performed with a BAS 100B potentiostat. A 
three compartment cell was used with an Ag/AgCl reference electrode, Pt counter 
electrode, and a glassy carbon working electrode. Freshly-distilled acetonitrile was used 
as the solvent with tetra-n-butylammonium phosphate as the supporting electrolyte (0.1 
M). Solutions containing 1 mmol
 
analyte were deaerated for 2 min by vigorous nitrogen 
purge. The measured potentials were corrected for junction potentials relative to 
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ferrocenium/ferrocene (0.543 mV vs. Ag/AgCl).
81
 All E1/2 values were calculated from 
(Epa + Epc)/2 at a scan rate of 100 mV/s, and ΔE = Epa - Epc. Cyclic voltammograms of 
selone and thione ligands (Figure 11) and their copper complexes showing the Cu
+/2+
 
potentials are given in Figures 13-15. Resistivity for each complex was measured in DMF 
solution (0.1 mM) at 25°C using a GDT-11 multimeter and converted to molar electrical 
conductivity. 
Infrared spectra were obtained using Nujol mulls on KBr salt plates with a Magna 
550 IR spectrometer. Abbreviations used in the description of vibrational data are as 
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization 
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System 
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a 
Turbo Ionspray ionization source. Samples were run under positive mode, with ionspray 
voltage of 5500 V, and TOF scan mode. Melting points were determined using a 
Barnstead Electrothermal 9100 apparatus in silicon-grease-sealed glass capillary tubes. 
Absorption spectra were collected using a Varian Cary-50 Bio spectrophotometer in 
quartz cuvettes with a path length of 1 cm. Elemental analysis was performed by Atlantic 
Microlabs, Inc.Preparation of complexes. [Tpm*Cu(dmise)][BF4] (1) Method 1: The 
dmise ligand (176 mg, 1 mmol) was dissolved in acetonitrile (20 mL) and was cannula 
transferred into a solution of [Cu(CNCH3)4][BF4] (312 mg, 1 mmol) in acetonitrile (20 
mL). The reaction mixture was stirred at room temperature for 3 h until it was clear and 
colorless. An equimolar amount of Tpm* (298 mg, 1 mmol) was then dissolved in 
acetonitrile (10 mL) and cannula transferred into the reaction mixture and stirred for an 
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additional 18 h. The solvent volume in the reaction mixture was reduced to about 4 mL 
and the product was precipitated with diethyl ether to afford an off-white solid that was 
dried in vacuo and analyzed. Yield 78% (486 mg, 0.78 mmol). 
 Method 2: [Tpm*Cu(NCCH3)][BF4]
51
 (250 mg, 0.5 mmol) was dissolved in 
dichloromethane (10 mL) and into this was cannula transferred dmise (90 mg, 0.5 mmol) 
in dichloromethane (10 mL). The reaction mixture was stirred for 3 h, and the solvent 
volume reduced to about 3 mL. The product was precipitated with diethyl ether to afford 
an off-white solid that was dried in vacuo and analyzed. Single crystals for X-ray analysis 
were grown from slow vapor diffusion of ether into acetonitrile solution. Yield: 89% (277 
mg, 0.445 mmol). 
1
H NMR (CD2Cl2): 2.18 (s, 9H, 3CH3), 2.541 (s, 9H, 3CH3), 3.88 (s, 




H} NMR (CD2Cl2): 10.72 (CH3), 13.16 (CH3), 37.58 (CH3 [dmise], 67.86 (CH), 


















H} NMR (CD2Cl2): -87.5. IR (cm
-1
): 481 s, 520 vs, 582 s, 610 s, 630 vs, 
661 vs, 703 s, 739 vs, 793 vs, 815 s, 853 w, 900 vs, 980 s, 1031 b, 1150 vs, 1239 b, 1306 
w, 1454 w, 1569 s, 1688 s, 2362 s, 2722 s, 3141 s, 3171 s, 3423 b. UV-vis (CH3CN): 273 
nm. Mp: 169-172
◦









. Anal. Calc. for C21H30BCuF4N8Se: 
C, 40.43; N, 17.96; H, 4.86. Found: C, 40.19; N, 17.74; H, 4.84. 
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[Tpm*Cu(dmit)][BF4] (2). Complex 2 was prepared following the procedure for 1 
using both methods except that dmit (1 mmol, 129 mg) was used in place of dmise. 
Yield: method 1, 64% (368 mg, 0.640 mmol); method 2, 78% (451 mg, 0.780 mmol). 
Single crystals for X-ray analysis were grown from slow vapor diffusion of ether into 
acetonitrile solution. 
1
H NMR (CD2Cl2): 2.18 (s, 9H, 3CH3), 2.53 (s, 9H, 3CH3), 3.80 (s, 




H}  NMR: 10.72 (CH3), 13.11 (CH3), 35.82 (CH3 [dmit]), 67.79 (CH), 106.74 (C-4 













H} NMR (CD3CN): -1.43. IR (cm
-1
): 481 
s, 520 s, 582 s, 611 m, 630 vs, 672 vs, 703 s, 734 vs, 751 vs, 795 m, 816 s, 854 m, 900 vs, 
976 s, 1058 b, 1149 vs, 1171 vs, 1239 m, 1306 s, 1393 b, 1570 s, 1676 s, 2723 s, 3141 vs, 
3171 vs, 3351 w. UV-vis (CH3CN): 273 nm. Mp: 167-170
◦














. Anal. Calc. for C21H30BCuF4N8S: C, 43.72; N, 
19.42; H, 5.24. Found: C, 43.78; N, 19.36; H, 5.27. 
 [TpmCu(dmise)][BF4] (3). Complex 3 was prepared following the procedure for 1 
using both methods except that Tpm (214 mg, 1 mmol) was used in place of Tpm*. 
Yield: method 1, 83% (447 mg, 0.83 mmol); method 2, 87% (471 mg, 0.87 mmol). 
Single crystals for X-ray analysis were grown from slow vapor diffusion of ether into a 
methanol solution. 
1
H NMR (CD3CN): 3.73 (s, 6H, CH3 [dmise]), 6.45 (b, 3H, CH [Pz]), 




H} NMR (CD3CN): 38.02 (CH3 [dmise]), 81.9 (CH), 107.87 (4-CH [Pz]), 122.24 
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H} NMR (CDCl3): -95.6. IR (cm
-
1
): 521 w, 603 w, 611 w, 656 w, 723 s, 761 vs, 799 vs, 815 vs, 917 w, 961 w, 978 w, 
1093 b, 1208 w, 1233 s, 1275 s, 1307 vs, 1351 s, 1379 vs, 1396 s, 1458 vs, 1507 s, 1522 
s, 1540 w, 1570 w, 1652 w, 1700 w, 2337 w, 2361 w, 2724 w, 2920 b, 3133 b. Mp: 204-





. Anal. Calc. for C15H18BCuF4N8Se: C, 33.38; N, 20.76; H, 3.36. Found: 
C, 33.17; N, 20.55; H, 3.34 
 [TpmCu(dmit)][BF4] (4). Complex 4 was prepared following the procedure for 1 
using both methods except that Tpm (214 mg, 1 mmol) and dmit (129 mg, 1 mmol) were  
used in place of Tpm* and dmise. Yield: method 1, 79% (389 mg, 0.791 mmol); method 
2, 75% (368 mg, 0.749 mmol). Single crystals for X-ray analysis were grown from slow 
vapor diffusion of ether into a methanol solution. 
1
H NMR (CD2Cl2): 3.82 (s, 6H, CH3 
[dmit]), 6.35 (t, JHH = 2 Hz, 3H, CH [Pz]), 7.04 (s, 2H, CH [dmit]), 7.53 (d, JHH = 2 Hz, 





(CD2Cl2): 35.93 (CH3 [dmit]), 76.08 (CH), 106.65 (4-CH [Pz]), 119.90 (2CH [dmit]), 




H} NMR (CD2Cl2): -






): 520 w, 613 vs, 661 w, 671 s, 719 vs, 750 
vs, 772 vs, 794 vs, 851 vs, 921 w, 970 s, 1020 b, 1092 b, 1174 s, 1232 s, 1242 vs, 1258 
w, 1288 vs, 1307 w, 1377 s, 1400 vs, 1464 vs, 1512 s, 1542 w, 1571 s, 2361 w, 2727 w, 
2925 b, 3016 w, 3107 w, 3137 w, 3173 w. Mp: 205-207ºC.  UV-vis (CH3CN): 273 nm. 









. Anal. Calc. for C15H18BCuF4N8S: C, 36.56; N, 22.74; H, 3.68. Found: C, 
36.61; N, 22.77; H, 3.63. 
 [Tpm
iPr
Cu(dmit)][BF4] (5). Complex 5 was prepared following the procedure for 
1 using both methods except that Tpm
iPr 
( 466 mg, 1 mmol) and dmit (129 mg, 1 mmol) 
were  used in place of Tpm* and dmise, respectively. Yield: method 1, 83% (617 mg, 
0.83 mmol). 
 Synthesis of complex 5 by method 2 was conducted following procedure for 1, 




 (660 mg, 1 mmol) was 
dissolved in dichloromethane (10 mL) and into this was cannula transferred dmit (128 
mg, 1 mmol) in dichloromethane (10 mL). The reaction mixture was stirred for 3 h, and 
the solvent volume reduced to about 3 mL. The product was extracted with diethyl ether 
to afford a yellowish solution that was dried in vacuo and analyzed. Yield: 87% (648 mg, 
0.872 mmol). Single crystals for X-ray analysis were grown via slow vapor diffusion of 
ether into dichloromethane solution. 
1
H NMR (CD2Cl2) : 1.19 (d, JHH = 7 Hz, 18H, 
3(CH3)2) , 1.33 (d, JHH = 7 Hz, 18H, 3(CH3)2) , 2.96 (sept, JHH = 7 Hz, 3H, 3CH), 3.12 
(sept, JHH = 6.75 Hz, 3H, 3CH), 3.77 (s, 6H, 2CH3 [dmit]), 6.05 (s, 3H, 3CH [Pz]), 7.03(s, 




H} NMR (CD2Cl2): 22.31 (CH(CH3)2), 22.88 
(CH(CH3)2), 26.18 (CH(CH3)2), 27.84 (CH(CH3)2), 35.81 (CH3 [dmit]), 67.28 (CH), 












(CD2Cl2): -4.69. IR (cm
-1
): 520 s, 582 s, 633 s, 669 vs, 695 s, 723 s,743 s, 799 s, 821 
46 
 
vs,879 s, 902 s, 914 s, 1005 s, 1053 b, 1180 vs, 1235 vs, 1289 s, 1366 s, 1394 m, 1464 w, 
1556 vs, 1569 s,1682 b, 1737 s, 2126 b, 2359 b, 2727 b, 3139 s, 3167 s, 3364 b. Mp: 
232
◦


















. Anal. Calc. for C33H54BCuF4N8S: C, 53.23; N, 15.15; H, 
7.26. Found: C, 53.44; N, 14.92; H, 7.42.  
 [Tpm
iPr
Cu(dmise)][BF4] (6). Complex 6 was prepared following the procedure 
for 1 using both methods except that Tpm
iPr
 (466 mg, 1 mmol) was used in place of 
Tpm*. Yield: method 1, 62% (491 mg, 0.619 mmol). Method 2 was modified as stated in 
procedure for 5. Yield: 67% (530 mg, 0.67 mmol). Single crystals for X-ray analysis 
were grown via slow vapor diffusion of ether into dichloromethane solution. 
1
H NMR 
(CD2Cl2): 1.17 (d, JHH = 7 Hz, 18H, 3(CH3)2), 1.32 (d, JHH = 7 Hz, 18H, 3(CH3)2), 2.98 
(sept, JHH = 6 Hz, 3H, 3CH), 3.11 (sept, JHH = 6.75 Hz, 3H, 3CH), 3.85 (s, 6H, 2CH3 





NMR (CD2Cl2): 22.40 (CH(CH3)2),  22.87 (CH(CH3)2), 26.19 (CH(CH3)2), 27.82 
(CH(CH3)2), 37.57 (CH3 [dmise]), 67.50 (CH), 99.64 (4-CH [Pz]), 121.47 (2CH [dmise]), 




H} NMR (CD2Cl2): 













(CDCl3): -95.6. IR (cm
-1
): 520 s, 583 s, 669 vs, 694 s, 723 s, 746 vs, 797 vs, 821 b, 878 s, 
902 s, 914 vs, 928 s, 964 s, 1004 s, 1044 b, 1150 s, 1182 s, 1234 b, 1289 b, 1383 b, 1458 
b, 1556 s, 1679 s, 2125 s, 2359 s, 2728 s, 3139 s, 3165 s, 3357 b. Mp: 234
◦
C. UV-vis 















. Anal. Calc. for C33H54CuN8SeBF4: 
C, 50.04; N, 14.15; H, 6.87. Found: C, 49.92; N, 14.23; H, 6.99. 
 Tp*Cu(dmit) (7). Method 1: The dmit ligand (134 mg, 1 mmol) was dissolved in 
acetonitrile (20 mL) and was cannula transferred into a solution of CuCl (99 mg, 1 mmol) 
in methanol (20 mL). The reaction mixture was stirred at room temperature for 3 h, and 
an equimolar amount of KTp* (330 mg, 1 mmol) dissolved in acetonitrile was cannula 
transferred into the reaction mixture, stirred for 18 h and dried in vacuo. The target 
product was extracted using dichloromethane and the filtrate was dried in vacuo and 
analyzed. Single crystals suitable for X-ray structure determination were grown by slow 
diffusion of ether into methanol/dichloromethane solution. Yield 75% (365 mg, 0.75 
mmol). 
 Method 2: [Tp*Cu(NCCH3)] (200 mg, 0.5 mmol) was dissolved in 
dichloromethane (10 mL) and dmit (90 mg, 0.5 mmol) in dichloromethane (10 mL) was 
added. The reaction mixture was stirred for 3 h, dried in vacuo and the solid product 
washed with hexane to afford a white precipitate which was filtered, dried in vacuo, and 
analyzed. Yield 89% (217 mg, 0.445 mmol). 
1
H NMR (CDCl3): 1.70 (s, 9H, 3(CH3)), 





H} NMR (CDCl3):  13.25 (CH3), 13.64 (CH3), 36.08 (CH3 [dmit]), 104.79 
(C-4 [Pz]), 119.33 (2CH [dmit]), 144.60 (C-3 [Pz]), 148.31 (C-5 [Pz]), 157.45 (C=S). IR 
(cm
-1
): 502 s, 516 s, 634 s, 656 s, 664 s, 679 s, 699 s, 743 s, 784 s, 813 s, 842 s, 979 s, 
1036 s, 1059 s, 1082 s, 1175 b, 1235 s, 1262 s, 1386 b, 1542 s, 1571 s, 1653 s, 1673 s, 
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1695 s, 1734 s, 2341 s, 2362 s, 2509 s, 2735 s, 2853 b, 3034 s, 3118 s, 3155 s. Mp: 223-
227
◦









. Anal. Calc. for CuC20BH30N8S: 
C, 49.13; N, 22.92; H, 6.20. Found: C, 48.83; N, 22.45; H, 6.18.  
 Tp*Cu(dmise) (8). Complex 8 was prepared following the procedure for 7 using 
both methods except that dmise (175 mg, 1 mmol) was used in place of dmit. Single 
crystals suitable for X-ray analysis were grown by slow vapor diffusion of ether into 
dichloromethane and methanol solution. Yield: method 1, 59% (316 mg, 0.59 mmol); 
method 2, 74% (397 mg, 0.74 mmol). 
1
H NMR (CDCl3): 1.70 (s, 9H, 3(CH3)), 2.44 (s, 





H} NMR (CDCl3): ): 13.25 (CH3), 13.64 (CH3), 37.45 (CH3 [dmise]), 





H} NMR (CDCl3): -31.5. IR (cm
-1
): 599 s, 635 s, 655 s, 666 s, 699 s, 723 
s, 748 s, 811 w, 839 s, 980 s, 1036 s, 1059 s, 1081 s, 1146 s, 1176 b, 1232 s, 1262 s, 1378 
b, 1443 b, 1541 s, 1569 s, 1594 s, 1699 s, 2508 s, 2734 s, 2851 s, 3116 s, 3152 s. Mp: 
223-227
◦









. Anal. Calc. for 
CuC20BH30N8Se: C, 46.04; N, 20.45; H, 5.52. Found: C, 45.05; N, 20.89; H, 5.69. 
 [Tpm*Cu(dmise)][Cl] (9). The dmise ligand (176 mg, 1 mmol) was dissolved in 
acetonitrile (20 mL) and was cannula transferred to a solution of CuCl (99 mg, 1 mmol) 
in methanol (20 mL). The reaction mixture was stirred for 3 h at room temperature and an 
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equimolar amount of Tpm* (298 mg, 1 mmol) was dissolved in acetonitrile and cannula 
transferred into the reaction mixture and stirred for 18 h. The reaction mixture was 
pumped down to ~5 mL and the target product was precipitated using ether. The 
precipitate was dried in vacuo to yield a white powder. Yield 52% (297 mg, 0.52 mmol). 
1
H NMR (CD2Cl2): 2.26 (s, 9H, 3CH3), 2.32 (s, 9H, 3CH3), 3.75 (s, 6H, 2CH3 [dmise]), 





(CD2Cl2): 10.70 (CH3), 13.37 (CH3), 37.22 (CH3 [dmise]), 106.99 (C-4 [Pz]), 119.98 





): 628 s, 652 s, 700 vs, 705 vs, 738 s, 799 vs, 813 s, 850 vs, 900 vs, 975 vs, 1035 vs, 
1098 w, 1150 s, 1240 vs, 1305 s, 1382 s, 1412 s, 1464 s, 1522 w, 1540 w, 1560 vs, 1653 
s, 1733 s, 2338 w, 2361 w, 2936 b. UV-vis (CH3CN): 273 nm. Mass spectrum (ESI-MS): 
m/z 537.1 [Tpm*Cu(dmise)]
+









. Anal. Calc. for C21H30CuN8SeCl: C, 44.06; N, 19.57; H, 
5.28. Found: C, 43.35; N, 19.43; H, 5.19. 
 [Tpm*Cu(dmit)][Cl] (10). Complex 10 was prepared following the procedure for 
9 except that dmit (129 mg, 1mmol) was used in place of dmise. Yield: 60% (315 mg, 
0.60 mmol). 
1
H NMR (CD2Cl2): 2.16 (s, 9H, 3CH3), 2.55 (s, 9H, 3CH3), 3.73 (s, 6H, 




H} NMR (CD2Cl2): 9.43 (CH3), 12.04 (CH3), 34.63 (CH3 [dmit]), 68.59 (CH), 
106.40 (C-4 [Pz]), 119.42 (CH [dmit]), 140.38 (C-3 [Pz]), 150.61 (C-5 [Pz]), 156.54 
(C=S). IR (cm
-1
): 630 s, 664 s, 670 s, 699 s, 706 s, 734 s, 749 s, 763 s, 817 s, 849 vs, 898 
s, 977 s, 1035 s, 1087 s, 1181 b, 1240 s, 1306 s, 1387 b, 1465 b, 1521 s, 1567 s, 1623 b, 
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1653 b, 2915 b, 3074 b, 3105 b. Mp: 275-277ºC. UV-vis (CH3CN): 273 nm. Mass 
spectrum (ESI-MS): m/z 489.1 [Tpm*Cu(dmit)]
+









. Anal. Calc. for C21H30CuN8SCl: C, 
47.91; N, 21.29; H, 5.71. Found: C, 47.65; N, 21.05; H, 5.69.  
[Tpm
iPr
Cu(dmit)][Cl] (11). Complex 11 was prepared following the procedure for 
9 except that dmit (129 mg, 1 mmol) and Tpm
iPr
 (466 mg, 1 mmol) were used in place of 
dmise and Tpm*. Yield: 62% (430 mg, 0.62 mmol). 
1
H NMR (CDCl3): 1.22 (d, JHH = 6 
Hz, 36H, 6(CH3)2), 3.11 (sept, JHH = 8.25 Hz, 3H, 3CH), 3.19 (br, 3H, 3CH), 3.70 (s, 6H, 





NMR (CDCl3): 22.64 (CH(CH3)2),  23.13 (CH(CH3)2), 25.88 (CH(CH3)2), 27.73 
(CH(CH3)2), 35.64 (CH3 [dmit]), 63.43 (HC), 99.96 (4-C (Pz)), 118.58 (2CH2 [dmit]), , 
150.76 (3-C (Pz)), 159.5 ( C=S), 160.09 (5-C (Pz)). IR (cm
-1
): 670 vs, 691 s,722 vs, 747 
vs, 763 vs, 797 vs, 806 s, 826 s, 861 s, 879 s, 903 s, 927 s, 961 s, 999 w, 1016 s, 1057 s, 
1071 s, 1109 s, 1177 s, 1243 s, 1270 s, 1291 s, 1309 s, 1364 s,1380 s, 1465 w, 1552 s, 
1571 s, 1621 s, 1656 b, 1729 s,  2722 b, 3038 b, 3079 s, 3104 s, 3148 s, 3196 b. Mp: 
223-227
◦




















. Anal. Calc. for 
C33H54CuN8SCl: C, 57.14; N, 16.16; H, 7.79. Found: C, 56.40; N, 15.69; H, 7.88. 
 [Tpm
iPr
Cu(dmise)][Cl] (12). Complex 12 was prepared following the above 
procedure for 9 except that Tpm
iPr
 (466 mg, 1 mmol) was used in place of Tpm*. Yield: 
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42% (311 mg, 0.42 mmol). 
1
H NMR (CDCl3): 1.22 (d, JHH = 6 Hz, 36H, 6(CH3)2), 3.10 
(sept, JHH = 6 Hz, 3H, 3CH), 3.19 (sept, JHH = 6 Hz, 3H, 3CH), 3.79 (s, 6H, 2CH3 





NMR (CDCl3): 22.66 (CH(CH3)2),  23.13 (CH(CH3)2), 25.93 (CH(CH3)2), 27.72 
(CH(CH3)2), 37.56 (CH3 [dmise]), 71.1 (HC), 99.92 (4-CH [Pz]), 120.54 (2CH [dmise]), 
150.81 (3-CH [Pz]),  152.03 (C=Se), 160.25 (5-CH [Pz]). IR (cm
-1
): 668 vs, 722 vs, 740 
vs, 752 vs, 797 vs, 806 s, 825 s, 860 s, 879 s, 903 s, 927 s, 1004 s, 1015 s, 1056 s, 1072 s, 
1109 s, 1151 s, 1180 vs, 1234 s, 1270 vs, 1290 s, 1308 s, 1380 s, 1464 b, 1552 s, 1565 s, 
1595 b, 1656 b, 2125 b, 3093 b, 3146 s. Mp: 234-236
◦
C. UV-vis (CH3CN): 205, 268 nm. 




















Calc. for C33H54CuN8SeCl: C, 53.51; N, 15.14; H, 7.30. Found: C, 52.89; N, 15.21; H, 
7.25.  
 X-ray Data Collection and Structural Determination. Single crystals grown from 
vapor diffusion were mounted on a glass filament with silicon grease and immediately 
cooled to 168 ± 2 K in a cold nitrogen gas stream. The crystals were grown by vapor 
diffusion of diethyl ether into an acetonitrile solution for [Tpm*Cu(dmise)][BF4] (1) and 
[Tpm*Cu(dmit)][BF4] (2); diethyl ether into a methanol solution for 
[TpmCu(dmise)][BF4] (3) and [TpmCu(dmit)][BF4] (4); diethyl ether into 
dichloromethane solution for [Tpm
iPr
Cu(dmise)][BF4] (6); and diethyl ether into a 
dichloromethane / methanol solution for Tp*Cu(dmit) (7) and Tp*Cu(dmise) (8). 
Intensity data were collected using a Rigaku Mercury CCD detector and an AFC8S 
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diffractometer. The space groups P21/c for 1, 2, and 3; P212121 for 4; C2/c for 6 and 
P21/m for 7 and 8 were determined from the observed systematic absences. Data 
reduction including the application of Lorentz and polarization (Lp) effects and 
absorption corrections used the CrystalClear program.
82
 The structures were solved by 
direct methods and subsequent Fourier difference techniques, and refined anisotropically, 
by full-matrix least squares, on F
2
 using SHELXTL 6.10.
83
 The quantity minimized by 
























































)/3]. In the final cycle of least and 
squares, independent anisotropic displacement factors were refined for the non-hydrogen 
atoms and the methyl hydrogen atoms were fixed in idealized positions with C-H = 0.96 
Å. Their isotropic displacement parameters were set equal to 1.5 times Ueq of the attached 
carbon atom. 
  For complex 1, the largest peak in the final Fourier difference map (0.81 e·A
-3
) 
was located 0.92 Å from F(2), and the lowest peak (-0.68 e·A
-3
) was located at a distance 
of 0.81 Å from Se. The largest peak for complex 2 in the final Fourier difference map 
(1.014 e·A
-3
) was located 0.02 Å from Cu, and the lowest peak (-0.676 e·A
-3
) was located 
at a distance of 0.76 Å from Cu. The largest peak for complex 3 in the final Fourier 
difference map (1.635 e·A
-3
) was located 0.29 Å from H(3AA), and the lowest peak (-
0.740 e·A
-3
) was located at a distance of 0.80 Å from Se(1A). The largest peak for 4 in 
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the final Fourier difference map (0.77 e·A
-3
) was located 1.59Å from H(11A), and the 
lowest peak (-0.41 e·A
-3
) was located at a distance of 0.80 Å from Cu. The largest peak for 
6 in the final Fourier difference map (0.94 e·A
-3
) was located 0.04 Å from Se(1), and the 
lowest peak (-0.60 e·A
-3
) was located at a distance of 0.89 Å from Se(1). The largest peak 
for 7 in the final Fourier difference map (0.583 e·A
-3
) was located 0.92 Å from H(20B), 
and the lowest peak (-0.628 e·A
-3
) was located at a distance of 0.11 Å from H(20A). The 
largest peak for 8 in the final Fourier difference map (0.71 e·A
-3
) was located 2.44 Å 
from H(13B), and the lowest peak (-0.51 e·A
-3
) was located at a distance of 0.81 Å from 
Se(1). Final refinement parameters for the structures of 1, 2, 3, 4, 6, 7, and 8 are given in 
Tables 2.10, 2.11, and 2.12. Crystal structure diagrams of the copper complexes are 
shown in Figures 2.3-2.5 and 2.7-2.10, and their crystal packing diagrams are shown in 









 1 2 
Chemical Formula C21H30BCuF4N8Se C21H30BCuF4N8S 
F.W. (g/mol) 623.84 576.94 
Space group P21/c P21/c 
Crystal system Monoclinic Monoclinic 
a, Å 12.199(2) 12.248(2) 
b, Å 16.322(3) 16.233(3) 
c, Å 13.043(3) 12.914(3) 
α, ° 90 90 
β, ° 93.54(3) 93.41(3) 




Z 4 4 
Dcal, Mg/m
3
 1.598 1.495 
Indices  (min) [-15, -20, -16] [-15, -20, -16] 
              (max) [12, 20, 15] [13, 19, 16] 
Parameters 333 333 
F(000) 1264 1192 
μ, mm
-1
 2.302 0.990 
2θ range,  2.50 - 26.71 3.01- 26.73 
Collected reflections 21217 22159 
Unique reflections 5472 5406 
Final R (obs. Data)
a
, R1 0.0435 0.0508 
                 wR2 0.1101 0.1349 
Final R (all data), R1 0.0508 0.0557 
                 wR2 0.1163 0.1426 
Goodness of fit (S) 1.110 1.098 
Largest diff.  Peak 0.808 1.014 
Largest diff.  Hole -0.682 -0.676 
 
 
Table 2.10. Summary of crystallographic data for complexes 1 and 2. 
a



































 3 4 
Chemical Formula C15H18BCuF4N8Se C15H18BCuF4N8S 
F.W. (g/mol) 539.69 492.78 
Space group P21/c P2(1)2(1)2(1) 
Crystal system Monoclinic Orthorhombic 
a, Å 10.176(2) 9.7241(19) 
b, Å 17.734(3) 11.335(2) 
c, Å 22.586(4) 18.262(4) 
α, ° 90 90 
β, ° 96.47(3) 90 




Z 8 4 
Dcal, Mg/m
3
 1.770 1.626 
Indices  (min) [-12, -21, -24] [-8, -14, -23] 
              (max) [11, 21, 26] [12, 14, 23] 
Parameters 546 274 
F(000) 2144 1000 
μ, mm
-1
 2.932 1.245 
2θ range,  2.96 – 25.05 2.76 – 26.72 
Collected reflections 30276 16710 
Unique reflections 7119 4255 
Final R (obs. Data)
a
, R1 0.0692 0.0354 
                 wR2 0.1713 0.0845 
Final R (all data), R1 0.0741 0.0388 
                 wR2 0.1732 0.0871 
Goodness of fit (S) 1.180 1.139 
Largest diff.  Peak 1.490 0.766 
Largest diff.  Hole -0.619 -0.412 
   
Table 2.11. Summary of crystallographic data for complexes 3 and 4. 
a


















 6 7 8 
Chemical Formula C33H54BCuF4N8Se C20H30BCuN8S C20H30BCuN8Se 
F.W. (g/mol) 792.15 488.93 535.83 
Space group C2/c P21/m P21/m 
Crystal system Monoclinic Monoclinic Monoclinic 
a, Å 23.822(5) 8.2925(17) 8.3319(17) 
b, Å 16.733(3) 11.808(2) 11.771(2) 
c, Å 19.931(4) 11.934(4) 12.082(2) 
α, ° 90 90 90 
β, ° 100.04(3) 91.32(3) 92.09(3) 
γ, ° 90 90 90 
V, Å
3 
7823(3) 1168.3(4) 1184.2(4) 
Z 8 2 2 
Dcal, Mg/m
3
 1.345 1.390 1.503 
Indices  (min) [-29, -20, -21] [-10, -14, -14] [-9, -14, -15] 
              (max) [28, 20, 24] [9, 14, 14] [10, 14, 11] 
Parameters 447 160 160 
F(000) 3296 512 548 
μ, mm
-1
 1.541 1.048 2.483 
2θ range,  2.43 – 26.32 3.02 – 26.74 3.02 – 26.29 
 
Collected reflections 38614 11607 9538 
Unique reflections 7938 2586 2494 
Final R (obs. Data)
a
, R1 0.0628 0.0394 0.0383 
             wR2 0.1619 0.1041 0.0953 
Final R (all data)R1 0.1023 0.0413 0.0465 
             wR2 0.1969 0.1073 0.1021 
Goodness of fit (S) 1.050 1.102 1.059 
Largest diff.  Peak 0.941 0.583 0.712 
Largest diff.  Hole -0.598 -0.628 -0.513 
Table 2.12. Summary of crystallographic data for complexes 6, 7, and 8. 
a

















Figure 2.13. Cyclic voltammetry (CV) scans for A) Tp*Cu(dmise), B) 
Tp*Cu(dmit), C) [TpmCu(dmise)][BF4], D) [TpmCu(dmit)][BF4], E) 
[Tpm*Cu(dmise)][BF4], F) [Tpm*Cu(dmit)][BF4]. All data collected with 1 










Figure 2.13 (cont.). Cyclic voltammetry (CV) scans for G) 


























Figure 2.13 (cont.). Cyclic voltammetry (CV) scans for M) 
[Tpm*Cu(NCCH3][BF4],  N) [Tpm
iPr
Cu(NCCH3][BF4], O) Tpm*CuCl,  P) 
Tpm
iPr
CuCl. All data collected with 10mM complex in acetonitrile. Potentials 






 Figure 2.14. Crystal packing diagram of [Tpm*Cu(dmise)][BF4] (1) at 50% 
probability density ellipsoids displaying H and F short contact interactions 









Figure 2.15. Crystal packing diagram of [TpmCu(dmise)][BF4] (3) at 50% 
probability density ellipsoids displaying H and F short contact interactions 








Figure 2.16. Crystal packing diagram of [Tpm*Cu(dmit)][BF4] (2) at 50% 










Figure 2.17. Crystal packing diagram of [TpmCu(dmit)][BF4] (4) at 50% 
probability density ellipsoids displaying H and F short contact interactions 









Figure 2.18. Crystal packing diagram of Tp*Cu(dmit) (7) at 50% probability 











Figure 2.19. Crystal packing diagram of Tp*Cu(dmise) (8) at 50% probability 
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REACTIVITY OF BIOLOGICALLY RELEVANT CHALCOGENONES AND THEIR 




Hydrogen peroxide (H2O2) is a byproduct of respiration and is reduced by copper 
(I) in the Fenton-like reaction, resulting in the formation of the damaging hydroxyl 
radical (reaction 1).
1




, making ˙OH formation 
catalytic.
2
 The generated ˙OH causes cellular DNA damage and can be enhanced by 
genetic diseases such as Wilson’s and Menkes disease that result in mis-regulation of 
copper levels.
3
 Copper-generated hydroxyl radical has been implicated as an underlying 
cause of diabetes, amyotrophic lateral sclerosis, cancer, inflammatory and 











   (1) 
Selenium and sulfur antioxidants can prevent or reduce oxidative DNA 
damage
8-11
 and may be important in preventing stomach, colorectal and prostate cancers, 
although their mechanism of action is not fully understood.
12-15 
Two major clinical trials 
(NPC and SELECT) showed conflicting results on the ability of selenium 
supplementation to prevent prostate cancer, emphasizing the need for additional research 
into selenium antioxidant mechanisms.
16,17
 Our previous research has determined that 
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metal coordination is required for inhibition of copper- mediated DNA damage by sulfur, 
oxo-sulfur, and selenium compounds,
8,9,18-21
 and this copper binding mechanism is 




To determine how coordination to sulfur and selenium inhibits  copper mediated 
oxidative damage, biologically relevant Cu
+
-N,N’-dimethylimidazole selone (dmise) and 
thione (dmit) complexes with tris(pyrazolyl)methane ligands have been synthesized,
23
 
and their reactivities examined with H2O2. The heterocyclic chalcogenone ligands used in 




 naturally occurring selenium and 
sulfur antioxidants found in animals and plants. Previous studies have shown that 
coordination of selone and thione ligands to copper in [Tpm*CuX]
+
 (Tpm* = tris(3,5-





 If similar complexes form in vivo, this lowered copper potential may prevent 
reduction of Cu
2+
 by cellular reductants such as NADH, preventing Cu
+
 regeneration and 
inhibiting catalytic generation of  
•
OH.  
In addition to altering Cu
2+/+
 reduction potentials, sulfur and selenium may also 
prevent DNA damage by acting as sacrificial antioxidants by reacting with H2O2 directly, 
preventing copper generation of 
•
OH. If this sacrificial reactivity occurs, it is expected 
that the more oxophilic selone will be a more effective antioxidant than the thione.
26
 The 
sacrificial antioxidant ability of selone and thione ligands was investigated by treating 







complexes  were  treated with H2O2 to determine whether the chalcogenone ligand or Cu
+
 
reacts preferentially with H2O2. If the chalcogenone ligands are more reactive with H2O2 
than Cu
+
, the bound selenium or sulfur ligand will hinder oxidation of the Cu
+
 center to 
Cu
2+
. Sacrificial oxidation of copper-bound sulfur and selenium ligands would represent 
an alternative antioxidant mechanism compared to prevention of copper redox cycling.  
 
Results and Discussion 
Oxidation of dmise and dmit. The oxidation of the dmise and dmit ligands was 
conducted by treating the chalcogenones compounds with one or two equiv of H2O2, 
respectively, in methanol under an argon atmosphere. 
1
H NMR spectra of the untreated 
dmise and dmit ligands have two resonances corresponding to the methyl protons (δ 3.60 
and δ 3.56, respectively ) and olefinic protons (δ 7.04 and δ 6.90, respectively; Figures 















Figure 3.1. Structures of the heterocyclic chalcogenone ligands 
(E = S, dmit; E = Se, dmise) showing A) 
1
H NMR resonance 




H} NMR resonance labels. Ring numbering 
is shown in A. 
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Upon treatment of dmise and dmit ligands with H2O2, the 
1
H NMR spectra show 
shifted resonances that correspond to the methyl protons (δ 3.98 for both)  and olefinic 
protons (δ 7.60 and δ 7.61 for dmise and dmit, respectively) along with the emergence of 
a new resonance at δ 8.91 (Figure 3.2). The methyl and olefinic protons of the H2O2-
treated chalcogenone ligands are shifted downfield relative to untreated dmise and dmit. 
The new resonance at δ 8.91 suggests cleavage of the selenium or sulfur atom from the 
heterocyclic ring followed by hydrogen insertion. This new resonance at δ 8.90 is very 






H NMR spectra of A) dmise before and after treatment with 1 equiv 







H} NMR spectra of dmise and dmit show three resonances 
corresponding to the methyl carbons (δ 37.0 and δ 36.3, respectively), olefinic carbons (δ 
120.5 and δ 119.2, respectively) and the quaternary carbon (δ 156.8 and 162.4, 





NMR resonances corresponding to the methyl carbons shift very little (δ 35.70  
and δ 35.20, respectively). In contrast, the olefinic C-4 and C-5 carbons are slightly 
shifted downfield (δ 123.59 and δ 123.50, respectively), whereas the C-2 carbon is 
shifted upfield by about δ 20. This upfield shift of the C-2 carbon coupled with the 
1
H 
NMR resonance at δ 8.90 indicates cleavage of the C=Se or C=S bonds from the 









H} NMR of A) dmise before and after treatment with 1 equiv  H2O2 
and B) dmit before and after treatment with 2 equiv H2O2. Solvent molecule labeled 




Electrospray ionization (ESI) mass spectra of the oxidized products obtained from 
the reaction of dmise or dmit with H2O2 confirm formation of the 
N,N’-dimethylimidazolium cation (m/z 97.071) as the major product in the positive 





one oxidized selenium product at m/z 112.96 [SeO2H]
-
 were identified in the negative 
ionization mode. The different oxidized species seen upon dmit and dmise oxidation may 
result from the higher concentration of H2O2 required for complete oxidation of dmit 
relative to dmise.  





NMR spectroscopy. The untreated dmise ligand has a selenium resonance at δ -29.5 in 
















H} NMR spectra of A) dmise ligand and B) oxidized dmise ligand 
after reaction with H2O2.  
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Based on our experimental results, treatment of the chalcogenone ligands with 
H2O2 results in the oxidation and cleavage of selenium and sulfur atoms from the 
five-membered heterocyclic ring with the formation of the 1,3-dimethylimidazolium 
cation (Figure 3.5). Reactivity of dmise and dmit with the reactive oxygen species 
peroxynitrite has been investigated by Bhabak et al.
26
 and the authors have determined 
that peroxynitrite oxidizes dmise and dmit to yield the 1,3-dimethylimidazolium cation 
and selenium and sulfur oxides, respectively. Elimination of the selenium and sulfur 
atoms from the five-membered rings occurs through formation of unstable 
selenic/sulfenic acids and seleninic/sulfinic acids. Theoretical DFT calculations 
conducted by our collaborator Dr. Craig Bayse (Old Dominion University) also suggest 
formation of unstable selenic/sulfenic and seleninic/sulfinic acid intermediates upon 
reaction of dmise or dmit with H2O2 leading to cleavage of C=Se or C=S bond. 
 
 
The higher oxophilicity of dmise relative to dmit is illustrated by the reactivity of 
this compound with H2O2. Upon reaction of dmise with 1 equiv of H2O2, the selenium 
atom is completely cleaved from the C-2 carbon, whereas the dmit ligand requires 2 
equiv H2O2 to completely react. Thus, dmise is a more sensitive H2O2 scavenger 






Figure 3.5. Reaction of dmise and dmit with H2O2 (E = Se, n = 
2; E = S, n = 3, 4). 
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effectively. These results are in agreement with results reported by Bhabak et al., 
indicating that selone containing compounds generally prevented more peroxynitrite 
mediated nitration of free tyrosine relative to analogous thione compounds.
26
 
Reactivity of tris(3,5-dimethylpyrazolyl)methane Cu selone and thione complexes 
with H2O2. The tris(3,5-dimethylpyrazolyl)methane copper selone and thione complexes 
were treated with H2O2 to determine whether the Cu
+
 or the chalcogenone atoms would 
preferentially react with H2O2. Acetonitrile solutions of the [Tpm*Cu(X)]
+
 (X = dmise or 
dmit) complexes were treated with 0.5, 1, and 2 molar equiv H2O2 for the selone complex 
or 1, 2, and 3 molar equiv H2O2 for the thione complex. 
1
H NMR spectra of the oxidized 
[Tpm*Cu(X)]
+
 (X = dmise or dmit) copper complexes (Figure 3.6) show sharply-defined 
peaks, indicating that the diamagnetic Cu
+
 center is not oxidized upon treatment with 
H2O2. The resonances corresponding to the tripodal Tpm* ligand do not shift upon H2O2 




H NMR spectra of the [Tpm*CuX]
+
 (X = dmise or dmit) copper complexes before 
treatment with H2O2 have dmise ligand resonances at δ 3.88 for the methyl protons and δ 
7.17 for the olefinic protons, whereas the corresponding dmit resonances are observed at 
δ 3.87 and δ 7.00 respectively.
23
 Upon treatment with H2O2, oxidized [Tpm*CuX]
+
 (X = 
dmise or dmit) copper complexes have dmise resonances at δ 3.86 for the methyl protons, 
δ 7.36 for the olefinic protons and a new resonance at δ 8.49 corresponding to an 







H NMR spectra of A) [Tpm*Cu(dmise)][BF4] upon treatment with 
0.5, 1.0, and 2.0 equiv of  H2O2 and B) [Tpm*Cu(dmit)][BF4] upon treatment with 
1.0, 2.0, and 3.0 equiv of  H2O2. Solvent and H2O resonances are labeled with an 
asterisk and pound sign respectively. 
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Upon similar oxidation, dmit resonances are observed at δ 3.85 for the methyl 
protons, δ 7.36 for the olefinic protons and a new resonance at 8.47 (Figure 3.6). The 
olefinic protons of the oxidized dmise and dmit ligands shift downfield relative to their 
resonances in the untreated copper selone or thione complexes.
23
 This downfield shift 
upon oxidation coupled with the appearance of a new resonance ~ δ 8.48 indicates 
oxidation of the selenium and sulfur and formation of the 1,3-dimethylimidazolium 
cation, similar to the oxidation products of dmise and dmit. Complete oxidation of the 
selone ligand in [Tpm*Cu(dmise)]
+
 requires 2 equiv of H2O2, whereas the analogous 
copper-thione complex requires 3 equiv of H2O2 to completely react, indicating that the 
bound selone is more oxophilic relative to the bound thione. Both copper-bound selone 




The ESI mass spectrometry data for the oxidized products obtained from the 
treatment of [Tpm*CuX]
+
 (X = dmise/dmit) complexes with H2O2 indicate formation of 
[Tpm*Cu(NCCH3)]
+
 (m/z 402.12) and N,N’-dimethylimidazolium (m/z 97.071) in the 
positive ionization mode, corroborating 
1
H NMR results. Negative ion ESI-MS results 
indicate several oxidized sulfur (m/z 79.98 [SO3H]
-
 and 96.99 [SO4H]
-
) and selenium 
products (112.96 [SeO2H]
-
). The different oxidized species arising from sulfur and 
selenium ligands may result from the higher concentration of H2O2 required for the 
complete oxidation of [Tpm*Cu(dmit)]
+
 complex (3 equiv H2O2)  relative to 
[Tpm*Cu(dmise)]
+








The overall reaction of [Tpm*CuX]
+
 (X = dmise or dmit) with H2O2 is given in 
Figure 3.7. Figure 3.8 reveals that both the Cu
+
 center and selenium atoms are accessible 






















CH3CN, rt, 8 h
+  EOnH+ N N
C
H
Figure 3.7. Reaction of [Tpm*CuX]
+
 (X = dmise or dmit) with H2O2 (E = Se, 
n = 2; E = S, n = 3, 4). 
 
 
Figure 3.8. Space filling diagram of [Tpm*Cu(dmise)]
+
 and X-ray crystal 
structure of [Tpm*Cu(NCCH3)]
+
 showing 50% probability density ellipsoids. 





ligand without oxidation of the Cu
+
 center. Similar to the results obtained in the oxidation 
of the unbound chalcogenones, dmise in [Tpm*Cu(dmise)]
+
 is a more sensitive H2O2 
scavenger compared to dmit in [Tpm*Cu(dmit)]
+
. These results indicate that the copper 
selone complexes may prevent copper-mediated oxidative damage by H2O2 more 
effectively than their thione analogs.  
 Cu
+





 Of particular interest is the reaction of 
[Tpm*Cu(NCCH3)]
+
 with H2O2 that results in the formation of an oxo-bridged dicopper 
Tpm* complex, [{Tpm*Cu(OH)}2]
2+






 The peroxo 
dicopper complexes previously obtained with tris(pyrazolyl)copper(I)-acetonitrile 
complexes and are usually characterized by formation of a deep purple solution at low 
temperatures,
30
 a phenomenon that was absent in our system.  
Treating [Tpm*CuX][BF4] (X = dmise/dmit) with H2O2 in acetonitrile rresults in 
the formation of [Tpm*Cu(NCCH3)][BF4]. The [Tpm*Cu(NCCH3)][BF4] complex can 
be independently synthesized from [Cu(NCCH3)4][BF4] and Tpm*,
31
 but its structure has 
not been reported.  The Cu
+
 center in [Tpm*Cu(NCCH3)][BF4] (Figure 3.8) adopts  
distorted tetrahedral geometry, bound in a κ
3
 fashion to three nitrogen atoms from the 
tridentate Tpm* ligand and terminally bound to an acetonitrile solvato ligand. The small 
bite angle of the Tpm* ligand results in pinning back of the nitrogen atoms upon 
coordination to copper, producing small N-Cu-N angles ranging from 85.9 to 89.9° 
(Table 3.1),
31
 with Cu-N bond lengths of 2.08-2.09 Å. These C-N bond lengths and 
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N-Cu-N angles are comparable to other tris(pyrazolyl)methane copper(I) complexes such 












Cu(CO)][PF6] (avg. 2.05 Å, 88.1º).
33
 The Cu-N bond distance of 1.87 Å for the 









Figure 3.9. X-ray crystal structure diagram of [Tpm*Cu(NCCH3)][BF4] 
showing 50% probability density ellipsoids. Hydrogen atoms and counterions 








Treating [Tpm*CuX][BF4] (X = dmise/dmit) with H2O2 in acetonitrile results in 
preferential oxidation of the dmise or dmit ligand and formation of oxidized selenium and 
sulfur species, the dimethylimidazolium cation and [Tpm*Cu(NCCH3)][BF4]. Since these 
copper-selone and -thione complexes undergo sacrificial oxidation of chalcogenone 
atoms without oxidation of the Cu
+
 center, if similar copper-selenium and -sulfur 
complexes are formed in vivo, such complexes may scavenge H2O2 and inhibit copper-
mediated oxidative damage. These studies indicate that coordination of selenium and 
sulfur compounds to Cu
+
 may prevent copper-mediated DNA damage in one of two 
ways: coordination of selone or thione to Cu
+
 alters the Cu
2+/+
 reduction potential hence 
preventing reduction of Cu
2+
 by NADH and inhibiting copper redox cycling or by 
efficiently scavenging H2O2 by bound selenium or sulfur compounds. 
 
Conclusions 
The reactivity of biologically relevant selone and thione ligands and their copper 
complexes with H2O2 has been determined and compared. Treatment of dmise and dmit 
with H2O2 results in cleavage of the C=Se or C=S bond and oxidation of the selenium 
Cu-N(1) 2.088(4) N(4)-Cu-N(1) 85.92(14) 
Cu-N(4) 2.080(4) N(4)-Cu-N(5) 89.93(14) 
Cu-N(4) 2.089(3) N(1)-Cu-N(5) 87.74(14) 
Cu-N(7) 1.865(4) N(7)-Cu-N(1) 130.26(16) 
N(7)-C(17) 1.137(7) N(7)-Cu-N(4) 124.68(16) 
  N(7)-Cu-N(5) 125.35(16) 




and sulfur atoms along with formation of the dimethylimidazolium cation. Treating 
[Tpm*CuX][BF4] (X = dmise/dmit) with H2O2 in acetonitrile results in preferential 
oxidation of the dmise or dmit ligand and formation of oxidized selenium and sulfur 
species, the dimethylimidazolium cation and [Tpm*Cu(NCCH3)][BF4]. In contrast, upon 
treating Cu
+
 complexes without bound selenium or sulfur ligands with the same number 




 Since these copper-selone and -thione 
complexes undergo sacrificial oxidation of chalcogenone atoms without oxidation of the 
Cu
+
 center, if similar copper-selenium and -sulfur complexes are formed in vivo, such 
complexes may scavenge H2O2 and inhibit copper-mediated oxidative damage. 
 
Experimental Section 
Materials. Methanol and acetonitrile were dried using standard procedures and 







 [Tpm*Cu(dmise)][BF4], and 
[Tpm*Cu(dmit)][BF4],
23
 were synthesized according to published procedures. The 
following reagents were used as received: selenium powder (VWR), sulfur powder 
(VWR), cuprous oxide (stabilized, Aldrich), 1-methylimidazole (VWR), methyliodide 











H} NMR spectra were obtained on 






H} NMR chemical 




H} NMR chemical shifts are 
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H} NMR spectra were externally referenced to CCl3F (  0).
39
  
Infrared spectra were obtained using nujol mulls on KBr salt plates with a Magna 
550 IR spectrometer. Abbreviations used in the description of vibrational data are as 
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization 
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System 
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a 
Turbo Ionspray ionization source. Samples were run under both positive and negative 
mode, with an ionspray voltage of 5500 V, and TOF scan mode. All the peak envelopes 
obtained match calculated isotopic abundances. 
Reactivity of dmise with H2O2. Dmise (175 mg, 1 mmol) was dissolved in 
methanol (15 mL), and H2O2 (115 μL of 30%, 8.667 M; 1 mmol) was added. The 
reaction mixture was stirred for 5 h and dried in vacuo to afford a light brown oil. Yield 
of oxidized dmise: 100 % by 
1
H NMR spectroscopy. 
1
H NMR (CD3OD): 3.978 (s, 




H} NMR (CD3OD): 35.70 (CH3), 




H} NMR (CD3OD): 1346.22. ESI-MS: m/z, 
positive ionization 97.07 [C5H9N2]
+
; negative ionization: 112.96 [SeO2H]
-
. 
Reactivity of dmit with H2O2. Dmit (128 mg, 1 mmol) was dissolved in methanol 
(15 mL) and treated with 1equiv H2O2 (115 μL of 30%, 8.667 M; 1 mmol) or 2 equiv of 
H2O2 (230 μL of 30%, 8.667 M; 2 mmol). Yield of oxidized dmit: 100 % by 
1
H NMR 
spectroscopy with 2 equiv H2O2. 
1
H NMR (CD3OD): 3.98 (s, 2CH3), 7.61 (2H, 2CH), 
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H} NMR (CD3OD): 35.20 (CH3), 123.50 (CH), 137.31(CH (C-
2)). ESI-MS: m/z, positive ionization 97.07 [C5H9N2]
+






Reaction of [Tpm*Cu(dmise)][BF4] with H2O2. [Tpm*Cu(dmise)][BF4] (320 mg, 
0.5 mmol) was dissolved in acetonitrile (10 mL) and to this was added 0.5, 1.0, or 2.0 
equiv of H2O2 (0.25, 0.5, or 1 mmol; 29, 58, or 115 μL). The reaction mixtures were 
stirred for 8 h and dried in vacuo. A control experiment using degassed water instead of 
H2O2 showed no reaction. Single crystals of [Tpm*Cu(NCCH3)][BF4] were grown via 
slow diffusion of ether into acetonitrile solution. Yield of oxidized dmise: 85% by 
1
H 
NMR spectroscopy with 2 equiv H2O2. 
1
H NMR (CD3CN): 2.31 (s, 9H, 3CH3), 2.51 (s, 
9H, 3CH3), 3.86 (s, 6H, 2CH3), 6.05 (s, 3H, 3CH), 7.36 (s, 2H, 2CH (dmise)), 7.75 (s, 




H} NMR (CD3CN): 11.05 (CH3), 13.48 (CH3), 
36.64 (CH3 (dmise)), 68.65 (CH), 107.22 (pz), 124.35 (CH (dmise)), 141.96 (CH (pz)), 
151.52 (CH (pz)). IR (cm
-1
): 520 w, 630 s, 662 s, 704 vs, 739 vs, 794 vs, 815 vs, 855 vs, 
970 vs, 978 w, 1066 b, 1150 s, 1176 s, 1252 vs, 1307 vs, 1392 vs, 1417 vs, 1464 vs, 1568 
vs, 1675 w, 2854 vs, 2924 b, 3142 s, 3171 s, 3501 w. ESI-MS: m/z positive ionization: 
402.12 [Tpm*Cu(NCCH3)]
+












[Tpm*Cu(dmit)][BF4] with H2O2. [Tpm*Cu(dmit)][BF4] (273 mg, 0.5 mmol) 
were dissolved in acetonitrile (10 mL) and to this was added 1, 2, or 3 equiv of H2O2 (0.5, 
1.0, or 1.5 mmol; 58, 115, or 173 μL). The reaction mixture was stirred overnight and 
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dried in vacuo. Yield of oxidized dmit: 68% by 
1
H NMR spectroscopy with 3 equiv 
H2O2.
 1
H NMR (CD3CN): 2.28 (s, 9H, 3CH3), 2.51 (s, 9H, 3CH3), 3.85 (s, 6H, 2CH3), 




H} NMR (CD3CN): 11.04 (CH3), 13.43 (CH3), 36.61 (CH3 (dmit)), 68.65 (CH), 
107.24 (pz), 124.35 (CH (dmit)),141.98 (CH (pz)), 151.53 (CH (pz)). IR (cm
-1
): 491 w, 
521 s, 631 s, 672 vs, 704 vs, 740 s, 814 s, 857 vs, 907 vs, 1065 b, 1175 s, 1258 vs, 1286 
w, 1308 vs, 1394 s, 1418 s, 1464 s, 1567 vs, 1676 w, 2917 b, 3144 s. ESI-MS: m/z 



















X-ray data collection and structural determination. Single crystals of 
[Tpm*Cu(NCCH3)][BF4] grown from vapor diffusion were mounted on a glass filament 
with silicon grease and immediately cooled to 168±2 K in a cold nitrogen gas stream. 
Intensity data were collected using a Rigaku Mercury CCD detector and an AFC8S 
diffractometer. The space groups C2/c for [Tpm*Cu(NCCH3)][BF4] was determined from 
the observed systematic absences. Data reduction including the application of Lorentz 
and polarization (Lp) effects and absorption corrections used the CrystalClear program.
40
 
The structures were solved by direct methods and subsequent Fourier difference 










Chemical Formula C18H25BCuF4N7 
F.W. (g/mol) 489.80 
Space group C2/c 
Crystal system Monoclinic 
a, Å 25.997(5) 
b, Å 7.598(15) 
c, Å 25.019(5) 
α, ° 90 
β, ° 116.18(3) 








Indices  (min) [-30, -7, -28] 






2θ range,  1.81-25.05 
Collected reflections 16722 
Unique reflections 3917 
Final R (obs. Data)
a
, R1 0.0636 
                 wR2 0.1724 
Final R (all data), R1 0.0823 
                 wR2 0.1948 
Goodness of fit (S) 1.060 
Largest diff.  Peak 1.173 
Largest diff.  Hole -0.761 
    















In the final cycle of least squares, independent anisotropic displacement factors 
were refined for the non-hydrogen atoms and the methyl hydrogen atoms were fixed in 
idealized positions with C-H = 0.96 Å. Their isotropic displacement parameters were set 
equal to 1.5 times Ueq of the attached carbon atom. The high wR2 value results from 
disorder in the tetrafluoroborate counterion. Final refinement parameters for structure of 
[Tpm*Cu(NCCH3)][BF4] are given in Table 3.1, and selected bond angles and distances 
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REDUCTION OF Cu(II) BY N,N’-DIMETHYLIMIDAZOLE CHALCOGENONES 
AND THE COORDINATION CHEMISTRY OF BIS(1-METHYLIMIDAZOLYL) 
DISELENIDE TO Cu(II) 
 
Introduction 
The applications and coordination chemistry of heterocyclic selenoamides and 
thioamides with transition metals has been extensively studied for the past 20 years 
because of their applications in catalysis, their use as precursors for the synthesis of 
semiconductors via chemical vapor deposition (CVD), and their use as mimics for 
metalloproteins in bioinorganic chemistry.
1-6
 Recently, we have investigated the ability of 




 as well 
as the coordination chemistry of bis(1-methylimidazolyl) diselenide with Cu
2+
. These 





 as well as the seleno-histidine selenoneine,
10
 naturally 
occurring antioxidant sulfur and selenium compounds found in plants and animals 
(Figure 4.1).  
Previous work has shown that Cu
+
 complexes of thio and selonoureas can be 
prepared via reduction of Cu
2+ 
salts using an excess seleno- and thioamide containing 
ligands with concomitant oxidation of the seleno- and thioamide compounds.
11-14
 Against 
this background, we carried out the reaction of CuCl2 and Cu(OTf)2 with molar 
equivalents of dmise or dmit to determine the products formed and the ability of these 
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. In biological systems, most 
thiols are oxidized upon interacting with metal ions such as Cu
2+
 or by other redox 
processes. Thiol oxidation results in formation of disulfide bonds that play important role 
in cellular redox regulation.
15
 Selenocysteine residues in SeI L selenoproteins or Grx3 
mutants also can form diselenide bonds. The diselenide-containing protein SeI L is absent 
in mammals but present in aquatic organisms such as jawless fish, tunicates, and 
crustaceans. SeI L selenoproteins have very low reduction potential (-332 mV) which 






Ergothioneine and selenoneine coordinate divalent metal ions such as Cu
2+
and are 























E = Se, selenoneine











Figure 4.1. A) Ligands used in this study. B) Structures of naturally occurring 
selone and thione antioxidants and the drug methimazole. 
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metal binding  properties of ergothioneine disulfide, and its selenium analog selenoneine 










) chlorides have been 
investigated by using bis(1-R-imidazolyl) disulfides and diselenides as coordination 




 These disulfide and diselenide mimics are 
excellent bidentate ligands, coordinating metals through the imidazolyl nitrogens and 












In this chapter, the coordination chemistry of Cu
2+
 with bis(1-methylimidazolyl) 
diselenide (MISeox) is explored to determine the potential binding modes of selenoneine 
diselenide. Cu
2+
 capping with the tripodal ligand tris(1,3-diisopropylpyrazolyl)methane 
(Tpm
iPr
) ligand is used to ensure Cu
2+
 coordination to only one diselenide ligand. 




 cation will determine the effect of 
diselenide coordination on the Cu
2+/+
 reduction potential.  
 
Results and Discussion 
Oxidation of dmise and dmit ligands. Oxidation of the chalcogenones dmise and 
dmit was performed by treating the anhydrous copper(II) salts Cu(OTf)2 and CuCl2 with 
1 equiv of dmise or dmit in acetonitrile (Scheme 4.1) to yield the diselenide (1 and 3) and 
disulfide (2) dication salts. Both the diselenide and disulfide dications are indefinitely 







H NMR spectra of dmise and dmit show two sets of resonances corresponding to 
the methyl protons (δ 3.60 for dmise and δ 3.56 for dmit) and olefinic protons (δ 7.04 for 
dmise and δ 6.90 for dmit).
19
 Upon oxidation of these chalcogenone compounds, these 
methyl and olefinic resonances shift downfield (δ 3.67 and 7.63 for 1, and δ 3.73 and 
7.64 for 2). The presence of only two resonances for the oxidized dmise and dmit 
compounds, coupled with the significant downfield shift of the olefinic protons compared 
with the unoxidized compounds, suggest the formation of aromatic dichalcogenone 
dications.  




H} NMR resonances at δ 37.6 (CH3 
groups), δ 125.9 (olefinic carbon atoms) and δ 140.6 (C-Se). The methyl and olefinic 
carbons of 1 are slightly shifted downfield compared to dmise by δ 0.6 and 6.2, 
respectively.
19
 In contrast, the C-2 carbon resonance of 1 is shifted upfield by δ 17 
compared to dmise. This upfield shift is consistent with a shift of electron density from 
the selenocarbonyl group to the neighboring N-C bond and formation of an aromatic 
2Cu(Otf)2  +  2
CNCH3
 [(OTf)2]  +  2[Cu(NCCH3)4] [(OTf)2]
3CuCl2  +  2
















E = Se, 1; 37% yield











H} NMR spectrum of the diselenide dication 1 shows 






H} NMR spectrum of the analogous disulfide 2 shows similar resonance shifts (δ 
+1, +9.3 and -20) for the methyl, olefinic, and S-C carbon atoms, respectively. The 
identities of the three diselenide and disulfide dications (1, 2, and 3) were confirmed by 
ESI mass spectrometry.  
Structural analysis of the disulfide and diselenide dications. The X-ray crystal 
structure of [(C5N2H8S)2]
2+
 (Figure 4.2) shows a [(C5N2H8S)2]
2+
 dication with a S-S bond 
length of 2.10 Å (Table 4.1). Formation of the disulfide dication 2 results in significantly 
longer S-C (1.746(3) Å) bond distance relative to dmit (1.681(5) Å).
24
 The bis(1,3-





Figure 4.2. Crystal structure diagram of [(C5N2H8S)2]
2+ 
(2) showing 50% 





S(1)-S(2) 2.1015(10) S(2)-S(1)-C(1) 100.17(9) 
S(1)-C(1) 1.746(3) S(1)-S(2)-C(6) 101.76(9) 






Table 4.1. Selected bond distances (Å) and angles (°) for 2. 
(deg) 
Figure 4.3. Crystal packing diagram of [(C5N2H8S)2][(OTf)2]
 
(2) along the a-
axis showing 50% probability density ellipsoids. Short contact interactions and 
hydrogen bonds between S-O, H-O, and F-H are shown. 
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The two triflate anions have short contact interactions between S(2)-O(1) (2.81 
Å), S(1)-O(2) (3.24 Å), S(1)-O(4) (2.94 Å), O(3)-H(3A) (2.46 Å), O(3)-H(2B) (2.56 Å), 
and F(6)-H(2A) (2.53 Å) (Figure 4.3). The S-S bond distance of 2.1015(10) Å in the 
crystal structure of 2 is slightly longer than the previously reported disulfide dications 
[(C4H6N2S)2]I8 (2.085(2) Å),
25
 [(C4H6N2S)2]I3I5 (2.085(3) and 2.094(3) Å).
25
 
X-ray structural analysis of the analogous diselenide compound 1 (Figure 4.4) 
shows a Se-Se bond length of 2.3598(7) Å (Table 4.2), a distance slightly shorter than the 
sum of their covalent radii (2.40 Å).
26
 The dication is charge-balanced by two triflate 
anions with short contact interactions between O(1)-Se(1) (2.80 Å), O(6)-Se(2) (2.96 Å), 
O(1)-C(1) (2.97 Å), O(6)-H(9A) (2.35 Å), O(3)-H(7C) (2.55 Å), O(6)-H(5C) (2.52 Å), 
and F(5)-H(2C) (2.55 Å) (Figure 4.5). The bis(1,3-dimethylimidazolium) diselenide 
dication has a C(1)-Se(1)-Se(2)-C(6) torsion angle of  -77.40°. The diselenide dication 1 
and the unoxidized dmise have almost identical Se-C bond lengths (1.885(3) and 
1.884(10) Å, respectively).
27
 The Se-Se bond distance of 2.3598(7) Å in 1 is comparable 
to that found in [(SeC(NH2)2]2Cl2] (2.381596) Å),
28
 but shorter than the Se-Se bond 




Upon treatment with anhydrous CuCl2, dmise is oxidized, resulting in the 
formation of a red solid with the formula [(C5N2H8Se)2][Cu3Cl5], 3 (Scheme 4.1). The X-
ray structure of 3 revealed a centrosymmetric [Cu3Cl5]
2-
 anion charge-balanced by a 
[(C5N2H8Se)2]
2+
 dication (Figure 4.6). The diselenide dication of 3 has a slightly longer 
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Se-Se bond distance of 2.3946(13) Å (Table 4.3) and a positive C(1)-Se(1)-Se(1A)-
C(1A) torsion angle of 70.91° compared to diselenide dication 1 (Se-Se distance of  







Se(1)-Se(2) 2.3598(7) Se(2)-Se(1)-C(1) 95.89(9) 
Se(1)-C(1) 1.885(3) Se(1)-Se(2)-C(6) 95.75(9) 
Se(2)-C(6) 1.893(3)   
 
Figure 4.4. Crystal drawing of [(C5N2H8Se-)2]
2+
 (1) showing 50% probability 
density ellipsoids. Hydrogen atoms and counterions are omitted for clarity. 







The crystallographically centrosymmetric [Cu3Cl5]
2-
 anion contains two 
geometrically different Cu
+
 centers bridged by chloride atoms. Cu(1) adopts distorted 
trigonal geometry with an average Cu-Cl bond distance of 2.32 Å (Table 4.3), and 
Cl-Cu-Cl angles of 107 to 146.1°. The second Cu
+
 center, Cu(2), adopts a distorted 
tetrahedral geometry with an average Cu-Cl bond distances of 2.38 Å and Cl-Cu-Cl  
Figure 4.5. Crystal packing diagram of [(C5N2H8Se)2][(OTf)2]
 
(1) along the a-
axis showing 50% probability density ellipsoids. Short contact interactions and 







Se(1)-Se(1A) 2.3946(13) Se(1A)-Se(1)-C(1) 94.01(15) 
Se(1)-C(1) 1.884(5) Se(1)-Se(1A)-C(1A) 94.01(15) 
Cu(1)-Cu(2) 2.9201(12) Cl(1)-Cu(1)-Cu(2) 161.11(7) 
Cu(1)-Cl(1) 2.2346(15) Cl(1)-Cu(1)-Cl(1A) 146.13(10) 
Cu(1)-Cl(2) 2.481(3) Cl(1)-Cu(1)-Cl(2) 106.94(5) 
Cu(2)-Cl(2) 2.4910(12) Cl(3)-Cu(2)-Cl(1A) 117.47(6) 
Cu(2)-Cl(3) 2.3648(17) Cl(1)-Cu(2)-Cl(2) 102.47(6) 
  Cl(3)-Cu(2)-Cl(3B) 101.00(5) 
 
angles ranging from 101.0° to 117.5°. The distance between the two geometrically 





 suggesting minimal Cu-Cu interaction. The diselenide dications in the 
Figure 4.6. Crystal structure diagram of [C10H16N4Se2][Cu3Cl5]
 
(3) showing 
50% density probability ellipsoids.  
 




crystal of 3 are arranged parallel to each other along the b-axis with the [Cu3Cl5]
2-
 
dianions positioned between the dications (Figure 4.7). This arrangement leads to short 
contact interactions between the Cl atoms of the anion and selenium and hydrogen atoms 
of the cation, thereby forming a two dimensional network (Figure 4.7). The Se-Cl short 
contact distance (3.38 Å) is significantly shorter than the sum of their van der Waals radii 
(3.80 Å),
30











Cu(MISeox)][OTf]2 complex (5) was synthesized in a two-step, two-pot 
procedure (Scheme 4.2). Treating Cu(OTf)2 with an equimolar amount of 
tri(3,5-diisopropylpyrazolyl)methane (Tpm
iPr
) in acetonitrile forms Tpm
iPr
Cu(OTf)2 (4) 
Figure 4.7. Crystal packing diagram of [C10H16N4Se2][Cu3Cl5] (3)
 
along the b-axis 
displaying 50% density probability ellipsoids. Short contact interactions between 




(MALDI-MS Figure 4.12). The second step is treatment of Tpm
iPr
Cu(OTf)2 (4) with 1 
equiv of bis(1-methylimidazolyl) diselenide (MISeox) in a mixed solvent system of 
dichloromethane and acetonitrile to afford 5 in relatively high yields.  
Scheme 4.2 









5; Yield 81%  
Single crystal X-ray diffraction data were collected for 
[Tpm
iPr
Cu(MISeox)][(OTf)2] (5), which crystallized as blue prisms. Structural parameters 
and selected bond lengths and angles for 5 are summarized in Tables 4.4 and 4.6, and its 
structure is shown in Figure 4.8. The Cu
2+
 center of 5 adopts distorted square pyramidal 
coordination geometry, with the Cu
2+
 bound to three nitrogen atoms from the tridentate 
ligand in a κ
3
 fashion and to the two nitrogen atoms of bis(1-methylimidazolyl) 
diselenide in a κ
2
 fashion. The N-Cu-N angles and Cu-N bond distances in 5 from the 
tris(1,3-diisopropylpyrazolyl)methane ligand range from 80.4 to 91.2º and 2.03 to 2.19 Å, 
respectively. Coordination of MISeox to Cu
2+
 results in N(7)-Cu-N(9) angle of 98.1° and 
average Cu-N bond lengths of 2.00 Å. The C-N bond distances in the bound diselenide 
ligand are slightly different with a Cu-N(9) distance of 1.972(6) Å and a Cu-N(7) 






Se(1)-Se(2) 2.3128(12) N(9)-Cu-N(7) 98.1(2) 
Cu-N(7) 2.027(6) N(9)-Cu-N(5) 167.6(3) 
Cu-N(9) 1.972(6) N(7)-Cu-N(5) 92.6(2) 
Cu-N(2) 2.055(6) N(9)-Cu-N(2) 88.2(3) 
Cu-N(5) 2.034(6) N(7)-Cu-N(2) 170.5(2) 
Cu-N(3) 2.190(6) N(5)-Cu-N(2) 80.4(3) 
  N(9)-Cu-N(3) 98.6(2) 
  N(7)-Cu-N(3) 94.8(2) 
  N(5)-Cu-N(3) 86.7(2) 
  N(2)-Cu-N(3) 91.2(2) 
 
Figure4.8. Crystal structure diagram of [Tpm
iPr
Cu(MISeox)][(OTf)2] (5) 
showing 50% probability density ellipsoids. Hydrogen atoms and counterions 
are omitted for clarity.  
Table 4.4. Selected bond distances (Å) and angles (°) for 5. 
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binding to copper. The Se-Se distance is reduced to 2.3128(12) Å upon complexation to 
Cu
2+
 relative to the unbound ligand (2.3568(15) Å),
31
 whereas the C-N distances in close 
proximity to the Cu-N bond are slightly increased. The N(9)-C(30)-Se(1) angle of 
122.9(5)° does not change upon binding to Cu
2+
, but the N(7)-C(29)-Se(2) angle of 
130.5(6)° increases compared to the unbound diselenide ligand (122.8(3)°).
31
 
The electrochemical behavior of bis(1-methylimidazolyl) diselenide and the Cu
2+
 
complex 4 were examined by cyclic voltammetry to determine the change in the Cu
2+/+
 
redox potential upon copper coordination. Bis(1-methylimidazolyl) diselenide has a 
reduction potential of -1.067 mV versus normal hydrogen electrode (NHE), and exhibits 
quasi-reversible electrochemical behavior (Figure 4.9 and Table 4.5). 
 
 
Figure 4.9. Cyclic voltammetry (CV) scan for MISeox in acetonitrile. 
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The cyclic voltammogram of the Tpm
iPr
Cu(OTf)2 (4) complex exhibits two one-





reduction and oxidation processes (Figure 4.10, Table 4.5). At negative potentials, a peak 
corresponding to Cu
+/0 
is observed at -911 mV. After switching the scan direction, the 
Cu
0
 is then stripped off the electrode at -647 mV. The Cu
2+/+
 reduction potential for 
Tpm
iPr
Cu(OTf)2 (4) is -339 mV and the complex exhibits small separation between the 
cathodic and anodic waves (∆E 204 mV) relative to previously synthesized 
tris(pyrazolyl)Cu(I)-acetonitrile complexes (∆E 844 to 1778 mV),
32
 suggesting fast 
electron transfer kinetics during the voltammetry scan,
33
 or small reorganization energies 
between a five-coordinate Cu
2+








Figure 4.10. Cyclic voltammetry (CV) scan for the Tpm
iPr
Cu(OTf)2 (4) complex in 
acetonitrile vs. NHE. 
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The cyclic voltammogram of [Tpm
iPr
Cu(MISeox)][(OTf)2] (5) is very different 
from the analogous acetonitrile complex, Tpm
iPr
Cu(OTf)2 (4) due to the fact that it does 
not exhibit a typical Cu
+/0
 reduction and oxidation wave, but instead shows two different 
reduction and oxidation waves (Figure 4.11). These two redox waves correspond to 
Cu
2+/+
 reduction couples for [Tpm
iPr
Cu(MISeox)][(OTf)2] (5) at -508 mV and most likely 
a ligand (MISeox) based reduction potential at -1334 mV (Table 4.5). Complexation of 
MISeox to Tpm
iPr
Cu(OTf)2 (4) lowers the Cu
2+/+
 redox potential by 170 mV. The Cu
2+/+
 
reduction potential of -508 in 5 is comparable to the macrocyclic copper(II) complex 
[Cu(dtne)](ClO4)2·CH3CH2OH (-544 mV),
35
 but more negative compared to other 
reported Cu
2+






Figure 4.11. Cyclic voltammetry (CV) scan for [Tpm
iPr
Cu(MISeox)][(OTf)2] 







Compound Epa (mV) Epc (mV) ∆E (mV) E1/2 (mV) 





-236 -440 204 -338 
[Tpm
iPr
Cu(MISeox)][(OTf)2]  (5) 
remove space 










-647 -1175 528 -911 
 
The bis(1-methylimidazolyl) diselenide is used to mimic coordination of naturally 
occurring selenoneine diselenide to biologically relevant divalent metals such as Cu
2+
. 
The coordination of MISeox to Cu
2+
 occurs at the imidazolyl nitrogen atoms and alters 
Cu
2+/+




 reduction potential of -508 mV 
for 5 is much lower than that of cellular reductant NADH (-324 mV),
37
 and if similar 
copper complexes are formed in vivo their potentials may be lower enough to prevent 
reduction of Cu
2+
 and biological copper redox cycling.  
 
Conclusions 




 with concomitant formation of the 
oxidized diselenide and disulfide dications. The reduction of Cu(OTf)2 by dmise or dmit 
Table 5. Reduction potentials of MISeox, Tpm
iPr
Cu(OTf)2 (4), and 
[Tpm
iPr






 reduction potential of  Tpm
iPr






results in formation of diselenide or disulfide dications which are stabilized by two 
triflate anions (1 and 2, respectively), whereas reduction of CuCl2 by dmise forms the 
diselenide dication stabilized by a centrosymmetric [Cu3Cl5]
2-
 anion (3). This complex 
anion has two geometrically distinct Cu
+
 centers bridged by chloride atoms. The 
diselenide compound MISeox coordinates Cu
2+
 through both the imidazolyl nitrogen 
atoms as a bidentate ligand. X-ray structural analysis revealed that the Cu
2+
 center in 
[Tpm
iPr
Cu(MISeox)][(OTf)2] (5) adopts a distorted square pyramidal geometry. MISeox 
coordination to Tpm
iPr
Cu(OTf)2 (4) lowers the Cu
2+/+
 reduction potential by 170 mV 
compared to Tpm
iPr
Cu(OTf)2, thus stabilizing Cu
2+
.  
The results presented in this chapter illustrate the ability of dmise and dmit to 
reduce Cu
2+
. In addition studies with Cu
2+
-MISeox coordination shed new light on the 
possible coordination chemistry of selenoneine diselenide and the analogous 
ergothioneine disulfide with biologically relevant metal ions such as Cu
2+
. Diselenide 
coordination may result in lowered Cu
2+/+
 reduction potentials, and could potentially slow 
the rate of copper redox cycling to inhibit copper-mediated oxidative damage. 
 
Experimental Methods 
Materials. Methanol and acetonitrile were dried using standard procedures and 
freshly distilled prior to use. The following compounds were synthesized according to 














 and bis(1-methylimidazolyl) diselenide.
31
 The 
following reagents were used as received: 3,5-dimethyl-1-pyrazole (Aldrich), tetra-n-
butylammonium bromide (Aldrich), sodium carbonate (VWR), selenium powder, sulfur 
powder, diisobutyrylmethane (VWR), hydrazine monohydrate (VWR), 1-
















H} NMR spectra were obtained 











H} NMR chemical 
shifts are reported relative to dimethyl selenide (δ 0) and externally referenced to 










Infrared spectra were obtained using nujol mulls on KBr salt plates using a Magna 
550 IR spectrometer. Abbreviations used in the description of vibrational data are as 
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization 
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System 
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a 
Turbo Ionspray ionization source. Samples were run under both positive and negative 
mode, with ionspray voltage of 5500, and TOF scan mode. MALDI-TOF-MS was 
conducted on a Bruker Microflex. Trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-
propenylidene]-malononitrile was used as a matrix for co-crystallization of the copper 
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complex characterized. All the peak envelopes matched their calculated isotopic 
distributions. 
Formation of [(C5N2H8Se)2][(OTf)2] (1) by oxidation with Cu(OTf)2. Cu(OTf)2 
(362 mg, 1 mmol) was dissolved in acetonitrile (15 mL) to give a light blue solution, and 
to this was cannula added a solution of dmise (175 mg, 1 mmol) in acetonitrile (10 mL). 
Upon addition, the solution color changed from light blue to orange. The reaction mixture 
was stirred for 6 h, and then the solvent volume was reduced to about 5 mL in vacuo. The 
desired product was precipitated by addition of ether, and the solid precipitate was 
filtered and dried in vacuo. Crystals of 1 were grown via slow vapor diffusion of ether 
into acetonitrile solution. Yield 37% (240 mg, 0.369 mmol). Mp. 227 °C. 
1
H NMR 




H} NMR (CD3CN): 37.59 (CH3), 








H} NMR (CD3CN): 
329.37. UV-vis (CNCH3): 206, 226 (shoulder), 275 nm. IR (cm
-1
): 517 s, 573 s, 620 s, 
637 vs, 666 s, 739 s, 749 vs, 778 s, 1029 vs, 1139 vs, 1223 vs, 1254 b, 1377 vs, 1407 w, 
1463 vs, 1502 vs, 1566 s, 1598 w, 2728 w, 2853 b, 3128 w, 3154 w, 3177 w. ESI-MS: 
m/z positive ionization: 175.9 [(C5N2H8Se)2]
2+
; negative ionization 148.97 [(CF3SO3)2]
2-
. 
Anal. Calc. for C12H16N4Se2O6S2F6 : C, 22.23; N, 8.64; H, 2.49. Found C, 22.05; N, 8.43; 
H, 2.28.
 
Formation of [(C5N2H8S)2][(OTf)2] (2) by oxidation with Cu(OTf)2. Cu(OTf)2 
(362 mg, 1 mmol) was dissolved in acetonitrile (15 mL), and to this solution was cannula 
added dmit (192 mg, 1.5 mmol) in acetonitrile (10 mL). Upon addition, the color changed 
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from light blue to light yellow. The reaction mixture was stirred for 6 h, and then the 
solvent volume was reduced to about 5 mL in vacuo. The product was precipitated out 
using ether and the precipitate was filtered and dried in vacuo. Crystals of 2 suitable for 
X-ray diffraction analysis were grown through slow vapor diffusion of ether into 
acetonitrile. Yield 34% (189 mg, 0.339 mmol). Mp. 181°C.
 1
H NMR (CD3CN): 3.73 (s, 6 









H} NMR (CD3CN): -79.24. UV-vis (CNCH3): 215, 265, 305 
(shoulder) nm. IR (cm
-1
): 517 s, 573 s, 637 vs, 679 s, 723 s, 741 s, 754 vs, 790 s, 1031 vs, 
1139 vs, 1232 vs, 1259 b, 1377 vs, 1407 s, 1463 vs, 1506 vs, 1564 s, 1603 w, 2361 w, 
2727 w, 2913 b, 3123 w, 3152 w. ESI-MS: m/z positive ionization: 128.2 [(C5N2H8S)2]
2+
; 
negative ionization; 148.98 [(CF3SO3)2]
2-
. Anal. Calc. for C12H16N4S4O6F6 : C, 25.99; N, 
10.10; H, 2.91. Found C, 25.85; N, 9.95; H, 2.73. 
Formation of [(C5N2H8Se)2][Cu3Cl5] (3) by oxidation with CuCl2. CuCl2 (135 mg, 
1 mmol) was dissolved in ethanol (15 mL), and to this solution was cannula added dmise 
(175 mg, 1 mmol) in dichloromethane (10 mL). Upon addition, the solution changed 
color from light brown to dark brown. The reaction mixture was stirred for 6 h and a red 
solid precipitated from the solution. The precipitate was filtered and dried in vacuo. 
Crystals of 3 were grown through slow vapor diffusion of ether into acetonitrile solution. 
Yield 20% (153 mg, 0.200 mmol). 
1





H} NMR (d6-DMSO): 37.03 (CH3), 122.25 (CH), C-Se resonance not 
observed. IR (cm
-1
): 467 w, 504 w, 660 vs, 739 vs, 761 s, 1079 w, 1155 s, 1223 vs, 1243 









Cu(OTf)2 (4). Cu(OTf)2 (362 mg, 1 mmol) was dissolved in acetonitrile (10 
mL), and to this was added Tpm
iPr
 (428 mg, 1 mmol) in acetonitrile (10 mL). The 
reaction mixture was stirred for 4 h, dried in vacuo, and the obtained green solid product 
was washed with diethyl ether and dried in vacuo to afford Tpm
iPr
Cu(OTf)2. Yield: 89% 
(724 mg, 0.89 mmol). UV-vis (CH3CN): 272 nm. Mp: 132°C. IR (cm
-1
): 517 s, 573 s, 
638 s, 673 s, 724 s, 755 s, 832 s, 904 w, 924 w, 1031 s, 1059 s, 1153 s, 1268 s, 1377 s, 









. Anal. Calc. for C39H60CuF6N10O7S2Se2: C, 39.68; 





Cu(OTf)2 (4) (414 mg, 0.5 mmol) was 
dissolved in acetonitrile (10 mL), and into this solution was cannula transferred MISeox 
(162 mg, 0.5 mmol) in dichloromethane (10 mL). Upon addition, the color of the reaction 
mixture changed from blue to brown. The reaction mixture was stirred for 4 h, the solvent 
volume was reduced to about 3 mL, and a light green solid was precipitated with ether. 
The solid was then filtered and dried in vacuo. Crystals of 4 suitable for X-ray analysis 
were grown by slow vapor diffusion of ether into acetonitrile solution. Yield: 81% (450 
mg, 0.405 mmol). UV-vis (CH3CN): 268 nm. IR (cm
-1
): 517 s, 573 w, 638 s, 683 s, 725 s, 
771 s, 831 s, 922 w, 944 w, 1014 w, 1030 s, 1057 s, 1156 s, 1189 w, 1224 w, 1261 s, 
1378 s, 1463 s, 1560 s, 1638 w, 2286 w, 2855 s, 2926 b, 3116 s, 3470 b. Mass spectrum 
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. Anal. Calc. for 
C39H60CuF6N10O7S2Se2: C, 39.68; N, 11.86; H, 5.12. Found: C, 40.12; N, 11.96; H, 5.24.  
X-ray data collection and structural determination. Crystals were grown by vapor 
diffusion of diethyl ether into an acetonitrile solution for [(C5N2H8Se)2][(OTf)2] (1), 
[(C5N2H8S)2][(OTf)2] (2), [(C5N2H8Se)2][Cu2Cl5] (3), and [Tpm
iPr
Cu(MISeox)][(OTf)2] 
(4). Single crystals were mounted on a glass filament with silicon grease and immediately 
cooled to 168±2 K in a cold nitrogen gas stream. Intensity data were collected using a 
Rigaku Mercury CCD detector and an AFC8S diffractometer. The space groups P21/c for 
1 and 2, C2/c for 3, and P21/n for 4 were determined from the observed systematic 
absences. Data reduction including the application of Lorentz and polarization (Lp) 
effects and absorption corrections used the CrystalClear program.
42
 The structures were 
solved by direct methods and subsequent Fourier difference techniques, and refined 
anisotropically, by full-matrix least squares, on F
2
 using SHELXTL 6.10.
43
 
Crystallographic data for 1, 2, 3, and 5 are summarized in Tables 4.7 and 4.8. In the final 
cycle of least squares, independent anisotropic displacement factors were refined for the 
non-hydrogen atoms and the methyl hydrogen atoms were fixed in idealized positions 
with C-H = 0.96 Å. Their isotropic displacement parameters were set equal to 1.5 times 
Ueq of the attached carbon atom. The high wR2 value for complex 5 is due to disorder of 





 1 2 
Chemical Formula C12H16F6N4O6S2Se2 C12H16F6N4O6S4 
F.W. (g/mol) 648.33 554.53 
Space group P21/c P21/c 
Temp./K 168±2 168±2 
Crystal system Monoclinic Monoclinic 
a, Å 8.5501(17) 8.5235(17) 
b, Å 20.249(4) 19.874(4) 
c, Å 13.002(3) 12.926(3) 
α, ° 90 90 
β, ° 100.53(3) 98.29(3) 




Z 4 4 
Dcal, Mg/m
3
 1.946 1.700 
Indices  (min) [-9, -21, -16] [-10, -22, -16] 
              (max) [10, 25, 16] [10, 24, 16] 
Parameters 293 293 
F(000) 1272 1128 
μ, mm
-1
 3.580 0.528 
2θ range,  2.57- 26.25 2.41 – 26.32 
Collected reflections 18636 18721 
Unique reflections 4449 4393 
Final R (obs. Data)
a
, R1 0.0346 0.0471 
                 wR2 0.0839 0.1192 
Final R (all data), R1 0.0383 0.0568 
                 wR2 0.0870 0.1304 
Goodness of fit (S) 1.125 1.105 
Extinction coefficient 0.0022(9)  
Largest diff.  Peak 0.621 0.689 
Largest diff.  Hole -0.712 -0.476 
 
  
Table 4.7. Summary of crystallographic data for complexes 1 and 2.  
 
a












 3 4 
Chemical Formula C12H16N4Se2Cu3Cl5 C39H60CuF6N10O7S2Se2 
F.W. (g/mol) 716.06 1180.55 
Space group C2/c P21/n 
Temp./K 168±2 168±2 
Crystal system Monoclinic Monoclinic 
a, Å 12.238(2) 15.196(3) 
b, Å 12.217(2) 24.359(5) 
c, Å 14.123(3) 15.260(3) 
α, ° 90 90 
β, ° 108.61(3) 116.96 




Z 4 4 
Dcal, Mg/m
3
 2.383 1.557 
Indices  (min) [-10, -15, -17] [-15, -28, -18] 
              (max) [15, 15, 17] [18, 28, 16] 
Parameters 112 614 
F(000) 1376 2412 
μ, mm
-1
 7.466 2.040 
2θ range,  3.04-26.29 2.69-25.05 
Collected reflections 8327 33101 
Unique reflections 2022 8864 
Final R (obs. Data)
a
, R1 0.0435 0.0771 
                 wR2 0.1043 0.1972 
Final R (all data), R1 0.0546 0.1001 
                 wR2 0.1137 0.2159 
Goodness of fit (S) 1.111 1.087 
Extinction coefficient   
Largest diff.  Peak 1.216 1.673 
Largest diff.  Hole -1.122 -0.731 
 
Table 4.8. Summary of crystallographic data for the complexes 3, and 4.  
 
  a












Figure 4.12. MALDI-TOF-MS for Tpm
iPr
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SYNTHESIS, CHARACTERIZATION, AND DFT STUDIES OF THIONE AND 
SELONE, Cu(I) COMPLEXES WITH VARIABLE COORDINATION GEOMETRIES 
 
Introduction 
  There is increased interest in the chemistry of copper with soft Lewis base 
donors such as thiolates, thioamides, selenolates and selenoamides for use in 
catalysis
1
 and in bioinorganic chemistry for the study of copper metallothioneins and 
metallochaperones.
2-5
 Of particular interest is the coordination chemistry of selenium 
with biologically-important transition metals (Cu, Fe, Ni, Zn, Mn, Mo, etc.), since 
selenium has been shown to possess stronger and unique antioxidant properties 
relative to sulfur.
6-8
 Our group has determined that copper coordination to sulfur and 
selenium containing ligands is a novel mechanism for selenium and sulfur antioxidant 
activity.
9-13
 We are interested in the chemistry of N,N’-dimethylimidazole selone 
(dmise) and thione (dmit) because these and similar ligands are effective antioxidants 
(FFigure 5.1).
14,15
 The dmise and dmit ligands are similar to methimazole, a drug 
currently used in the treatment of hyperthyroidism,
16





 sulfur- and selenium-containing antioxidants 
naturally found in plants and animals. 
  The coordination of heterocyclic thioamides and selenoamides to copper 
results in diverse architectures ranging from mononuclear complexes to polynuclear 
networks with a variety of binding modes. The coordination modes of the heterocyclic 
125 
 
chalcogenones range from monodentate to bridging via coordination of sulfur or 
selenium atoms.
19-21
 Mono-alkylated heterocyclic thiones and selones can also bind 
metals via the non-alkylated nitrogen atom.
22-24
 The applications and coordination 











 Although the 
coordination chemistry of N-alkylimidazole thiones and N,N‟-dialkylimidazole 
thiones with transition metals is well developed,
1,20,21,25,26,31-34
 few reported 














 HgCl2(N-i-PrImSe)2, (N-i-PrImSe = N-isopropyl-
imidazolidine-2-selone),
40










[2ClO4], (phen = phenanthroline),
42
 Cu2LY3 (Y = Cl, Br; L = N,N’-
dimethylimidazolidine selone),
43






  This work reports the synthesis of copper halide complexes with dmise and 
dmit ligands, with the aim of studying their different coordination modes and 
















; Y = Cl
-
) have been synthesized 










H} NMR spectroscopy, cyclic 
voltammetry, X-ray structural analysis, X-ray powder diffraction (XRD), and  
electrospray ionization mass spectrometry (ESI-MS). Observed differences in the 
coordination geometries and packing orientations of these complexes are also 
examined using density functional theory (DFT) calculations. This chapter has been 
submitted to Dalton Transactions for publication (Kimani, M. M.; Brumaghim, J. L.; 




Results and Discussion 
 Synthesis of Cu(I)-chalcogenone halide complexes. The target metal 
complexes were synthesized by treating copper halides with either one or two molar 
equivalents of selone or thione. The reaction of CuI and CuBr with one molar 
equivalent of dmise resulted in formation of tetranuclear copper complexes with 
bridging selone ligands (1 and 6; Figure 5.2A). The tetranuclear copper-iodide-selone 
complex (1) can also be synthesized via a two-step, one-pot reaction with molar 
equivalents of [Cu(NCCH3)4][BF4] and dmise in acetonitrile followed by cannula 
addition of KI in methanol. The reaction of CuI with dmise results in an insoluble 
precipitate that is redissolved by addition of KI in methanol, similar to a method 
previously described by Niu, et al.
46
 Both synthetic methods result in similar yields of 
1. 
  Treating CuI with two molar equivalents of dmise or dmit in acetonitrile  and 
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dichloromethane results in the formation of monomeric three-coordinate copper-iodo 
complexes (2 and 3a) characterized by intramolecular π-π interactions between the 
two heterocyclic five-membered rings (Figure 5.2B). In contrast, treating two molar 
equivalents of dmit with CuI in a mixed solvent system of ethanol and 
dichloromethane results in the formation of a trigonal copper complex (3b) with no 
intramolecular π-π interactions (Figure 5.2C). 
    
 
 
   
  The three-coordinate copper chloride or bromide complexes (4, 5, 7, and 8) are 
Figure 5.2. Synthetic procedures for the preparation of tetrameric and trigonal 
planar copper complexes. 
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synthesized by treating two molar equivalents of dmit or dmise with CuCl or CuBr in 
a mixed solvent system (Figure 5.2C). The X-ray crystal structure of Cu(dmit)2Cl has 
been reported by Kim, et al. but its synthesis and characterization was not reported.
1
 
The trigonal copper complexes (2, 3a, 3b, 4, 5, 7 and 8) can be synthesized with good 
yields (85-92%), whereas the tetrameric complexes 1 and 6 have an average yield of 
23%. Crystals of the target metal complexes are stable in air but the Cu
+
 ions are 
easily oxidized to Cu
2+
 in solution. 
 Crystallographic studies of tetrameric Cu(I) halides complexes with 
heterocyclic selone ligands. The X-ray crystal structures of Cu4(μ-dmise)4(μ-
I)2I2·1.5CNCH3 (1) and Cu4(μ-dmise)4(μ-Br)2Br2·0.5CNCH3  (6) show two different 
coordination geometries around the copper ions (Figure 5.3). Two selenium atoms 
and one iodide or bromide ion coordinate to a single Cu(I) ion, forming a three-
coordinate complex with the selone ligands adopting a cis conformation relative to 
I(2)/Br(2) and I(2A)/Br(2A) along the copper chalcogenone bond. The Cu(2) and 
Cu(2A) ions have distorted trigonal planar geometry. Trigonal copper bond angles 
range from 116.11(3)° to 121.81(6)° in 1 and from 119.56(3)° to 119.71(5)° for the 
less distorted trigonal copper centers in 6. Cu-I and Cu-Br bond distances are 2.58 Å 
and 2.43 Å, respectively, for 1 and 6, and the Cu-Se bond distances are 2.42 Å and 
2.41Å, respectively. 
  The two additional copper centers (Cu(1) and Cu(1A)) in 1 and 6 adopt 









1:1 complex X=I; Y=Se  
(EXP)  (1) 
X=I; Y=Se  
(DFT) 
X=Br; Y=Se  
(EXP)  (6) 
X=Br; Y=Se  
(DFT) 
Cu(1)-Y 2.4148(8) 2.470 2.4087(7) 2.446 
Cu(1)-X(1) 2.7613(9) 2.731 2.6470(10) 2.582 
Cu(1)-Cu(1A) 2.607(2) 2.591 2.631(2) 2.630 
Cu(2)-Y(2) 2.4203(9) 2.459 2.4130(8) 2.434 
Cu(2)-X(2) 2.5820(13) 2.566 2.4298(13) 2.382 
Cu(2)-X(1) 3.251 3.492 3.428 3.763 
Y-Cu(2)-Y 121.81(6) 119.9 119.71(5) 118.3 
Y-Cu(2)-X(2) 116.11(3) 118.7 119.56(3) 120.7 
Y-C(1) 1.882(5) 1.904 1.890(5) 1.900 
 
distance 2.62 Å) and two bridging selenium atoms from the dmise ligand. Each Cu
+
 
ion in the core has distorted tetrahedral geometry with angles about each copper 
Table 5.1. Experimental crystal data (EXP) vs. theoretical DFT calculations 
for selected bond lengths (Å) and angles (deg) of  Cu4(μ-dmise)4(μ-I)2I2 (1) 
and Cu4(μ-dmise)4(μ-Br)2Br2 (6).    
 
Figure 5.3. X-ray crystal structure diagrams of Cu4(μ4-dmise)(μ-I2)I2 (1; left) 
and Cu4(μ4-dmise)(μ-Br2)Br2  (6; right) showing 50% probability density 




varying from 89.6 to 140.7° in 1 and 90.3° to 142.7° in 6. The central Cu2(μ-I)2 core  
in 1 is rhomboidal with bridging Cu-I bond distances of 2.76 Å, longer than the 
terminal Cu-I bond distances of 2.58 Å. The angles in the Cu2(μ-I)2 core are 56.3° for 
I(1)-Cu(I)-(1A) and 123.7° for Cu(1)-I(1)-Cu(1A), whereas the Cu2(μ-Br)2 core in 6 
has Br(1)-Cu(1)-Br(1A) and Cu(1)-Br(1)-Cu(1A) angles of 50.6° and 120.4°, 
respectively (Table 5.1). The tetrameric complex 6 has bridging Cu-Br bond distances 
of 2.65 Å, longer than the terminal Cu-Br bond distances of 2.43 Å. 
  In the X-ray structures of 1 and 6, the average Cu-Se bond lengths of  2.41 Å 
are shorter or comparable to most reported bridging copper-selenium complexes in 
the literature
47-49
 but longer than previously synthesized mononuclear copper-selone 
complexes such as [Tpm*Cu(dmise)]
+
 (2.30 Å) and Tp*Cu(dmise) (2.33 Å).
19
  The 
bond distances for Cu(1)-I(1) (2.76 Å), Cu(2)-I(2) (2.58 Å), Cu(1)-Br(1) (2.65 Å) and 









 (2.73 Å), respectively.
50
 Short-contact interactions between iodine 
and hydrogen atoms are observed in the packing diagram of complex 1 (Figure 5.8), 
whereas the packing diagram of complex 6 shows no short-contact interactions. The 
short contact interactions of 3.16 Å between I(2)-H2B in 1 are within the sum of their 
van der Waals radii (3.18 Å) and possibly promote stability of this complex. The long 
Cu(1)-Cu(1A) distances in 1 and 6 indicate little interaction between these ions. 
 Density functional theory studies for tetrameric copper(I) halide complexes. 
Theoretical DFT calculations were conducted on the tetrameric complexes 1 and 6 to 
determine the effects of the halide and chalcogenone ligands on the observed crystal 
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structures. The DFT(B3PW91)-optimized structures of 1 and 6 were optimized in C2h 
symmetry and are in good agreement with X-ray crystallographic data (Table 5.1) 
with bond distances and angles generally within 0.04 Å and 2° of experimental 
values. The Cu(2)-X(1) short contact is underestimated (DFT(B3PW91) = 0.25-0.35 
Å; DFT(BP86) = 0.4-0.55 Å), especially for the BP86 xc functional which is known 
to perform poorly for non-bonding interactions. Slight overestimation of the 
calculated X-H2B short contacts may be attributed to the absence of intermolecular 
X-H interactions in the gas phase. The DFT(B3PW91)-optimized geometries of the 
hypothetical thione analogs (1(S) and 6(S)) were similar to 1 and 6 with shorter Cu-Y 
bond distances. The energies of formation (ΔE+ZPE) of these species relative to the 
CuX(dmit/dmise) monomers were ~10 kcal/mol less favorable than for 1 and 6. 
 Crystallographic studies of trigonal Cu(I) halides complexes with heterocyclic 
selone and thione ligands Treating copper halides with two equivalents of dmise or 
dmit results in the formation of monomeric three-coordinate complexes with differing 
geometries. The molecular structures and atom numbering schemes for Cu(dmise)2I 
(2), Cu(dmit)2I (3a), and Cu(dmise)2Br (8) are given in Figure 5.4, and Table 5.2 lists 
their selected bond distances and angles. X-ray structural studies established that 
these complexes are monomeric with two non-bridging selone and thione ligands 
coordinated to copper. The heterocyclic rings in complexes 2, 3a, and 8 adopt a trans 
conformation relative to the halogen atom along the copper-chalcogenone bond. The 
Cu
+
 ion has distorted trigonal geometry with angles ranging from 111.56° to 136.87° 
for Cu(dmise)2I (2); 111.82° to 136.87° for Cu(dmit)2I (3a); and 108.0° to 144.0° for 
132 
 
Cu(dmise)2Br (8). The Cu-Se and Cu-S bond distances are 2.34 Å for 2 and 8 and 
2.23 Å for 3a, whereas the avg. Cu-I bond distance of in 2 and 3a is 2.56 Å. Short 
contact interactions between iodine and hydrogen atoms are found within the unit cell 
of Cu(dmit)2I (3a; Figure 5.9) but are absent in the unit cell of the selenium analog 
Cu(dmise)2I (2). The short contact interaction of 3.18 Å between I and H5C is equal 





   
1:2 
complex 
X=I; Y=S  
(EXP) (3a) 
X=I; 














Cu-X 2.5742(6) 2.497 2.5585(10) 2.507 2.4117(10) 2.334 
Cu-Y 2.2345(10) 2.301 2.3351(8) 2.394 2.3430(7) 2.408 
X-Cu-Y 111.823(19) 114.3 111.56(2) 111.4 107.983(17) 113.7 
Y-Cu-Y 136.35(4) 131.4 136.87(4) 137.1 144.03(4) 132.6 
C-Y-Cu 107.59(7) 113.2 105.55(13) 110.0 103.74(12) 110.6 
Y-C(1) 1.715(2) 1.710 1.864(4) 1.871 1.867(4) 1.867 
Table 5.2. Experimental X-ray data (EXP) vs. theoretical DFT calculations for 
selected bond lengths (Å) and angles (deg) for Cu(dmit)2I (3a), Cu(dmise)2I (2), and 
Cu(dmise)2Br (8). 
Figure 5.4. X-ray crystal structure diagrams of the trans structures: A) Cu(dmise)2I 
(2), B) Cu(dmit)2I (3a), and C) Cu(dmise)2Br (8) showing 50% probability ellipsoids. 




  Relatively short distances between the selone heterocyclic ligands ranging 
from 3.63 Å (A) to 3.95 Å (B) are observed for 2 (Figure 5.5), whereas distances of 
3.67 Å (A) to 3.90 Å (B) are observed between the two heterocyclic thione ligands in 
complex 3a, indicating intramolecular π-π interactions are present in both. In contrast, 
complex 8 exhibits no intramolecular π-π interactions between the two heterocyclic 
rings (minimum distance 4.13 Å) due to a shift in the C(1)-Se(1)-Cu(1)-Se(1A) 
torsion angle (-11.08°) that results in a staggered orientation of the two five-
membered rings. The copper complexes 2, 3, and 8 have no intermolecular π-π 




  Treating copper halides with two equivalents of dmit or CuCl with two 
equivalents of dmise also results in the formation of monomeric copper thione/selone 
complexes. X-ray structural analysis shows that Cu(dmit)2I (3b), Cu(dmit)2Cl (4), 
Cu(dmise)2Cl (5), and Cu(dmit)2Br (7) have planar, three-coordinate geometry around 
the Cu
+
 ion with one halide anion and two terminal thione or selone ligands. In each 
case, the heterocyclic rings of the thione or selone ligands adopt a cis conformation 
relative to the halide atoms (Figure 5.6).  
Figure 5.5. Diagram showing π-π 













 X=Cl; Y=S 
(EXP) (4) 
X=Cl; Y=S  
(DFT) 
X=Br; Y=S  
(EXP) (7) 
X=Br; Y=S  
(DFT) 
Cu-X 2.2497(9) 2.252 2.3857(8) 2.387 
Cu-Y 2.2376(6) 2.282 2.2298(9) 2.285 
X-Cu-Y 120.692(17) 121.69 118.84(2) 121.67 
Y-Cu-Y 118.62(3) 116.62 122.32(5) 116.66 
C-Y-Cu 106.07(7) 98.26 104.00(10) 98.84 
Y-C(1) 1.714(2) 1.72 1.717(3) 1.72 
Figure 5.6. Crystal structure diagrams of A) Cu(dmit)2I (3b), B) Cu(dmit)2Cl (4), C) 
Cu(dmit)2Br (7), and D) Cu(dmise)2Cl (5) displaying 50% probability density 
ellipsoids. Hydrogen atoms are omitted for clarity. 
 
Table 5.3. Experimental crystal data vs. theoretical DFT calculations for 






  The Cu
+
 ion has distorted trigonal geometry with angles ranging from 116.8° 
to 123.4° for Cu(dmit)2I (3b); 118.6° to 120.7° for Cu(dmit)2Cl (4); and 118.8° to 
122.3° for Cu(dmit)2Br (7). The Cu-S bond distances in complexes 3a (trans-
Cu(dmit)2I), 3b (cis-Cu(dmit)2I), 4, and 7 range 2.23 to 2.41 Å (Table 5.3 and 5.4). 
The Cu
+
 ion in complex 5 has a distorted trigonal geometry with angles ranging from 
113.9° to 125.8°, and its Cu-Se bond distance of 2.34 Å is identical to that of 
Cu(dmise)2I (2) and Cu(dmise)2Br (8) (2.34 Å) but shorter than those found in the 
tetrameric copper complexes 1 (2.42 Å) and 6 (2.41 Å). 
  Changes in the halide ligand have no significant effects on Cu-S bond 
distances, since the Cu-S bond lengths of 2.2345(10) Å for trans-Cu(dmit)2I (3a), 
avg. 2.2401(11) Å for cis-Cu(dmit)2I (3b), 2.2376(6) Å for Cu(dmit)2Cl (4) and 
2.2298(9) Å for Cu(dmit)2Br (7) are very similar. The Cu-S bond distances in 3a, 3b, 
4, and 7 are comparable to previously reported trigonal planar or tetrahedral 
coordinated copper complexes,
19,51-55
 but shorter than other reported copper thione 
complexes such as Cu2X2(mimzSH)4 (X = Cl, Br, I, and mimzSH = 1-methyl-1,3-




X=Cl; Y=Se (EXP) 
(5) 
X=Cl; Y=Se  
(DFT) 
Cu-X 2.5373(9) 2.550 2.238(2) 2.253 
Cu-Y 2.2401(11) (avg) 2.291 2.3459(14) (avg.) 2.392 
X-Cu-Y 120.085(3) (avg) 122.8 123.00(7) (avg.) 122.0 
Y-Cu-Y 119.84(5) 114.5 113.89(5) 116.0 
C-Y-Cu 99.425(12) (avg) 99.3 104.5(2) 94.9 
Y-C(1) 1.712(3) (avg.) 1.720 1.862(8) 1.878 
Table 5.4. Experimental crystal data vs. theoretical DFT calculations for selected 











-S-μ-C5H5NS)(p-Tol3P)]2 (2.39 and 2.42 Å).
31
 Coordination of the thione 
ligand to copper in complexes 3a, 3b, 4, and 7 results in almost identical S-C(1) bond 
distances, 1.71-1.72 Å, which are longer than the S-C(1) bond distance in the free 
thione ligand (1.68 Å).
58
 Increasing van der Waals radii of the halogens coordinated 
to copper (1.7-1.9 Å for Cl < 1.8-2.0 Å for Br < 1.95-2.12 Å for I),
50
 results in 
decreased C(1)-S(1)-Cu(1) bond angles; Cu(dmit)2Cl (4; 106.1°), Cu(dmit)2Br (7; 
104°), and cis-Cu(dmit)2I (3b; average 99.5°). 
  The three-coordinate copper-selone complexes Cu(dmise)2I (2), Cu(dmise)2Cl 
(5), and Cu(dmise)2Br (8) have identical Cu-Se bond distances of 2.34 Å, distances 
shorter than previously-reported copper selenium complexes such as [Cu(o-
C6H4(SeMe)2)2][PF6] (2.42 Å),
59
 and [Cu(C11H14Se2)2][BF4] (average 2.41 Å).
60
 The 
Cu-Se bond length of 2.34 Å in complexes 2, 5, and 8 is longer than that in the 





(2.29-2.31 Å), and Tp*Cu(dmise) (2.33 Å).
19
 Coordination of the selone ligand to 
copper results in relatively unchanged Se-C(1) bond lengths of 1.88 Å for 1 and 1.89 
Å for 6, but slightly shorter Se-C(1) bond lengths of 1.86 Å for 2 and 5 and 1.87 Å for 
8, relative to that of the uncoordinated dmise ligand (1.89 Å).
61
 The polarizability and 
size differences between chloride, bromide and iodide have the most pronounced 
effect on the X-ray structures of complexes 1, 2, 3a, 3b, 4, 5, 6, 7, and 8, but have no 




 Density functional theory studies for trigonal copper halide complexes. 
DFT(B3PW91) geometry optimizations predict the cis isomer to be the lowest energy 
conformation for each of the 1:2 Cu:thione/selone complexes. The geometries of 3b, 
4, 5, and 7 agree with the X-ray structures of (Table 5.3 and 5.4) and accurately 
reproduce the X-H5C short contacts (3.160, 2.711, 2.742, 2.888 Å, respectively). Full 
optimization of complexes 2, 3a, and 8 in C2 symmetry using the BP86 xc functional 
led to a C2v configuration in which there is no -π interaction and the imidazole rings 
of the thione/selone ligands form an electrostatic interaction with the halide (anion-π 
interaction). Surprisingly, the C2v conformation is roughly degenerate (ΔE+ZPE < 1.0 
kcal/mol) with the experimentally observed structures indicating that the anion-π and 
X-H5C interactions between the halide and the dimethylimidazole fragment are 
similar in magnitude. 
  To obtain conformations with -π interactions, the 1:2 complexes were 
optimized with the N2(2)-C(2)-Se-Cu dihedral angles constrained to the experimental 
value followed by a full optimization with a small step size in the search algorithm.  
The local minima with π-π interactions were found only for 2, 3a, and 8 and their 
structures generally agree with the experimental X-ray crystal data (Table 5.2).  
However, these structures were ~10 kcal/mol less stable than structures without 
intramolecular π-π interactions. In addition, the experimental structures show an 
apparent attractive interaction between the π-clouds of the dimethylimidazole rings 
(d(C1-C1A) < d(C3/4-C3/4(A)), not found in the DFT calculations. This attraction 
may be due to X-H3/4 interactions between molecules in the crystal, which would 
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explain why the „attractive‟ interaction is more pronounced when X is the smaller 
bromide (8). This suggests that for the structures of 2, 3a, and 8, π-π interactions may 
actually be preferred conformations due to the weak hydrogen-bonding interactions 
between units of the crystal.  Such a conformation would be disfavored for X = Cl due 
to repulsive forces at the shorter C3/4-C3/4(A) distances required for Cl-H3/4 
interactions to the smaller halogen. The lack of π-π interactions in 8 may be explained 
similarly if Br-H3/4 interactions are comparable to Se-H5 interactions such that 
complex 8 maintains the face-to-face orientation of the heterocyclic rings, but with a 
twist to increase the Se-H5 interaction. 
  For comparison to 1 and 6, the energies of formation of the cis 1:2 complexes 
from CuX(dmit/dmise) and an additional dmit/dmise ligand were calculated. The 
energy per chalcogenone is lower for the selones than the thiones (ΔE+ZPE = -6.0–-




). These values are comparable to the 
formation energy per chalcogenone for the hypothetical 1:1 sulfur analogues 1(S) 6(S) 




, respectively). Therefore, the 1:1 clusters are 
energetically preferred for selones, but, the similar energies per thione suggest that 
experimental conditions favor the 1:2 complexes. 
 Powder X-ray diffraction studies of copper(I) halide complexes. Powder X-ray 
diffraction (XRD) studies of both the tertrameric and monomeric copper complexes 
were carried out to determine whether more than one conformer was present in the 
reaction products. Experimental powder XRD patterns of the copper chloride 
complexes 4 and 5 fully matched their simulated patterns, suggesting that only the cis 
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conformer is formed and corroborating DFT calculation results (Figures 5.18-5.19). In 
contrast, powder XRD patterns reveal the presence of both cis and trans conformers 
of CuI(dmit)2 (3a and 3b; Figure 5.7) in powder samples. Diffraction patterns for Cu 
complexes 1, 2, 6, 7, and 8 also do not fully match the simulated patterns determined 
from their respective single crystallographic data (Figures 5.10-5.17), indicating that 
more than one conformer may be present.  Attempts to grow crystals of additional 
conformers using different solvent systems, seeding the crystallization solution with 
an analogous crystal of the desired conformer, or crystallizing at low temperatures 
were not successful. 
 
 Figure 5.7. Experimental powder X-ray diffraction pattern  of A)  CuI(dmit)2 
and simulated powder patterns for B) trans-CuI(dmit)2 (3a) and C) cis-




  Generally, structural and stoichiometric predictions of metal complexes 
depend on the geometrical flexibility of the metal ion coupled with the steric and 
electronic requirements of ligands. We found that changing the halide ligand had the 
most profound effect on the coordination number and geometry of the resulting 
copper-chalcogenone complexes. Similarly to previous reports,
62-64
 formation of 
halide bridges are generally favored for the soft iodide but not for the harder chloride 
ligands, whereas both bridging and terminal bonding modes were observed for the 
bromide ligands, since bromide lies on the borderline between soft and hard Lewis 
bases. Formation of the tetrameric bridging selone complexes 1 and 6 are likely 
favored by the presence of two highly polarizable atoms, selenium and iodine or 
bromine, with high propensities to bridge metal centers.  
  The conformations obtained for the three coordinate copper complexes 2, 3a, 
3b, 4, 5, 7, and 8, depend on several factors, including packing forces, halide ligand, 
and the number and strength of stabilizing short-contact interactions between X-H or 
Y-H (X = I, Br, or Cl; Y = Se or S). For the trigonal complexes 2 and 3a that have 
intramolecular π-π interactions between the heterocyclic rings, only very weak short 
contact intermolecular interactions between I-H atoms of 3.18 Å exist in 3a, whereas 
2 has no short-contact intermolecular interactions.  In contrast, complexes without 
intramolecular π-π interactions (3b, 4, 5, 7, and 8) have more significant short- 
contact intermolecular interactions between the halides or chalcogenones and 
neighboring hydrogen atoms. These short- contact interactions likely stabilize the cis 
conformations (or the twisted trans conformation of 8) of these complexes relative to 
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the trans conformations of 2 and 3a, corroborating DFT results indicating that 
complexes with intramolecular π-π interactions were generally less stable than 
structures without intramolecular π-π interactions. The lack of short contact 
interactions in 2 and 3a suggest that these complexes may be stabilized by the 
intramolecular π-π interactions between the heterocyclic rings, whereas complexes 
3b, 4, 5, 7, and 8 are primarily stabilized by crystal packing forces resulting from 
short-contact intermolecular interactions between X-H (X = Cl, Br, I, Se, and S). 
   IR spectroscopy. In the IR spectra of the copper thione complexes, the 
diagnostic ν(C=S) peak appears at lower wavenumbers (1171-1173 cm
-1
) for the 
trigonal complexes 3, 3b, 4, and 7 compared to 1181cm
-1
 for uncoordinated dmit.
65
 In 
contrast, the ν(C=Se) peaks are shifted to slightly higher energies (1149-1163 cm
-1
) 




 Although it 
is not clear why this difference between S and Se coordination occurs between these 
complexes, the shift to lower energy for ν(C=S) upon coordination of dmit to copper 
may indicate weakening of C=S bond due to copper back-bonding, whereas the shift 
to higher energy for ν(C=Se) upon dmise coordination to copper indicates a slight 
strengthening of the C=Se bond due to Cu-Se donor bond formation. The same trend 
was observed for tetrahedral coordinated tris(pyrazolyl)methane/borate-copper-thione 
(ν(C=S) 1172-1178 cm
-1









 complexes of these ligands.
32,38,68
 DFT calculations assign the 
C=Se/S stretching band as symmetric and asymmetric modes.  For 3b, 4, 5, and 7, the 
lower-frequency asymmetric mode is more intense, whereas the symmetric stretch is 
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more intense for the face-to-face complexes 2, 3a, and 8.   
 NMR spectroscopy of copper(I) halide thione and selone complexes. For all the 
copper complexes 1-8, the 
1
H NMR resonances for the methyl and olefinic protons of 
the copper-bound dmise or dmit ligands are shifted downfield relative to unbound 
ligand, consistent with reports by Lobana, et al.,
20,21,56









H} NMR spectra, upfield shift of the C-2 resonance of the 
dmise  and dmit (both δ ~6) is also observed upon copper complexation. Similar 







 and Tp*Cu(L) (L = dmit or dmise).
19
 The downfield shift of the 
olefinic protons resonances in the 
1
H NMR spectra, as well as similar downfield shifts 




H} NMR spectra, may result from minor 
increases in deshielding effects on C-4 and C-5 carbons due to increased electron 
density on the C-N bond of the heterocyclic five-membered ring upon metal 
complexation and concomitant weakening of the C=S/Se bond.
70,71
 This explanation 
is consistent with the observed shift of the ν(C=S) band to lower energies upon dmit 
coordination, but not consistent with the observed shift of the ν(C=Se) band to higher 
energies, indicating differences between S and Se coordination in these complexes. 
  The trans conformer (3a) has thione 
1




H} resonances at  36.0, 120.4, and 155.1, whereas the cis conformer (3b) has 
thione 
1




H} resonances at  35.9, 120.2, and 
155.9. When the cis and trans conformers were combined in a single NMR sample, a 






H} NMR, indicating 
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H} NMR resonances for the copper-selone complexes 1, 2, 5, 6, and 8 
are shifted upfield (δ -13.4 to -75.0) upon copper coordination relative to the free 
dmise ligand (δ 21.8). This upfield shift is a result of the selenium atom binding to the 




H} NMR shifts. 
 Electrochemical studies of the copper halide complexes. Electrochemical 
properties of the copper(I)-halide complexes 1, 2, 3a, 3b, 4, 5, 6, 7, and 8 were 
examined by cyclic voltammetry (CV) to determine the difference in Cu
2+/+
 redox 
potential upon Cu-selone or Cu-thione coordination. Cyclic votammograms of these 





 redox potentials. A wave corresponding to the Cu
+/0
 redox 
couple is observed at potentials more negative than -1000 mV vs. NHE. The Cu
0
 is 
then stripped off the electrode after switching the scan direction at a potential around 
-800 mV (Table 5.6). 
  Electrochemical studies of the three-coordinate copper complexes 2, 3a, 3b, 4, 
5, 7, and 8 were carried out in acetonitrile solution with tetra-n-butylammonium 
phosphate electrolyte and a carbon working electrode. All the complexes exhibit 
chemically reversible Cu
2+/+ 
reduction waves. Complexes 2, 4, 5, 7 and 8 exhibit 
quasi-reversible oxidation and reduction waves, whereas complexes 1, 3a, 3b, and 6 
exhibit irreversible electrochemical behavior for the Cu
2+/+ 
couple (Table 5.5). The 
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selone complexes 2, 5, and 8 have lower Cu
2+/+
 reduction potentials ranging from 
-340 to -362 mV compared to Cu
2+/+
 reduction potentials of the analogous thione 
complexes 3a, 3b, 4, and 7, which range from -177 to -284 mV (CV voltammograms 
are provided in Figures 5.20). Additionally, the thione- copper complexes show larger 
peak separations between the cathodic and anodic waves compared to the copper 
selone complexes. The large peak separations of the copper thione complexes may 
indicatre instability of the oxidized products during the voltammetry sweep due to 
slow electron transfer kinetics.
72
 
  The copper selone complexes CuX(dmise)2 (X = I, Br and Cl) have reduction 
potentials more negative by an average of 108 mV relative to the copper thione 
complexes CuX(dmit)2 (X = I, Br and Cl), consistent with previous reports.
19
 The 
CuI(dmit)2 complex 3b (cis-conformation, -177 mV), has a more positive Cu
2+/+
 
reduction potential than complex 3a (trans-conformation, -239 mV). A mixed sample 
of the two conformers revealed a single Cu
2+/+







H} NMR data, indicate that these conformers interconvert 
in solution.  
  Cyclic voltammogram for CuCl(dmit)2 (4), CuCl(dmise)2 (5), CuBr(dmit)2 (7), 





redox potentials. In contrast, cyclic voltammograms of Cu4(μ4-dmise)(μ-I)2I2 (1),  
CuI(dmise)2 (2), CuI(dmit)2 (3a), CuI(dmit)2 (3b), and Cu4(μ4-dmise)(μ-Br)2Br2 (6) 












/Br2 reduction couples. As previously observed for copper 
halide complexes,
73,74
 the weakly coordinated iodide ligand in complexes 1, 2, 3a, and 
3b or bromide ligand in complex 6 may undergo ligand subtitution with solvent 
acetonitrile resulting in the observed halogen reduction peaks.   
  Differential pulse voltammetry (DPV) studies of complexes 1 and 6 exhibit 
two distinct reduction and oxidation peaks in their voltammograms, corresponding to 
Cu
2+/+
 and their respective halogen redox potentials (Figure 5.21). Thus, the 
tetrameric copper complexes 1 and 6 exhibit a single Cu
2+/+
 reduction potential at 










ΔE (mV) E1/2 (mV) 
Cu4(μ4-dmise)(μ-I2)I2       (1) 83, -235  0, -986 1069 -452 
Cu4(μ4-dmise)(μ-I2)I2       (1)
a 
34, -285 126, -
664 
92, 379 80, -475 







64, 381 -74, -436 
CuCl(dmise)2                    (5) -139 -570 431 -355 
CuCl(dmit)2                      (4) 52 -620 672 -284 
CuBr(dmise)2                    (8) -151 -584 432 -362 
CuBr(dmit)2                      (7) 41 -524 565 -241 
trans-CuI(dmit)2              (3a) 176 -653 829 -239 
cis-CuI(dmit)2                  (3b) 298 -651 949 -177 
Mixed (cis + trans)-CuI(dmit)2 192 -705 897 -256 




Table 5.5. Reduction potentials of Cu
2+/+
 for the copper selone and thione 









Epc (mV) ΔE (mV) E1/2 
(mV) 
Cu4(μ4-dmise)(μ-I2)I2       (1) -866 -1355 489 -1111 
Cu4(μ4-dmise)(μ-Br2)Br2  (6) -881 -1274 393 -1078
CuCl(dmise)2                    (5) -821 -1211 390 -1016 
CuCl(dmit)2                      (4) -861 -1232 371 -1046 
CuBr(dmise)2                    (8) -812 -1203 391 -1008 
CuBr(dmit)2                    (7) -850 -1219 369 -1034 
trans-CuI(dmit)2             (3a) -828 -1335 507 -1082 
cis-CuI(dmit)2                 (3b) -868 -1335 467 -1101 
Mixed (cis + trans)-CuI(dmit)2 -656 -1.321 665 -989 
CuI(dmise)2                    (2) -878 -1223 345 -1051 
 
The changes in Cu
2+/+
 reduction potentials of the three-coordinate complexes 2, 
3a, 3b, 4, 5, 7, and 8 are correlated to the halide and chalcogenone ligands. For the 
copper thione complexes, reduction potentials are shifted to lower voltages in the 
following order: CuI(dmit)2 (3b; -177 mV), CuBr(dmit)2 (7; -241 mV), and CuCl(dmit)2 
(4; -284 mV), a trend previously observed for copper halide complexes.
74
 Less 
polarizable halide ligands stabilize Cu
2+
 relative to Cu
+
, resulting in a more negative 
Cu
2+/+
 reduction potential for the copper thione complexes. The analogous copper selone 
complexes have more negative potentials relative to the thione complexes, but the trend 
observed for the thione complexes is not fully followed: CuI(dmise)2 (2; -340 mV), 
CuCl(dmise)2 (5; -355 mV), and CuBr(dmise)2 (8; -362 mV).  
 
 
Table 5.6. Reduction potentials of Cu
+/0
 for the copper selone and thione 




  Copper halides (CuI, CuBr, and CuCl) with selone and thione ligands have 
been synthesized and characterized, and their electrochemistry has been investigated 
and compared. The X-ray crystal structures for tetranuclear complexes 1 and 6, and 
trigonal complexes 2, 3, 3b, 4, 5, 7, and 8 have been determined. The tetrameric 
omplexes 1 and 6 have two different copper coordination environments and a Cu2(μ-
I)2 or Cu2(μ-Br)2 core coordinated to two bridging selenium atoms. In contrast, the 
three-coordinate thione and selone complexes 2, 3a, 3b, 4, 5, 7 and 8 adopt distorted 
trigonal planar geometry, where Cu
+
 is bound to a halide (Cl, Br, or I) and two thione 
or selone ligands. The geometry and stochiometry of the copper complexes obtained 
depends on several factors, including halide and chalcogenone ligand, intramolecular 
π-π interactions, and intermolecular short contact interactions in the crystal. DFT 
calculations show good correlation to the observed X-ray structures for compounds 1-
8. Cyclic voltammetry studies for the three-coordinate complexes show lower 
reduction potentials for copper selone complexes relative to the copper thione 
complexes regardless of the coordinated halide ligand. These results highlight the rich  




 Materials. The synthesis and manipulation of all copper complexes was 
performed under an inert atmosphere of argon or nitrogen using standard Schlenk 
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techniques. Acetonitrile, methanol, dichloromethane, and ether were purified using 
standard procedures and freshly distilled under argon atmosphere prior to use. N,N’-





 were synthesized according to published procedures.  Selenium 
powder, sulfur powder, cuprous chloride (Aldrich), cuprous iodide (Aldrich), cuprous 
bromide (Alfa Aesar), cuprous oxide (stabilized, Aldrich), potassium iodide 












H} spectra were obtained on a Bruker-






H} NMR chemical shifts are 





NMR chemical shifts were externally referenced to diphenyl diselenide (δ 461),
77
 and 
reported relative to dimethyl selenide (δ 0). Electrochemical experiments were 
performed with a BAS 100B potentiostat. A three compartment cell was used with a 
Ag/AgCl reference electrode, a Pt counter electrode, and a carbon working electrode. 
Freshly distilled acetonitrile was used as the solvent with tetra-n-butylammonium 
phosphate as the supporting electrolyte (0.1 M). Solutions containing 1 mM analyte 
were deaerated for 2 min by vigorous nitrogen purge. All E
1/2
 values were calculated 
from (Epa + Epc)/2 at a scan rate of 100 mV/s. Differential pulse voltammetry (DPV) 
experiments were conducted using a pulse amplitude of 0.080 V and a pulse width of 
0.050 s, in conjunction with a sample width of 0.045 s and a pulse period of 0.200 s. 
The powder X-ray diffraction (XRD) patterns were measured using an angle 
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dispersive diffractometer (Rigaku Ultima IV) with monochromated Cu-Kα (λ = 1.540) 
radiation at 40 kV. Infrared spectra were obtained using nujol mulls on KBr salt 
plates with a Magna 550 IR spectrometer. Abbreviations used in the description of 
vibrational data are as follows: vs, very strong; s, strong; m, medium; w, weak; b, 
broad. Electrospray ionization mass spectrometry (ESI-MS) was performed using a 
QSTAR XL Hybrid MS/MS System from Applied Biosystems via direct injection of 
sample (0.05 mL/min flow rate) into a Turbo Ion spray ionization source. Samples 
were run under positive mode, with ion-spray voltage of 5500 V, and TOF scan mode. 
Melting points were determined using a Barnstead Electrothermal 9100 apparatus in 
silicon-grease-sealed glass capillary tubes. UV-vis spectra were collected using a 
Shimadzu UV-3101 PC spectrophotometer in quartz cuvettes with a path length of 1 
cm. Elemental analysis was performed by Atlantic Microlabs, Inc.  
 Theoretical methods. Geometry optimizations were performed with the 
B3PW91 and BP86 exchange-correlation (xc) functionals using PQS version 3.3.
78
 
Copper and selenium were represented by the Ermler-Christiansen relativistic 
effective core potential.
79
  The copper basis set was modified to include the Couty-
Hall 4p contraction.
80
 The Wadt-Hay RECP basis set for sulfur and the halogens were 
augmented with a set of diffuse s- and p-functions.
81
 Nitrogen, oxygen and hydrogen 
centers attached to non-carbon heavy atoms were represented by the Dunning split-
valence triple-δ plus polarization function basis set (TZVP).
82
 Hydrocarbon fragments 





calculations were used to confirm that the reported structures are minima on the 
respective potential energy surfaces. 
  
 Cu4(μ4-dmise)(μ-I2)I2 (1). Method 1. The dmise ligand (176 mg, 1 mmol) was 
dissolved in acetonitrile (20 mL) and this solution was cannula transferred into a 
solution of [Cu(CNCH3)4][BF4] (312 mg, 1 mmol) in acetonitrile (20 mL). The 
reaction mixture was stirred at room temperature for 1 h until the reaction mixture 
was clear and colorless. Into this reaction mixture was cannula transferred KI (332 
mg, 2 mmol) in methanol (15 mL) and the reaction was stirred for 5 h. The solvent 
was removed in vacuo, and the product was extracted using acetonitrile. Acetonitrile 
was removed in vacuo, yielding a white solid. Yield: 234 mg, 16%. Single crystals for 
X-ray analysis were grown from slow vapor diffusion of ether into an 
acetonitrile/DMF solution of the complex.  
  Method 2. The dmise ligand (176 mg, 1 mmol) was dissolved in acetonitrile 
(20 mL) and this solution was cannula transferred into a solution of CuI (190 mg, 1 
mmol) in acetonitrile (20 mL). The reaction mixture was stirred at room temperature 
for 1 h, resulting in the formation of a white precipitate. Into this reaction mixture 
was cannula transferred KI (332 mg, 2 mmol) in methanol (15 mL), resulting in a 
clear solution followed by gradual formation of a white precipitate. The mixture was 
stirred for 6 h, dried in vacuo, and the desired product was extracted using acetonitrile 
(10 mL). The filtrate was dried in vacuo to yield a white powder. Single crystals for 
X-ray analysis were grown from slow vapor diffusion of ether into 
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anacetonitrile/DMF solution of the complex. Yield: 312 mg, 21%. Mp. 193 °C. 
Found: C, 16.83; N, 7.15; H, 2.22; requires C20H32Cu4N8Se4I4 C, 16.43; N, 7.66; H, 




)] in CH3CN: 245 (206,028), 276 sh (53,555). 
IR (cm
-1
): 623 s, 658 s, 751 s, 773 s, 831 s, 1027 s, 1082 s, 1144 s, 1163 s, 1229 s, 
1378 s, 1465 b, 1561 s, 1600 s, 1660 b, 2923 b. δH (500 MHz; CD2Cl2; Me4Si): 3.88 
(6H, s, 2CH3), 6.97 (2H, s, 2CH). δC (500 MHz; CD2Cl2; Me4Si): 37.58 (CH3), 121.60 











 Cu(dmise)2I  (2). A dichloromethane solution (20 mL) of dmise (350 mg, 2 
mmol) was cannula transferred into a solution of CuI (190 mg, 1 mmol) in acetonitrile 
(20 mL). The reaction mixture was stirred at room temperature for 6 h, resulting in 
the formation of a white precipitate. The white precipitate was filtered and dried in 
vacuo to yield a white powder. Single crystals for X-ray analysis were grown by slow 
vapor diffusion of ether into an acetonitrile/DMF solution in the complex.
 
Yield: 459 
mg, 85%. Mp. 156 °C. Found: C, 22.31; N, 10.19; H, 2.85; requires C10H16CuN4Se2I  




)] in CH3CN: 228 
(65,990). IR (cm
-1
): 474 w, 623 s, 662 s, 724 w, 750 s, 772 s, 831 s, 1092 s, 1117 s, 
1148 s, 1163 s, 1232 vs, 1378 vs, 1466 vs, 1566 vs, 1600 w, 2855 vs, 2924 b, 3110 s, 
3143 s. δH (500 MHz; (CD3)2SO; Me4Si): 3.70 (6H, s, 2CH3), 7.46 (2H, s, 2CH). δC 
(500 MHz; (CD3)2SO; Me4Si): 37.66 (CH3), 122.20 (CH), 147.81 (C=Se). δSe (500 
152 
 









.   
 trans-Cu(dmit)2I  (3a). Method 1. A dichloromethane solution (20 mL) of dmit 
(260 mg, 2 mmol) was cannula transferred into a solution of CuI (190 mg, 1 mmol) in 
acetonitrile (10 mL). The reaction mixture was stirred at room temperature for 6 h, 
resulting in the formation of a white precipitate. The white precipitate was filtered 
and dried in vacuo to yield a white powder. Single crystals for X-ray analysis were 
grown by slow vapor diffusion of ether into an acetonitrile/DMF solution in the 
complex.
 
Yield: 410 mg, 92%.  
 Method 2. An acetonitrile solution (20 mL) of dmit (260 mg, 2 mmol) was 
cannula transferred into a solution of CuI (190 mg, 1 mmol) in acetonitrile (20 mL). 
The reaction mixture was stirred at room temperature for 1 h, resulting in the 
formation of a white precipitate. To this reaction mixture was added KI (332 mg, 2 
mmol) in methanol (15 mL), resulting in a clear solution that was stirred for 6 h, and 
then dried in vacuo. The desired product was extracted using acetonitrile (10 mL), 
and the filtrate was dried in vacuo to yield a white powder. Single crystals for X-ray 
analysis were grown from slow vapor diffusion of ether into acetonitrile solution. 
Yield: 401 mg, 89%. Mp. 152 °C. Found: C, 26.51; N, 12.39; H, 3.55. requires 





CH3CN: 246 (38,384). IR (cm
-1
): 629 s, 673 s, 721 s, 744 s, 826 s, 1030 s, 1082 s, 
1171 s, 1227 s, 1379 s, 1466 s, 1564 s, 2926 b. δH (500 MHz; (CD3)2SO; Me4Si): 3.63 
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(6H, s, 2CH3), 7.32 (2H, s, 2CH). δC (500 MHz; (CD3)2SO; Me4Si): 36.02 (CH3), 
120.46 (CH), 155.12 (C=S); m/z (ESI-MS): 318.98 [Cu(dmit)2]
+






 cis-Cu(dmit)2I (3b). A dichloromethane solution (20 mL) of dmit (260 mg, 2 
mmol) was cannula transferred into a solution of CuI (190 mg, 1 mmol) in acetonitrile 
(20 mL). The reaction mixture was stirred at room temperature for 6 h. The reaction 
mixture was reduced to about 5 mL in vacuo and the desired product precipitated by 
addition of ether. The precipitate was filtered, dried in vacuo to yield a white powder. 
Single crystals for X-ray analysis were grown from slow vapor diffusion of ether into 
an acetonitrile/dichloromethane solution of the complex. Yield 404 mg, 90%.
 
Mp. 152 
°C. Found: C, 26.51; N, 12.39; H, 3.55; requires C10H16CuN4S2I C, 26.88; N, 12.54; 








): 629 s, 
673 s, 721 s, 744 s, 826 s, 1030 s, 1082 s, 1171 s, 1227 s, 1379 s, 1466 s, 1564 s, 2926 
b. δH (500 MHz; (CD3)2SO; Me4Si): 3.59 (6H, s, 2CH3), 7.27 (2H, s, 2CH). δC (500 
MHz; (CD3)2SO; Me4Si):  35.88 (CH3), 120.22 (CH), 155.87 (C=S); m/z (ESI-MS): 
318.98 [Cu(dmit)2]
+





 Cu(dmit)2Cl (4). A dichloromethane (20 mL) solution of dmit (260 mg, 2 
mmol) was cannula transferred into a solution of CuCl (99 mg, 1 mmol) in ethanol 
(20 mL). The reaction mixture was stirred at room temperature for 1 h, resulting in 
the formation of a white precipitate. The filtrate was removed via cannula filtration 
and the precipitate was dried in vacuo yielding a white powder. Single crystals for X-
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ray analysis were grown from slow vapor diffusion of ether into an 
acetonitrile/methanol solution of the complex. Yield: 313 mg, 87%. Mp. 158 °C. 
Found: C, 33.76; N, 15,67; H, 4.48; requires C10H16CuN4S2Cl C, 33.80; N, 15.76; H, 




)] in CH3CN: 261 (22,595). IR (cm
-1
): 663 s, 
670 s, 730 s, 748 s, 763 vs, 803 w, 867 w, 1087 s, 1173 vs, 1242 vs, 1378 vs, 1464 vs, 
1571 s, 1621 s, 1728 w, 2924 b, 3147 w. δH (500 MHz; (CD3)2SO; Me4Si): 3.56 (6H, 
s, 2 CH3), 7.28 (2H, s, 2 CH2). δC (500 MHz; (CD3)2SO; Me4Si): 35.75 (CH3), 120.45 
(CH), 154.63 (C=S); m/z (ESI-MS): 318.98 [Cu(dmit)2]
+








 Cu(dmise)2Cl  (5). Complex 5 was prepared using the same procedure for 4 
except that dmise (350 mg, 2 mmol) was used instead of dmit. Single crystals for X-
ray analysis were grown from slow vapor diffusion of ether into an acetonitrile/DMF 
solution of the complex. Yield: 414 mg, 92%. Mp. 170 °C. Found: C, 26.98; N, 12.52; 





)] in CH3CN: 273 (9,844). IR (cm
-1
): 653 s, 658 s, 719 vs, 743 vs, 764 
vs, 868 w, 1027 vs, 1069 b, 1149 vs, 1243 vs, 1378 vs, 1465 vs, 1570 s, 1625 w, 2916 
b. δH (500 MHz; (CD3)2SO; Me4Si): 3.66 (6H, s, 2 CH3), 7.44 (2H, s, 2 CH2). δC (500 
MHz; (CD3)2SO; Me4Si): 37.55 (CH3), 122.36 (CH), 146.23 (C=Se).
 
δSe (500 MHz; 















 Cu4(μ4-dmise)(μ-Br2)Br2 (6). CuBr (144 mg, 1 mmol) was dissolved in ethanol 
(15 mL) and to this was cannula added a solution of dmise (175 mg, 1 mmol) in 
dichloromethane (15 mL). The reaction was stirred for 6 h, and the solvent reduced in 
vacuo to about 5 mL. The desired product was precipitated using ether (10 mL). This 
white precipitate was filtered and dried in vacuo. Single crystals suitable for X-ray 
analysis were grown by slow diffusion of ether into an acetonitrile solution of the 
complex.
 
Yield: 306 mg, 24%. Mp. 212°C. Found: C, 18.89; N, 8.81; H, 2.60; 





)] in CH3CN: 261 (26545). IR (cm
-1
): 659 s, 744 s, 770 w, 1103 w, 1150 s, 1227 
s, 1261 s, 1378 vs, 1464 vs, 1563 s, 2925 b. δH (500 MHz; (CD3)2SO; Me4Si): 3.65 (6 
H, s, 2 CH3), 7.41 (2 H, s, 2 CH2). δC (500 MHz; (CD3)2SO; Me4Si): 37.43 (CH3), 
122.67 (CH), 144.69 (C=Se). δSe (500 MHz; (CD3)2SO; Me4Si): -75.0; m/z (ESI-MS): 
414.85 [Cu(dmise)2]
+
, 270.91 [Cu(dmise) + MeOH]
+






 Cu(dmit)2Br (7). CuBr (144 mg, 1 mmol) was dissolved in ethanol (15 mL), 
and to this was cannula added a solution of dmit (260 mg, 2 mmol) in 
dichloromethane (15 mL). The reaction was stirred for 6 h, the solvent was reduced in 
vacuo to about 5 ml, and the desired product was precipitated with ether (10 mL). The 
white precipitate was filtered and dried in vacuo. Single crystals suitable for X-ray 
analysis were grown by slow diffusion of ether into an acetonitrilesolution of the 
complex.
 
Yield 347 mg, 86%. Mp. 152 °C. Found C, 29.83; N, 13.84; H, 3.90; 







)] in CH3CN: 261 (32,442). IR (cm
-1
): 671 s, 722 w, 757 vs, 1073 b, 1173 s, 1244 
s, 1377 vs, 1464 vs, 1570 s, 1611 w, 2854 s, 2929 b, 3080 w, 3102 w, 3146 w. δH 
(500 MHz; (CD3)2SO; Me4Si): 3.58 (6H, s, 2 CH3), 7.25 (2H, s, 2 CH2). δC (500 
MHz; (CD3)2SO; Me4Si): 35.65 (CH3), 119.99 (CH), 156.30 (C=S); m/z (ESI-MS): 
318.98 [Cu(dmit)2]
+







.   
 Cu(dmise)2Br (8). CuBr (144 mg, 1 mmol) was dissolved in ethanol (15 mL), 
and to this was cannula added a solution of dmise (350 mg, 2 mmol) in 
dichloromethane (15 mL). The reaction was stirred for 48 h and resulted in the 
formation of a white precipitate, which was filtered and dried in vacuo. Single 
crystals suitable for X-ray analysis were grown by slow diffusion of ether into an 
acetonitrile/DMF solution of the complex.
 
Yield 450 mg, 91%. Mp. 160 °C. Found C, 
24.43; N, 11.43; H, 3.17; requires C10H16CuN4Se2Br C, 24.33; N, 11.35; H, 3.27%. 




)] in CH3CN: 258 (15,611). IR (cm
-1
): 617 w, 662 s, 
740 vs, 749 vs, 804 w, 854 w, 1025 w, 1087 vs, 1150 vs, 1233 vs, 1379 vs, 1394 s, 
1464 vs, 1565 vs, 1599 w. 2920 b, 3094 w, 3145 w. δH (500 MHz; (CD3)2SO; Me4Si): 
3.67 (s, 6 H, 2 CH3), 7.42 (s, 2 H, 2 CH2). δC (500 MHz; (CD3)2SO; Me4Si): 37.48 
(CH3), 122.01 (CH), 147,74 (C=Se). δSe (500 MHz; (CD3)2SO; Me4Si): -13.4; m/z 
(ESI-MS): 414.85 [Cu(dmise)2]
+
, 270.91 [Cu(dmise) + MeOH]
+







.   
 X-ray structural data collection and processing. Single crystals of Cu4(μ4-
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dmise)(μ-I)2I2 (1), Cu(dmise)2I (2), Cu(dmit)2I (3a, 3b), Cu(dmit)2Cl (4), 
Cu(dmise)2Cl (5), Cu4(μ4-dmise)(μ-Br)2Br2 (6), Cu(dmit)2Br (7), and Cu(dmise)2Br 
(8) were mounted on a glass filament with silicon grease and immediately cooled to 
168 ± 2 K in a cold nitrogen gas stream. Intensity data were collected using a Rigaku 
Mercury CCD detector and an AFC8S diffractometer. The space groups C2/m for 1 
and 6, C2/c for 2, 3a, 4, 7, and 8, and P21/c for 3b and 5 were determined from the 
observed systematic absences. Data reduction, including the application of Lorentz 
and polarization effects (Lp) and absorption corrections were performed using the 
CrystalClear program.
84
 The structures were solved by direct methods and subsequent 
Fourier difference techniques, and refined anisotropically on F
2
 using full-matrix least 
squares, with SHELXTL 6.10.
85
 The presence of several residue electron density 
peaks in 1 and 6, indicating disordered solvent peaks, could not be fully described and 
were accounted for with the Squeeze routine in PLATON.
86
 Squeeze calculated a 
solvent-accessible void volume of 166.00 Å
3
, corresponding to 29 electrons per unit 
cell for 1, and a solvent-accessible void volume of 159.00 Å
3
, corresponding to 26 
electrons per unit cell, for 6. The contribution of these diffusely-scattering species 
was removed from subsequent structure factor calculations. The reported F(000), 
Dcalc, and formula weight (FW) for 1 and 6 reflect known unit cell contents only. In 
the final cycle of least squares, independent anisotropic displacement factors were 
refined for the non-hydrogen atoms and the methyl hydrogen atoms were fixed in 
“idealized” positions with C-H = 0.96 Å. Their isotropic displacement parameters 
were set equal to 1.5 times Ueq of the attached carbon atom.  
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  For complex 1, the largest peak in the final Fourier difference map (1.03 e·Å
-3
) 
was located 1.62 Å from H(5A), and the lowest peak (-0.94 e·Å
-3
) was located at a 
distance of 0.89 Å from I(1). The largest peak for complex 2 in the final Fourier 
difference map (1.20 e·Å
-3
) was located 1.64 Å from C(3), and the lowest peak (-0.79 
e·Å
-3
) was located at a distance of 0.81 Å from I(1). The largest peak for complex 3a 
in the final Fourier difference map (0.53 Å) was located (1.70 Å) from H(4A), and the 
lowest peak (-0.80 e·Å
-3
) was located at a distance of 0.71 Å from I. The largest peak 
for 3b in the final Fourier difference map (1.12 e·Å
-3
) was located 0.03Å from I(1), 
and the lowest peak (-0.99 e·Å
-3
) was located at a distance of 0.98 Å from I(1). The 
largest peak for 4 in the final Fourier difference map (0.70 e·Å
-3
) was located 1.73 Å 
from C(1), and the lowest peak (-0.40 e·Å
-3
) was located at a distance of 0.80 Å from 
Cu1. The largest peak for 5 in the final Fourier difference map (2.05 e·Å
-3
) was 
located 0.04 Å from Se(2), and the lowest peak (-0.95 e·Å
-3
) was located at a distance 
of 0.93 Å from Se(2). The largest peak for 6 in the final Fourier difference map (1.69 
e·Å
-3
) was located 0.07Å from Br(1), and the lowest peak (-0.1.15 e·Å
-3
) was located 
at a distance of 0.72 Å from Cu(2). The largest peak for 7 in the final Fourier 
difference map (1.15 e·Å
-3
) was located 1.73 Å from H(2A), and the lowest peak 
(-0.49 e·Å
-3
) was located at a distance of 0.78 Å from Cu(1). The largest peak for 8 in 
the final Fourier difference map (0.93 e·Å
-3
) was located 1.72 Å from N(2), and the 
lowest peak (-0.93 e·Å
-3
) was located at a distance of 0.87 Å from Se(1). Final 
refinement parameters for the structures of 1, 2, 3a, 3b, 4, 5, 6, 7, and 8 are given in 
Tables 5.7, 5.8, and 5.9; selected bond distances and angles are provided in Tables 
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5.7, 5.8, 5.9, and 5.10. 
 
 1 2 3a 




F.W. (g/mol) 1462.1 540.63 446.83 
Space group C2/m C /c 
 
C /c 
Crystal system Monoclinic Monoclinic Monoclinic 
a, Å 18.802(4) 15.278(3) 
 
15.062(6) 
b, Å 12.833(3) 10.874(2) 10.726(2) 
c, Å 8.4800(3) 11.190(2) 11.085(2) 
α, ° 90 90 90 
β, ° 95.07(3) 118.56(3) 117.73(2) 
γ, ° 90 90 90 
V, Å
3 
2046.0(7) 1632.8(6) 1585.2(8) 
Z 2 4 4 
Dcal, Mg/m
3
 2.374 2.199 1.864 
Indices  (min) [-14, -16, -10] [-16, -13, -13] [-18, -13, -14] 
              (max) [23, 16, 10] [19, 13, 12] [19, 13, 10] 
Parameters 98 86 85 
F(000) 1344 1016 864 
μ, mm
-1
 8.650 7.676 3.577 
2ζ range,  3.01 - 26.71 2.66-26.40 4.16- 26.76 
Collected reflections 15543 6421 6879 
Unique reflections 2263 1674 1522 




0.0341 0.0323 0.0237 
                 wR2 0.0778 0.0721 0.0576 
Final R (all data), R1 0.0425 0.0395 0.0244 
                 wR2 0.0818 0.0775 0.0583 
Goodness of fit (S) 1.107 1.132 1.203 
Largest diff.  Peak 1.031 1.197 0.531 






Table 5.7. Summary of crystallographic data for complexes 1, 2, and 3a. 
a











 3b 4 5 
Chemical Formula C10H16CuIN4S2 C10H16ClCuN4S2 C10H16ClCuN4S
e2 
F.W. (g/mol) 446.83 355.38 449.18 
Space group P21/c C2/c P21/c 
Crystal system monoclinic Monoclinic Monoclinic 
a, Å 9.925(2) 10.348(2) 15.794(3) 
b, Å 10.861(2) 9.328(19) 7.0226(14) 
c, Å 14.868(3) 16.123(3) 14.263(3) 
α, ° 90 90 90 
β, ° 92.02(3) 105.64(3) 104.64(3) 
γ, ° 90 90 90 
V, Å
3 
1601.8(6) 1498.6(5) 1533.7(5) 
Z 4 4 4 
Dcal, Mg/m
3
 1.853 1.575 1.949 
Indices  (min) [-12,-11,-18] [-12, -11, -20] [-18,-8,-16] 
              (max) [12,13,18] [12, 10, 20] [18,7,16] 
Parameters 167 85 167 
F(000) 872 728 872 
μ, mm
-1
 3.540 1.902 6.345 
2ζ range,  2.05-26.34 2.62 – 26.34 2.67 – 25.05 
Collected reflections 13385 6856 10854 
Unique reflections 3225 1522 2713 




0.0386 0.0303 0.0684 
                 wR2 0.0916 0.0753 0.1680 
Final R (all data), R1 0.0422 0.0318 0.0797 
                 wR2 0.0943 0.0764 0.1868 
Goodness of fit (S) 1.039 1.123 1.138 
Largest diff.  Peak 1.119 0.700 2.050 















Table 5.8. Summary of crystallographic data for complexes 3b, 4, and 5. 
a

















F.W. (g/mol) 1274.18 399.84 493.64 
Space group C2/m C2/c 
 
C2/c 
Crystal system Monoclinic Monoclinic Monoclinic 
a, Å 18.374(4) 10.385(2) 
 
10.297(2) 
b, Å 12.867(3) 9.583(2) 10.390(2) 
c, Å 8.4581(17) 16.002(3) 14.824(3) 
α, ° 90 90 90 
β, ° 96.71(3) 104.15 (3) 101.47(3) 
γ, ° 90 90 90 
V, Å
3 
1985.9(7) 1544.2(5) 1554.2(5) 
Z 2 4 4 
Dcal, Mg/m
3
 2.131 1.72 2.110 
Indices  (min) [-22, 0, 0] [-12, -11, -18] [-12,-12,-18] 
              (max) [22, 15, 10] [12, 11, 19] [9,12,18] 
Parameters 98 86 85 
F(000) 1200 800 944 
μ, mm
-1
 9.826 4.261 8.648 
2ζ range,  2.42 - 26.26 2.93-26.27 2.80-26.28 
Collected reflections 8469 6419 6449 
Unique reflections 2049 1552 1560 




0.0379 0.0346 0.0389 
                 wR2 0.1042 0.0842 0.0906 
Final R (all data), R1 0.0423 0.0404 0.0437 
                 wR2 0.1079 0.0884 0.0955 
Goodness of fit (S) 1.110 1.150 1.114 
Largest diff.  Peak 1.693 1.15 0.933 




Table 5.9. Summary of crystallographic data for complexes 6, 7, and 8. 
a













Figure 5.8. Crystal packing diagram of Cu4(μ-dmise)4(μ-I)2I2·1.5CNCH3  (1) 









Figure 5.9. Crystal packing diagram of CuI(dmit)2 (3a) along the a-axis 










Figure 5.10. Powder X-ray diffraction pattern of A) Cu4(μ-dmise)4(μ-I)2I2 (1), 
vs. simulated powder pattern B) for Cu4(μ-dmise)4(μ-I)2I2 (1). 
 
Figure 5.11. Powder X-ray diffraction pattern for A) CuI(dmise)2 (2), vs. 









Figure 5.12. Experimental powder X-ray diffraction pattern of 
A) Cu4(μ-dmise)4(μ-I)2I2 (1), vs. simulated powder pattern for B) 
Cu4(μ-dmise)4(μ-I)2I2 (1), and C) CuI(dmise)2 (2).  
 
Figure 5.13. Powder X-ray diffraction pattern for A) CuI(dmit)2 (3b) 









Figure 5.14. Powder X-ray diffraction pattern for A) CuI(dmit)2 (3a) vs. 
simulated powder pattern for B) CuI(dmit)2 (3a). 
 
Figure 5.15. Experimental powder x-ray diffraction pattern of 
A) Cu4(μ-dmise)4(μ-Br)2Br2  (6) vs. simulated powder pattern 









Figure 5.16. Experimental powder x-ray diffraction pattern of 
B) CuBr(dmise)2 (8), vs. simulated powder pattern A) for 
CuBr(dmise)2 (8). 
 
Figure 5.17. Experimental powder x-ray diffraction pattern of 
A) Cu4(μ-dmise)4(μ-Br)2Br2 (6), vs. simulated powder pattern 









Figure 5.18. Experimental powder X-ray diffraction pattern of A) 
CuCl(dmit)2 (4), vs. simulated powder pattern for B) CuCl(dmit)2 (4). 
 
Figure 5.19. Experimental powder X-ray diffraction pattern of A) 














Figure 5.20. Cyclic voltammetry scans for A) CuCl(dmit)2, B) CuCl(dmise)2, 
C) CuBr(dmit)2, D) CuBr(dmise)2, E) CuI(dmit)2 3a, F) CuI(dmit)2 3b. All data 


















Figure 5.20 (cont.). Cyclic voltammetry scans for G) mixed trans- and cis-
CuI(dmit)2 (3a and 3b), H) CuI(dmise)2, I) Cu4(μ-dmise)4(μ-Br)2Br2, J) Cu4(μ-





















Figure 5.21. Differential pulse voltammograms: A) positive scan of Cu4(μ4-dmise)(μ-
Br)2Br2 (6); B) negative scan of Cu4(μ4-dmise)(μ-Br)2Br2 (6). DPV data were collected 
at a concentration of 1 mM in acetonitrile. 
 
A B 
Figure 5.22. Differential pulse voltammograms: A) positive scan of Cu4(μ4-
dmise)(μ-I)2I2 (1); B) negative scan of Cu4(μ4-dmise)(μ-I)2I2 (1). DPV data 
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SYNTHESIS , CHARACTERIZATION AND ELECTROCHEMICAL STUDIES OF 
DINUCLEAR Cu(I)-COMPLEXES WITH 
BIS(SELENO/THIOIMIDAZOLYL)METHANE OR ETHANE AND N,N’-
DIMETHYLIMIDAZOLE SELONE AND THIONE LIGANDS 
 
Introduction 
The chemistry of monodentate and bidentate “soft” sulfur and selenium Lewis 
donor ligands with soft and borderline metals has recently received much attention due to 





bioinorganic, organometallic and coordination chemistry.
4
 Great strides have been made 
in understanding the coordination chemistry of bis(thioimidazolyl)borate and methane 




 but the neutral selenium analog, 
bis(selenoimidazolyl)methane, has received relatively little attention. We are interested in 
the coordination chemistry of N,N’-dimethylimidazole selone, N,N’-dimethylimidazole 
thione, bis(thioimidazolyl)methane and bis(selenoimidazolyl)methane, 
bis(thioimidazolyl)ethane and bis(selenoimidazolyl)ethane ligands with copper in the 
hope of understanding the fundamentals of copper-selenium/sulfur coordination and it’s 
effects on Cu
2+/+
 reduction potentials. The high propensity for selenium and sulfur to 
bridge also results in diverse coordination architectural frameworks
7
 and these ligands are 
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also potential synthons for the formation of heterocyclic carbenes via potassium metal 
reduction.
8
 There is also increased interest in copper chalcogenolates and mixed 
chalcogenolates as single source precursors in the synthesis of semiconductor materials 
via metal organic chemical vapor deposition.
9
 









































 have been reported, but it's 
rather surprising that their Cu
+
 complexes have not been synthesized to date. While the 
coordination chemistry of mbit with transition metals is well established, that of the 
analogous selenium ligand (mbis) is very uncommon. Only a handful of transition metal 
complexes with mbis or ebis ligands have been reported: [Cp*Ir(ebis)Cl][Cl], 
[Cp*Rh(mbis)Cl][Cp*RhCl3],
1
 NiBr2(mbis), NiBr2(ebis), [CoCl2(mbis)]n and 
[CoCl2(ebis)]n.
16
 It is expected that coordination of mbis and ebis to copper should have 
stronger coordination bonds relative to mbit and ebit due to increased nucleophilicity and 
polarizability of selenium compared to that of sulfur.
17
 
In this chapter, we report the synthesis and crystal structures of dinuclear, three- 
and four-coordinate Cu
+
 complexes with the aim of understanding their modes of 
coordination and the effect of the alkane linker and chalcogenone binding on Cu
2+/+
 
reduction potentials. The Cu
2+/+
 reduction potentials can also be tuned by synthesizing 
homoleptic copper complexes using a variety of different selone and thione ligands or 
heteroleptic copper complexes using mixed chalcogenone ligands. Such redox tuning has 
practical applications ranging from understanding biological processes such as electron 
180 
 
transfer in blue copper proteins and respiration,
18
 to industrial and synthetic applications 
in catalysis.
2,19
 Copper(I) complexes bearing homogeneous and heterogeneous 
monodentate (dmise or dmit) and bidentate (mbis, mbit, ebis and ebit) chalcogenone 














H} NMR spectroscopy, X-ray structural analysis, electrospray ionization mass 





Results and Discussion 
Synthesis of dinuclear Cu(I) selone and thione complexes. Homoleptic dinuclear 
copper complexes were synthesized via the reaction of appropriate amounts of 
[Cu(NCCH3)4][BF4] with N,N’-dimethylimidazole selone (dmise) and 
Figure 6.1. Chalcogenone ligands used in this study. 
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N,N’-dimethylimidazole thione (dmit) in acetonitrile (Scheme 6.1, reaction 1) or  
bis(selenoimidazolyl)methane (mbis), bis(selenoimidazolyl)ethane (ebis), 
bis(thioimidazolyl)methane (mbit), and bis(thioimidazolyl) ethane (ebit) in a mixed 
solvent system of acetonitrile and dichloromethane (Scheme 6.1, reactions 2 and 3).  
 
 
Heteroleptic dinuclear complexes of Cu
+
 were synthesized via a convenient two-
step, one-pot synthesis by treating equimolar amounts of [Cu(NCCH3)4][BF4] and dmise 
or dmit in acetonitrile, followed by cannula addition of mbis or mbit in dichloromethane 
(Scheme 6.1, reaction 4). Treating equimolar amounts of [Cu(NCCH3)]4[BF4] with dmit 






    CH2Cl2, 12 h
[Cu2(-Y)2(X)2][2BF4]




    CH2Cl2, 12 h
[Cu(-dmit)(mbit)]n[BF4]n
CH3CN, rt, 3 h
[Cu(NCCH3)4][BF4]








X = dmise (1);dmit (2)
Y = mbis (3); mbit (4)
Y = mbis; X = dmise (7);dmit (8)
Y = mbit; X = dmise (9)









in acetonitrile followed by addition of equimolar amount of mbit in dichloromethane 
afforded a copper complex with infinite chains of mbit and dmit (Scheme 6.1, reaction 5). 
 Structural analysis of dinuclear copper complexes. Single crystal diffraction data 
were collected for [Cu2(μ-dmise)(dmise)4][2BF4]·CH3CN  (1), [Cu2(μ-mbis)(mbis)2]-
[2BF4]·CH3CN (3), [Cu2(ebit)3][2BF4] (6), [Cu2(μ-mbis)2(dmise)2][2BF4] (7), 
[Cu2(μ-mbis)2(dmit)2][2BF4]  (8), and [Cu(mbit)(μ-dmit)]n[BF4]n (10), which crystallized 
as colorless plates. The structural parameters for 1, 3, 6, 7, 8, and 10 are summarized in 
Tables 6.1 to 6.4, and their structures are shown in Figures 6.2 to 6.5.  
 The X-ray crystal structure of [Cu2(μ-dmise)(dmise)4][2BF4]·CH3CN (1) is shown 
in Figure 6.2, and selected bond lengths and angles are given in Table 6.1. The structural 
unit of [(Cu(dmise)2)(μ-dmise)][2BF4] is made up of a dimer with two Cu
+
 centers, with 
one of the Se atoms of the dimethylimidazole selone (dmise) bridging two Cu atoms, 
forming a trigonal Cu2Se core. Each copper atom is further bonded to two selenium 
atoms from dmise and thus each copper adopts a distorted trigonal geometry. The Cu-Cu 
bond distance, 2.63 Å is longer than sum of ionic radii of Cu
+
 (1.48 Å). The average Cu-
Se bond distance is 2.37 Å which is slightly longer than monomeric copper selone 
complexes reported by Kimani, et al.
20
 The average bond length of bridging Cu-Se bond 
(2.42 Å) is longer than the average non bridging Cu-Se bond length (2.35 Å). The 
dinuclear copper selone complex 1 adopts a distorted trigonal planar geometry with 
average Cu-Se bond lengths of 2.37 Å, longer than the previously synthesized three-
183 
 
coordinate copper-selone complexes Cu(dmise)2X, (X = I, Br, or Cl) with Cu-Se bond 
distances of 2.34 Å,
21






Cu(1)-Se(1) 2.3986(9) Se(5)-Cu(1)-Se(3) 118.37(4) 
Cu(2)-Se(1) 2.4382(10) Se(5)-Cu(1)-Se(1) 128.11(4) 
Cu(1)-Se(3) 2.3460(10) Se(3)-Cu(1)-Se(1) 113.34(3) 
Cu(1)-Se(5) 2.3377(9) Se(2)-Cu(1)-Se(4) 133.26(4) 
Cu(2)-Se(2) 2.3458(11) Se(2)-Cu(1)-Se(1) 111.91(4) 
Cu(2)-Se(4) 2.3592(12) Se(4)-Cu(1)-Se(1) 112.68(4) 
Cu(1)-Cu(2) 2.6326(11)   
 
The molecular structure of [Cu2(μ-mbis)(mbis)2][2BF4]·CH3CN (3) is shown in 
Figure 6.3 and the selected bond lengths and angles are given in Table 6.2. The structural 
Figure 6.2. The crystal structure diagram of [Cu2(μ-dmise)(dmise)4][2BF4]·CH3CN 
(1) showing 50% probability ellipsoids. Hydrogen atoms, counterions, and the solvent 
molecule are omitted for clarity.  
 
 
Table 6.1. Selected bond lengths (Å) and angles (°) for 1. 
184 
 
unit of [Cu2(μ-mbis)(mbis)2][2BF4] (3) is made up of a Cu
+
 dimer, and two of the Se 
atoms from bis(seleno-methylimidazole) methane (mbis) bridge two copper atoms 
forming a Cu2Se2 core. The Cu
+
 ions are bound to two additional selenium atoms from 
the bidentate mbis ligand, hence each Cu
+
 ion adopts a distorted tetrahedral geometry 
with angles ranging from 100.50 to 123.36°. The Cu-Cu distance, 2.96 Å is longer than 
the sum of their ionic radii, suggesting the absence of Cu-Cu interactions. The average 
bond length of the bridging Cu-Se bonds (2.54 Å) is longer than the average non-bridging 




Figure 6.3. The crystal structure diagram of [Cu2(μ-mbis)(mbis)2][2BF4] showing 
50% probability ellipsoids. Hydrogen atoms, counterions and the solvent molecules 









Cu(1)-Se(1) 2.5128(12) Se(1)-Cu(1)-Se(2) 100.50(4) 
Cu(1)-Se(2) 2.5617(13) Se(1)-Cu(1)-Se(5) 115.76(4) 
Cu(1)-Se(5) 2.4221(11) Se(1)-Cu(1)-Se(6) 100.21(4) 
Cu(1)-Se(6) 2.4315(12) Se(5)-Cu(1)-Se(2) 110.93(4) 
Cu(2)-Se(1) 2.5073(12) Se(5)-Cu(1)-Se(6) 115.10(5) 
Cu(2)-Se(2) 2.4981(12) Se(1)-Cu(2)-Se(2) 102.43(4) 
Cu(2)-Se(3) 2.4091(15) Se(1)-Cu(2)-Se(3) 122.52(4) 
Cu(2)-Se(4) 2.4267(11) Se(1)-Cu(2)-Se(4) 95.13(4) 
Cu(1)-Cu(2) 2.9616(18) Se(2)-Cu(2)-Se(3) 107.50(4) 
  Se(2)-Cu(2)-Se(4) 102.71(4) 
  Se(3)-Cu(2)-Se(4) 123.36(4) 
 
The copper complex [Cu2(ebit)3][2BF4] (6) (Figure 6.4) has two Cu
+
 centers, each 
arranged in a distorted trigonal planar geometry. The distorted trigonal geometry results 
from coordination of sulfur atoms from the ebit ligand and a third sulfur atom from an 
additional ebit ligand that bridges the two separate copper centers. The angles around the 
copper centers are 117.72(5)° for S(3)-Cu(1)-S(2), 114.70(6)° for S(4)-Cu(1)-S(3) and 
122.49(5)° for S(4)-Cu(1)-S(2), with an average Cu-S bond distance of 2.29 Å (Table 
6.3). 
The molecular structure of [Cu2(μ-mbis)2(dmise)2][2BF4] (7) is shown in Figure 
6.5, and the selected bond length and angles are given in Table 6.4. The structural unit of 
[Cu2(μ-mbis)2(dmise)2][2BF4] is dimeric, with two of the Se atoms from bis(seleno-
methylimidazole) methane (mbis) bridging two Cu
+
 ions to form a Cu2Se2 core that 
resembles a parallelogram. The copper ions are bound to two additional selenium atoms,  







Cu(1) - S(4) 2.2871(16) 
Cu(1) - S(3) 2.3030(16) 
Cu(1) - S(2) 2.2900(14) 
S(4) - Cu(1) - S(2) 122.49(5) 
S(4) - Cu(1) - S(3) 114.70(6) 
S(3) - Cu(1) - S(2) 117.72(5) 
 
Figure 6.4. Crystal structure diagram of [Cu2(ebit)3][2BF4] (6) displaying 
50% probability density ellipsoids. Hydrogen atoms are omitted for clarity.   









Cu-Se(1) 2.5349(12) Se(1)-Cu-Se(2) 105.02(5) 
Cu-Se(A1) 2.4950(13) Se(1)-Cu-Se(3) 107.35(5) 
Cu-Se(2) 2.4583(13) Se(1)-Cu-Se(A1) 114.02(5) 
Cu-Se(3) 2.4238(14) Se(2)-Cu-Se(3) 115.95(5) 
Cu(A)-Se(1) 2.4950(13) Se(2)-Cu-Se(A1) 94.97(5) 
Cu-Cu(A) 2.739(2) Se(3)-Cu-Se(A1) 118.58(4) 
 
one from an mbis ligand, and the other from a dmise ligand, hence each Cu
+
 center 
adopts a distorted tetrahedral geometry with angles ranging from 105.02 to 115.95°.The 
Table 6.4. Selected bond distances (Å) and angles (°) for7.  
 
Figure 6.5. Crystal structure diagram of [Cu2(μ-mbis)2(dmise)2][2BF4] 
(7) showing 50% probability ellipsoids. Hydrogen atoms and counterions 




Cu-Cu distance, 2.74 Å, is slightly shorter than the sum of their van der Waals radii, 
suggesting weak Cu-Cu interactions. The average length of the bridging Cu-Se bonds 
(2.52 Å) is longer than the average non-bridging Cu-Se bond length (2.44 Å). 
 The X-ray crystal structure diagram of [Cu2(μ-mbis)2(dmit)2][2BF4] (8) is shown 
in Figure 6.6, and the selected bond length and angles are given in Table 6.5. The dimer 
in the structural unit of 8 with a Cu2Se2 core is similar to that found in 7. The copper ions 
in complex 8 are bound to two bridging and two terminal Se atoms from bis(seleno-
methylimidazole) methane (mbis) and two additional sulfur atoms from dmit ligand. Each 
Cu
+
 ion adopts a distorted tetrahedral geometry with angles ranging from 95.38 to  
 
 
Figure 6.6. Crystal structure diagram of [Cu2(μ-mbis)2(dmit)2][2BF4] 
(8) showing 50% probability ellipsoids. Hydrogen atoms and 






Cu(1)-S(1) 2.3455(16) S(1)-Cu(1)-Se(2) 116.36(6)  
 
Cu(1)-Se(2) 2.4222(12) S(1)-Cu(1)-Se(1A)  95.38(5) 
Cu(1)-Se(1A) 2.5013(11) Se(2)-Cu(1)-Se(1A)  118.61(4) 
Cu(1)-Se(1) 2.5328(11) S(1)-Cu(1)-Se(1)               
 
105.58(5) 
Se(1)-Cu(1A) 2.5013(11) Se(2)-Cu(1)-Se(1)             105.96(4) 
Cu(1)-Cu(1A)  2.7297(19)  
 
Se(1A)-Cu(1)-Se(1)         114.33(4) 
 
118.61°. The Cu-Cu distance, 2.73 Å is slightly shorter than the sum of their van der 
Waals radii, suggesting weak Cu-Cu interaction. The average Cu-Se bond distance is 
2.45 Å, whereas the Cu-S bond length is 2.35 Å. The average bond length of bridging 
Cu-Se bond (2.52 Å) is longer than the average non bridging Cu-Se bond length (2.42 Å). 
The X-ray crystal structure of [Cu(mbit)(μ-dmit)]n[BF4]n reveals an infinite chain 
of tetrahedrally coordinated Cu
+
 centers bound to two sulfur atoms from a bidentate mbit 
ligand and to bridging sulfur atom from dmit ligand (Figure 6.7). The geometry around 
Cu(1) is best described as distorted tetrahedral geometry with S-Cu-S angles ranging 
from 95.06° to 123.18°, and avg. Cu-S bond lengths of 2.36 Å (Figure 6.8, Table 6.6).  
The tetrahedrally coordinated dinuclear copper selone complexes 3, 7, and 8 have 
average Cu-Se bond lengths of 2.48 Å, longer than the average Cu-Se bond distance of 
2.30 Å for [Tpm
R
Cu(dmise)][BF4] (R = H, Me, and iPr), 2.33 Å Tp*Cu(dmise),
20
 
Cu(C11H14Se2)2][BF4] (avg. 2.41 Å),
23
 but slightly shorter than the Cu-Se bond distance 
of 2.49 Å found in [Cu(1,10-phen)2(C5H10N2Se)][2ClO4].
24
 The Se-C bonds in 1, in the  
 










Figure 6.7. Crystal structure diagram of [Cu(mbit)(μ-dmit)]n[BF4]n  (10) 
showing the extended chain network. Hydrogen atoms and counterions are 
omitted for clarity. 
 
Figure 6.8. Crystal structure diagram of [Cu(mbit)(μ-dmit)]n[BF4]n 




Cu(1)-S(1) 2.3689(10) S(1)-Cu(1)-S(2) 110.51(5) 
Cu(1)-S(2) 2.3748(10) S(1A)-Cu(1)-S(2) 95.06(4) 
Cu(1)-S(3) 2.3347(10) S(1A)-Cu(1)-S(1) 123.18(2) 
Cu(1)-S(1A) 2.3520(10) S(3)-Cu(1)-S(1) 105.05(4) 
Cu(1A)-S(1) 2.3520(10) S(3)-Cu(1)-S(1A) 105.05(4) 
S(1)-C(1) 1.718(3) S(3)-Cu(1)-S(2) 117.58(3) 
S(2)-C(6) 1.698(3) C(1)-S(1)-Cu(1) 104.53(11) 
S(3)-C(14) 1.694(3) C(6)-S(2)-Cu(1) 99.25(11) 
 




The copper thione complexes 6, 8, and 10 have average Cu-S bond distances of 
2.33 Å, longer than most previously reported copper thione and thiolate complexes such 
as [Tpm
R
Cu(dmit)][BF4] (2.20 Å, R = H, Me), Tp*Cu(dmit),
20









 but shorter than 
[Cu(PPh3)2(bzimH2)Cl] (2.38 Å),
28





 The S-C bond lengths in complexes 6, 8, and 
10 (1.694-1.704 Å), are slightly lengthened relative to those in uncoordinated dmit (1.68 
Å),
31
and 1-methyl-4-imidazoline-2-thione (1.68 Å).
32
 
NMR spectroscopy of dinuclear copper thione and selone complexes. The 















NMR spectroscopy. In the 
1
H NMR spectra of dmise, dmit, mbis, mbit, ebis, and ebit the 
olefinic CH protons on the heterocyclic ring are shifted downfield by  0.2 to 0.5 from its 
position in the free ligand upon coordination to copper. This same downfield shift was 
Table 6.6. Selected bond distances (Å) and angles (°) for 10. 
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 (R = H; Tpm, R = Me; Tpm*, R = 
iPr; Tpm
iPr






H} NMR resonances for the 
complexed and uncomplexed selone and thione ligands are given in Table 6.7. 
Substantial shifting of the C=Se/S resonances of the dmise, dmit, mbis, and mbit  carbon 
atoms are observed upon complexation to copper. Coordination of the selones and 
thiones via the selenium and sulfur atoms results in upfield shifts of  5 to 8 for both the 
C=Se and C=S carbons. The upfield shift in C=Se/S resonance results in decreased 
double bond character of the seleno- and thio-carbonyl bond while enhancing that of the 






C=S (dmit) 77Se 
Dmise  155.57t 
 
 -6 
Dmit  162.42t  
Mbis 157.03b  16.02 
Mbit  163.71b  
Ebis 155.63b  22.65 
Ebit  162.29b  
[Cu2(μ-dmise)(dmise)4][2BF4] (1) 147.19
t   




149.67b  -28.01 
[Cu2(mbit)3][BF4]2 (4) 
 
 158.04b  
[Cu2(ebis)3][BF4]2 (5) 
 
147.98b  -42.91 
[Cu2(ebit)3][BF4]2 (6) 
 
 155.22b  
[Cu2(μ-mbis)2(dmise)2][2BF4] (7)  
 
148.99t, 151.27b  -26.01 
[Cu2(μ-mbis)2(dmit)2][2BF4]  (8) 
 
151.63b 157.65t -24.20 
[Cu2(mbit)2(dmise)2][2BF4]  (9) 
 
149.25t 158.75b  
[Cu(μ-dmit)(mbit)]n[BF4]n  (10) 
 
 156.61t, 158.40b  
 
t
 = terminal, 
b









H} NMR chemical shifts of the selone and thione 








H} NMR spectroscopy studies revealed upfield shifts of selenium 




H} NMR signal for complex 1 could not be obtained, whereas all the complexes 
with mbis and ebis ligands exhibited upfield selenium resonance shifts ~δ 40 upon 




H} NMR resonance upon copper 
binding is direct evidence that mbis and ebis ligands bind to copper in a bidentate fashion 
via the selenium atoms. 
Electrochemical studies of the dinuclear copper complexes. Cyclic voltammetry 
studies of the chalcogenones and their dinuclear copper complexes were conducted to 
determine the influence of the alkyl linker on the redox potential of the chalcogenone 
ligands and the change in Cu
2+/+
 reduction potential upon coordination of the 
chalcogenone ligands to copper. All the uncoordinated chalcogenone ligands exhibit 
chemically reversible and quasi-reversible electrochemical behavior, with the selone 
ligands having more negative reduction potentials relative to the analogous thione 
ligands. The unbound bidentate ethylene-bridged ligands (ebis and ebit) have larger peak 
separation between the oxidized and reduced products relative to the methylene- bridged 
ligands (mbis and mbit), suggesting faster electron transfer in the latter.
34
 The reduction 
potentials of the unbound selone ligands are: dmise -367 mV < ebis (-342 mV) < mbis (-
333 mV). The analogous thione ligands follow the same trend: dmit (-169 mV) < ebit (-
148 mV) < mbit (-118 mV), versus normal hydrogen electrode (NHE; Table 6.10). The 
reduction potentials of the uncoordinated bidentate chalcogenones indicate that 
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increasing the length of the alkyl linker from methylene to ethylene results in more 





 redox potentials of the complexes versus NHE are given in Table 6.10. 
The cyclic voltagrams (CV) of the copper complexes 1, 2, 3, 4, 5, 6, 7, and 10 exhibit 




 couples, with 
exception of complexes 8 and 9 which exhibit three, one-electron redox potential waves. 
The Cu
+/0
 redox couple commences at potentials more than -1000 mV vs. NHE and after 
switching the scan direction at potentials close to 750 mV, Cu
0
 is stripped off the 
electrode (Figure 6.10). All the dinuclear copper selone and thione complexes exhibit 
chemically reversible, Cu
+/2+
 one-electron oxidation and reduction, but the peak 
separation between the anodic and cathodic waves is much higher relative to the 
Figure 6.9. Cyclic voltammetry (CV) scan for A) mbit (dashed lines) and 
mbis (solid lines), B) ebit (dashed lines) and ebis (solid lines). All data were 
collected with 1mM complex in acetonitrile.   
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ferrocene/ferrocenium couple at the same conditions, suggesting an electrochemically 
quasi-reversible process (Figures 6.10-6.12).  
 
 
Upon examination of the reduction potentials for the copper complexes 1, 2, 3, 4, 
5, and 6, it is clear that the selone containing complexes exhibit more negative reduction 
potentials relative to the analogous thione complexes, a similar trend observed by 




 complexes (X = dmise or 
dmit).
20
 Interestingly, increasing the length of the alkyl bridge in the bidentate ligands 
from methylene to ethylene results in lower reduction potentials for [Cu2(ebis)3][2BF4] 
(5) (-369 mV) compared to [Cu2(μ-mbis)(mbis)2][2BF4] (3) (-306 mV), and the same 
trend is observed for the thione complex [Cu2(ebit)3][2BF4] (6) (-203 mV) relative to  
Figure 6.10. Cyclic voltammetry (CV) scans for  [Cu2(μ-mbis)2(dmise)2][2BF4]  




 Epa Epc ΔE E1/2 
(mV) 
vs. NHE 
Dmise 39 -773 812 -367 
Dmit 424 -761 1158 -167 
Mbis -53 -613 560 -333 
Mbit 289 -525 814 -118 
Ebis 83 -768 851 -342 
Ebit 292 -587 879 -148 
[Cu2(μ-dmise)(dmise)4][2BF4] (1) -101 -603 502 -352 
[Cu2(dmit)5][2BF4] (2) 147 -565 712 -210 
[Cu2(μ-mbis)(mbis)2][2BF4]  (3) -37 -575 538 -306 
[Cu2(mbit)3][2BF4]  (4) 120 -500 620 -180 
[Cu2(ebis)3][2BF4]  (5) -131 -606 475 -369 
[Cu2(ebit)3][2BF4]  (6) 228 -634 862 -203 
[Cu2(μ-mbis)2(dmise)2][2BF4]  (7) -68 -645 577 -356 
[Cu2(μ-mbis)2(dmit)2][2BF4] (8) 192, -6 -44, -478 225, 439 74, -242 
[Cu2(mbit)2(dmise)2][2BF4]  (9) 
 
174, -23 31, -608 149, 585 102, -315 
[Cu(μ-dmit)(mbit)]n[BF4]n  (10) 
 
147 -535 682 -195 
 
 
 Epa Epc ΔE E1/2 
(mV) 
vs. NHE 
[Cu2(μ-dmise)(dmise)4][2BF4] (1) -724 -1107 383 -920 
[Cu2(dmit)5][2BF4] (2) -747 -1129 382 -938 
[Cu2(μ-mbis)(mbis)2][2BF4]  (3) -796 -1336 540 -1066 
[Cu2(mbit)3][2BF4]  (4) -742 -1298 556 -1020 
[Cu2(ebis)3][2BF4]  (5) -936 -1152 216 -1044 
[Cu2(ebit)3][2BF4]  (6) -816 -1299 483 -1058 
[Cu2(μ-mbis)2(dmise)2][2BF4]  (7) -774 -1231 457 -1003 
[Cu2(μ-mbis)2(dmit)2][2BF4] (8) -710 -1119 409 -915 
[Cu2(mbit)2(dmise)2][2BF4]  (9) 
 
-671 -1107 436 -889 
[Cu(μ-dmit)(mbit)]n[BF4]n  (10) 
 
-791 -1222 431 -1007 
 
Table 6.8. Redox potentials and Cu
+/2+




 reuction potentials of dinuclear copper complexes vs. NHE.  
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[Cu2(mbit)3][2BF4] (4) (-180 mV). The dinuclear copper complex 7 with both mbis and 
dmise ligands has a lower reduction potential of (-356 mV) relative to complex 10 which 
has both mbit and dmit ligands (-195 mV) (Table 6.8). 
The heterogeneous dinuclear complex [Cu2(μ-mbis)2(dmit)2][2BF4] (8; Figure 
6.12I) exhibits two different reduction and oxidation potentials for the Cu
2+/+
 couple, 
whereas [Cu2(μ-mbit)2(dmise)2][2BF4] (9; Figure 6.12H) exhibits three oxidation and 
reduction waves. One reduction and oxidation wave in the dinuclear copper complex 9 
likely corresponds to the reduction potential of the bidentate mbit ligand (E1/2 = -51 mV), 
whereas the remaining two waves correspond to Cu
2+/+
 reduction potentials, similar to 
those observed for complex 8. These two different Cu
2+/+
 reduction potentials are only 
observed for the dinuclear copper complexes with mixed sulfur and selenium ligands 
(Table 6.8).  
The unbound dmise and dmit have more negative reduction potentials than the 
bidentate chalcogenones (mbis, mbit, ebis and ebit). The reduction potentials from the 
bidentate chalcogenones indicate that increasing the length of the alkyl linker from 
methylene to ethylene results in more negative reduction potentials. All the synthesized 
copper-selone complexes have more negative Cu
2+/+
 reduction potentials relative to the 
analogous copper-thione complexes. The copper-selone complexes stabilize the Cu
2+
 
oxidation state more effectively than the copper-thione complexes by an average of 144 




 reduction potential of the 
dinuclear copper chalcogenone complexes 1 to 10 can be tuned from a range of 102 mV 
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to -369 mV by simply changing the chalcogenone and denticity of selone and thione 
ligands. Compared to naturally occurring cupredoxins with Cu
2+/+
 reduction potential 
range of 90 mV to 670 mV,
35
 the synthesized copper chalcogenone complexes have more 
negative Cu
2+/+
 reduction potentials. 
Conclusions 
 Dinuclear homoleptic and heteroleptic Cu
+
 complexes with monodentate and 
bidentate chalcogenone ligands have been synthesized and characterized, and the 
electrochemistry of the resulting Cu
+
 complexes has been investigated and compared. 
Treating the Cu
+
 starting material [Cu(NCCH3)4][BF4] with bidentate (mbit, mbis, ebit, 
and ebis) and monodentate chalcogenone ligands (dmise and dmit) results in the 
formation of dinuclear copper complexes (1, 2, 3, 4, 5, and 6). The dinuclear copper 
complexes adopt either trigonal or tetrahedral coordinate geometries with both terminal 
and bridging selone or thione ligands. The heterogeneous dinuclear copper complexes 
[Cu2(μ-mbis)2(dmise)2][2BF4] (7) and [Cu2(μ-mbis)2(dmit)2][2BF4] (8) adopt distorted 
tetrahedral geometry where each copper is coordinated to three selenium atoms from 
mbis ligand and one selenium atom from dmise for 7 and one sulfur atom from dmit for 
8. Interestingly, the mixed ligand complex 10 consist of infinite chains of tetrahedrally 
coordinated Cu
+
 ions bound to two sulfur atoms from a mbit ligand and a bridging sulfur 
atom from a dmit ligand.  
The copper selone complexes 1, 3, 5, and 7 have more negative Cu
2+/+
 reduction 
potentials relative to their sulfur analogs (2, 4, 6, and 10), and increasing the length of the 
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alkyl linker in the bidentate chalcogenone ligands results in more negative reduction 
potentials for their copper complexes. This study provides detailed comparative 
coordination chemistry of selones and thiones with copper and its effect on the Cu
2+/+
 
reduction potentials. Simply changing the chalcogens and denticity of the selone and 
thione ligands results in Cu
2+/+
 reduction potentials of the synthesized copper 
chalcogenone complexes that can be tuned in a range of 471mV, a difference that would 
have significant effects in redox-mediated reactions. 
 
Experimental Section 
Materials. The synthesis and manipulation of all copper complexes was 
performed under an inert atmosphere of argon or nitrogen using standard Schlenk 
techniques. Acetonitrile, methanol, and ether were purified using standard procedures and 
freshly distilled under argon atmosphere prior to use. N,N’-Dimethylimidazole-selone 





(selono-imidazolyl)methane (mbis), bis (thio-imidazolyl)methane (mbit), 
bis(selono-imidazolyl)ethane (ebis), bis(thio-imidazolyl)ethane (ebit)
1
 were synthesized 
according to published procedures. The following reagents were used as received: 
selenium powder (VWR), sulfur powder (VWR), cuprous oxide (stabilized, Aldrich), 















H} spectra were obtained on 





















NMR chemical shifts were obtained in CDCl3 and externally referenced to diphenyl 
diselenide (δ 461),
39
 and reported relative to dimethyl selenide (δ 0).  
Electrochemical experiments were performed with a BAS 100B potentiostat. A 
three compartment cell was used with an Ag/AgCl reference electrode, Pt counter 
electrode, and a glassy carbon working electrode. Freshly-distilled acetonitrile was used 
as the solvent with tetra-n-butylammonium phosphate as the supporting electrolyte (0.1 
M). Solutions containing 1 mM analyte were deaerated for 2 min by vigorous nitrogen 
purge. The measured potentials were corrected for junction potentials relative to 
ferrocenium/ferrocene (0.586 mV vs. Ag/AgCl).
40
 All E1/2 values were calculated from 
(Epa + Epc)/2 at a scan rate of 100 mV/s, and ΔE = Epa - Epc.  
Infrared spectra were obtained using Nujol mulls on KBr salt plates with a Magna 
550 IR spectrometer. Abbreviations used in the description of vibrational data are as 
follows: vs, very strong; s, strong; m, medium; w, weak; b, broad. Electrospray ionization 
mass spectrometry (ESI-MS) was conducted using a QSTAR XL Hybrid MS/MS System 
from Applied Biosystems via direct injection of sample (0.05 mL/min flow rate) into a 
Turbo Ionspray ionization source. Samples were run under positive mode, with ionspray 
voltage of 5500 V, and TOF scan mode. MALDI-TOF-MS was conducted on a Bruker 
Microflex. Trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]-malononitrile was 
used as a matrix for co-crystallization of the copper complex characterized. All the peak 
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envelopes matched their calculated isotopic distributions. Melting points were determined 
using a Barnstead Electrothermal 9100 apparatus in silicon-grease-sealed glass capillary 
tubes. Absorption spectra were collected using a Varian Cary-50 Bio spectrophotometer 
in quartz cuvettes with a path length of 1 cm.  
 [Cu2(μ-dmise)(dmise)4][2BF4] (1). Dmise (437 mg, 2.5 mmol) was dissolved in 
acetonitrile (30 mL) and cannula transferred to a solution of [Cu(NCCH3)4][BF4] (312 
mg, 1 mmol) in acetonitrile (20 mL). The reaction was stirred at room temperature for 3 
h, and the solvent volume was reduced in vacuo to about 5 mL. The product was 
precipitated with diethyl ether (10 mL) to afford an off-white solid that was dried in 
vacuo. Single crystals for X-ray analysis were grown from slow vapor diffusion of 
diethyl ether into acetonitrile solution. Yield: 85% (496 mg, 0.425 mmol). Mp. 126°C. 1H 




H} NMR (CD3CN): 37.06 




H} NMR (CD3CN): -151.56, -151.61. IR (cm
-
1
): 521 s, 624 w, 660 s, 744 s, 933 s, 1021 b, 1238 s, 1285 s, 1378 s, 1457 s, 1570 s, 1818 
w, 2252 w, 2276 vs, 2304 vs, 2918 b, 3139 w, 3172 w, 3230 w. MALDI-TOF-MS: 
415.07 [Cu(dmise)2]
+
. Anal. Calc. for C25H40Cu2N10Se5B2F8: C, 25.53; N, 11.91; H, 3.43. 
Found: C, 25.42; N, 11.73; H, 3.45. 
[Cu2(dmit)5][2BF4] (2). Complex 2 was prepared following the same procedure 
for 1 except that dmit (322 mg, 2.5 mmol) was used instead of dmise. Yield: 74% (350 





H} NMR (CD3CN): 35.13 (CH3), 120.35 (CH), 157 (C=S). IR (cm
-1
): 521 s, 672 vs, 
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724 vs, 746 vs, 801 s, 1047 b, 1175 vs, 1236 vs, 1284 v, 1378 s, 1464 vs, 1569 vs, 1684 
w, 2276 s, 2304 s, 2723 w, 2859 b, 3118 w, 3142 w. MALDI-TOF-MS: 319.51 
[Cu(dmit)2]
+
. Anal. Calc. for C25H40Cu2N10S5B2F8: C, 31.89; N, 14.87; H, 4.28. Found: 
C, 31.80; N, 14.56; H, 4.23. 
[Cu2(mbis)3][BF4]2 (3). Mbis (215 mg, 0.75mmol) was dissolved in 
dichloromethane (20 mL) before being cannula transferred to a solution of 
[Cu(CNCH3)4][BF4] (160 mg, 0.5 mmol) in acetonitrile (10mL). The reaction mixture 
was stirred at room temperature for 3 h. The solvent volume in the reaction mixture was 
then reduced to about 5 mL and the product was precipitated with diethyl ether. Single 
crystals for X-ray analysis were grown from slow vapor diffusion of ether into 
acetonitrile solution. Yield: 45% (262 mg, 0.225 mmol). 
1
H NMR (DMSO): 3.54 (s, 6H, 









H} NMR (DMSO): -151.59, -151.63. 
77
Se NMR (DMSO): -28.008. UV-vis 
(CH3CN):  291.6 nm. Mp. 139°C; 460 s, 473 w, 521 vs, 604 w, 655 s, 697 s, 731 vs, 779 
w, 790 s, 1059 b, 1207 s, 1234 s, 1249 s, 1318 s, 1378 s, 1464 vs, 1575 vs, 1676 vs, 2727 









. Anal. Calc. for 
C29H39Cu2N13Se6B2F8: C, 25.91; N, 13.55; H, 2.92. Found: C, 25.98; N, 13.12; H, 3.04. 
[Cu2(mbit)3][BF4]2 (4). Complex 4 was prepared following the same procedure 
for 3 except that mbit (186 mg, 0.75 mmol) was used instead of mbis. The growth of 
203 
 
single crystals for X-ray analysis was attempted from slow vapor diffusion of diethyl 
ether into acetonitrile solution. Yield: 56% (297 mg, 0.283 mmol). 
1
H NMR (CD3CN): 














BF4). UV-vis (CH3CN): 
274.4 nm. Mp. 128°C; IR (cm-1): 521 s, 604 w, 663 s, 703 s, 734 s, 759 s, 784 s, 1046 b, 
1168 s, 1215 s, 1238 s, 1286 s, 1319 s, 1378 s, 1398 s, 1467 s, 1576 s, 1700 w, 2272 w, 
2304 w, 2727 w, 2855 b, 3141 w. Anal. Calc. for C27H36Cu2N12S6B2F8: C, 31.74; N, 
16.45; H, 3.55. Found: C, 30.07; N, 16.25; H, 3.61. 
[Cu2(ebis)3][BF4]2 (5). Complex 5 was prepared following the procedure for 3 
except that ebis (223 mg, 0.75 mmol) was used in place of mbis. Yield: 30% (174 mg, 
0.153 mmol). 
1
H NMR ((CD3)2SO): 3.58 (s, 6H, 2CH3), 4.73 (s, 4H, 2CH2), 7.33 (d, 2H, 




H} NMR: 39.70 (CH3), 47.46 (CH2), 121.47 (CH), 122.76 











42.91 (s, Se). UV-vis (CH3CN): 288.4 nm; Mp. 270°C; IR (cm
-1
): 522 s, 666 vs, 724 vs, 
738 vs, 747 vs, 800 w, 930 w, 1057 vs, 1128 vs, 1183 vs, 1223 s, 1246 vs, 1287 w, 1378 
vs, 1409 vs, 1467 vs, 1569 vs, 2854 vs, 2919 b, 3114 w, 3146 w, 3173 w. Anal. Calc. for 
C30H42Cu2N12Se6B2F8: C, 26.79; N, 12.49; H, 3.15. Found: C, 26.97; N, 12.48; H, 3.12. 
[Cu2(ebit)3][BF4]2 (6). Complex 6 was prepared following the procedure for 3 
except ebit (191 mg, 0.75 mmol) was used in place of mbis. Yield: 47% (252 mg, 0.236 
mmol). 
1
H NMR ((CD3)2SO): 3.52 (s, 6H, 2CH3), 4.63 (s, 4H, 2CH2), 7.18 (d, 2H, 2CH), 
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H} NMR: 35.59 (CH3), 45.67 (CH2), 119.70 (imidazole), 120.89 









(CH3CN): 272.5 nm; Mp. 230°C; IR (cm
-1
): 501 w, 522 s, 622 w, 670 s, 680 s, 720 vs, 
736 vs, 1059 vs, 1137 w, 1197 s, 1227 s, 1247 vs, 1287 w, 1378 vs, 1415 vs, 1466 vs, 
1570 vs, 1694 w, 2927 b, 3137 w. Anal. Calc. for C30H42Cu2N12S6B2F8: C, 33.87; N, 
15.50; H, 3.98. Found: C, 29.88; N, 13.68; H, 3.45. 
[Cu2(μ-mbis)2(dmise)2][2BF4] (7). Dmise (176 mg, 1 mmol) was dissolved in 
acetonitrile (20 mL) and cannula transferred to a solution of [Cu(NCCH3)4][BF4] (312 
mg, 1 mmol) in acetonitrile (10 mL). The reaction was stirred at room temperature for 3 
h, resulting in the formation of a yellow solution. To this reaction mixture was cannula 
added mbis (336 mg, 1 mmol) in dichloromethane (10 mL) and stirred overnight. The 
solvent volume was reduced in vacuo to about 3 mL and the product was precipitated 
with diethyl ether to afford an off-white solid which was dried in vacuo. Single crystals 
for X-ray analysis were grown from slow vapor diffusion of diethyl ether into acetonitrile 
solution. Yield: 46% (558 mg, 0.456 mmol). 
1
H NMR (CD3CN): 3.62 (s, 6H, 2CH3), 3.68 
(s, 6H, 2CH3), 6.68 (s, 2H, CH2), 7.14 (s, 2H, 2CH), 7.24 (d, JHH 2.0, 2H, 2CH), 7.40 (d, 




H} NMR: 36.45(CH3), 37.82 (CH3), 60.53 (CH2), 121.05 (CH), 





NMR (CD3CN): -151.56, -151.61. 
77
Se NMR (CD3CN): -26.01. UV-vis (CH3CN): 277.6 
nm. Mp. 193°C. IR (cm-1): 521 s, 623 s, 650 s, 658 s, 724 s, 745 s, 791 s, 837 s, 1055 b, 
1176 s, 1207 s, 1230 vs, 1248 s, 1287 s, 1320 s, 1378 b, 1464 vs, 1571 vs, 1673 s, 2925 











. Anal. Calc. for 
C28H40Cu2N12Se6B2F8: C, 25.49; N, 12.74; H, 3.06. Found: C, 24.85; N, 12.48; H, 3.00. 
[Cu2(μ-mbis)2(dmit)2][2BF4] (8). Complex 8 was prepared following the same 
procedure for 7 except that dmit (129 mg, 1 mmol) was used instead of dmise. Single 
crystals for X-ray analysis were grown from slow vapor diffusion of diethyl ether into 
acetonitrile solution. Yield: 38% (427 mg, 0.378 mmol). 
1
H NMR (CD3CN): 3.60 (s, 6H, 
2CH3), 3.62 (s, 6H, 2CH3), 6.65 (s, 2H, CH2), 6.98 (s, 2H, 2CH), 7.23 (d, JHH 2.5, 2H, 




H} NMR: 35.84(CH3), 37.77 (CH3), 60.51 (CH2), 








H} NMR (CD3CN): -24.20. UV-vis 
(CH3CN): 273.7 nm. Mp. 209 °C. IR (cm
-1
): 508 s, 521 s, 611 s, 640 s, 650 s, 657 s, 676 
s, 723 vs, 746 vs, 790 vs, 839 s, 867 s, 1033 b, 1145 s, 1177 s, 1207 s, 1229 s, 1249 s, 
1290 s, 1321 s, 1372 s, 1395 s, 1465 s, 1571 vs, 1602 s, 1673 s, 2920 b, 3088 s.; Mass 











. Anal. Calc. for 
C28H40Cu2N12Se4S2B2F8: C, 27.44; N, 13.72; H, 3.29. Found: C, 27.28; N, 13.60; H, 3.27. 
[Cu2(dmise)2(mbit)2][2BF4] (9). Complex 9 was prepared following the same 
procedure for 7 except that mbit (242 mg, 1 mmol) was used in place of mbis. The 
growth of single crystals for x-ray analysis was attempted from slow vapor diffusion of 
diethyl ether into acetonitrile solution. Yield: 30% (347 mg, 0.302 mmol). 
1
H NMR 
(CD3CN): 3.52 (s, 6H, 2CH3, mbit), 3.69 (s, 6H, 2CH3, dmise), 6.48 (s, 2H, CH2), 7.04 
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NMR: 35.88 (CH3), 37.74 (CH3), 57.45 (CH2), 118.91 (CH), 121.40 (CH), 122 (CH), 




H} NMR (CD3CN): -151.48, -151.53. 
UV-vis (CH3CN): 268.9 nm. Mp. 174°C;  IR (cm
-1
): 521 s, 672 vs, 725 vs, 741 vs, 761 
vs, 796 vs, 848 s, 983 s, 1033 b, 1217 vs, 1234 vs, 1250 vs, 1287 s, 1314 s, 1376 vs, 1401 
vs, 1429 s, 1464 b, 1571 vs, 1699 b, 2851 b, 3141 s, 3171 s. Anal. Calc. for 
C28H40Cu2N12Se2S4B2F8: C, 29.72; N, 14.85; H, 3.56. Found: C, 29.60; N, 14.61; H, 3.53. 
[Cu(mbit)(μ-dmit)]n[BF4]n (10). Complex 10 was prepared following the same 
procedure for 7 except that dmit (129 mg, 1 mmol) was used in place of dmise and mbit 
(242 mg, 1 mmol) was used instead of mbis. Single crystals for x-ray analysis were 
grown from slow vapor diffusion of diethyl ether into acetonitrile solution. Yield: 34% 
(354 mg, 0.335 mmol). 
1
H NMR (CD3CN): 3.52 (s, 6H, 2CH3, mbit), 3.62 (s, 6H, 2CH3, 





H} NMR: 35.94 (CH3), 57.52 (CH2), 119.00 (CH), 120.30 (CH), 121.50 




H} NMR (CD3CN): -151.30, -
151.35. UV-vis (CH3CN): 267.8 nm. Mp. 159°C; IR (cm
-1
): 503 s, 521 s, 603 s, 633 s, 
670 vs, 729 vs, 760 s, 782 s, 848 s, 1032 b, 1174 s, 1234 vs, 1286 s, 1395 vs, 1464 vs, 
1572 vs, 1684 b, 2250 s, 2725 s, 2921 b, 3140 b. Anal. Calc. for C28H40Cu2N12S6B2F8: C, 
32.41; N, 16.20; H, 3.88. Found: C, 32.55; N, 16.15; H, 3.97. 
 X-ray data collection and structural determination. Single crystals grown from 
vapor diffusion were mounted on a glass filament with silicon grease and immediately 
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cooled to 168.15K in a cold nitrogen gas stream. The crystals were grown by vapor 
diffusion of diethyl ether into an acetonitrile solution for [Cu2(μ-dmise)(dmise)4][2BF4] 
(1), [Cu2(μ-mbis)(mbis)2][2BF4] (3), [Cu2(ebit)3][BF4]2 (6), [Cu2(μ-
mbis)2(dmise)2][2BF4] (7), [Cu2(μ-mbis)2(dmit)2][2BF4] (8), and [Cu(mbit)(μ-
dmit)]n[BF4]n (10). Intensity data were collected using a Rigaku Mercury CCD detector 
and an AFC8S diffractometer. The space groups P-1 for 1, 3, 6, 8, and 10 and P21/c for 7 
were determined from the observed systematic absences. Data reduction including the 
application of Lorentz and polarization (Lp) effects and absorption corrections used the 
CrystalClear program.
41
 The structures were solved by direct methods and subsequent 
Fourier difference techniques, and refined anisotropically, by full-matrix least squares, on 
F
2
 using SHELXTL 6.10.
42
 In the final cycle of least squares, independent anisotropic 
displacement factors were refined for the non-hydrogen atoms and the methyl hydrogen 
atoms were fixed in “idealized” positions with C-H = 0.96 Å. Their isotropic 
displacement parameters were set equal to 1.5 times Ueq of the attached carbon atom. 
 For complex 1, the largest peak in the final Fourier difference map (1.08 e·A
-3
) 
was located 0.83 Å from Se(4) and the lowest peak (-0.81 e·A
-3
) was located at a distance 
of 0.86 Å from Se(4). The largest peak for complex 3 in the final Fourier difference map 
(0.82 e·A
-3
) was located 0.08 Å from Se(4) and the lowest peak (-0.79 e·A
-3
) was located 
at a distance of 0.77 Å from Se(5). The largest peak for 7 in the final Fourier difference 
map (1.16 e·A
-3
) was located 1.19 Å from H(6C) and the lowest peak (-0.74 e·A
-3
) was 
located at a distance of 0.92 Å from Se(1). The largest peak for 8 in the final Fourier 
difference map (1.10 e·A
-3





) was located at a distance of 0.88 Å from Se(1). The largest peak for 10 in the final 
Fourier difference map (0.42 e·A
-3
) was located 1.73 Å from S(1), and the lowest peak 
(-0.42 e·A
-3
) was located at a distance of 0.76 Å from Cu(1). Final refinement parameters 
for the structures of 1, 3, 6, 7, 8, and 10 are given in Tables 6.10 and 6.11. 
 
 1 3 6 
Chemical Formula C27H43Cu2N11Se5B2F8 C29H39Cu2N13Se6B2F8 C33H46Cu2N13S6B2F8 
F.W. (g/mol) 1217.22 1344.19 1437.29 
Space group P-1 P-1 
 
P-1 
Crystal system Triclinic Triclinic Triclinic 
a, Å 11.712(2) 11.972(2) 
 
10.368(2) 
b, Å 14.126(3) 14.325(3) 10.699(2) 
c, Å 14.800(3) 15.568(3) 10.804(2) 
α, ° 87.32(3) 89.58(3) 98.29(3) 
β, ° 73.78(3) 77.29(3) 116.81(3) 
γ, ° 71.01(3) 68.69(3) 91.25(3) 
V, Å3 2220.5(8) 2418.7(8) 1053.4(4) 
Z 2 2 2 
Dcal, Mg/m
3 1.821 1.846 1.677 
Indices  (min) [-14, -17, -18] [-14, -17, 0] [-12, -11, -13] 
              (max) [14, 17, 18] [14, 17, 19] [12, 11, 13] 
Parameters 508 548 274 
F(000) 1184 1296 542 
μ, mm-1 5.124 5.462 1.384 
2θ range,  3.19 - 26.38 2.94-26.34 3.09- 26.30 
Collected reflections 18943 9716 9129 
Unique reflections 8943 9716 9129 
Final R (obs. Data)a, R1 0.0461 0.0470 0.0553 
                 wR2 0.1125 0.1116 0.1363 
Final R (all data), R1 0.0616 0.0666 0.0553 
                 wR2 0.1263   0.1276 0.1581 
Goodness of fit (S) 1.117 1.062 1.046 
Largest diff.  Peak 1.081 0.817 0.929 
Largest diff.  Hole -0.813 -0.792 -0.880 
 
Table 6. 10. Summary of crystallographic data for complexes 1, 3, and 6. 
 








 7 8 10 
Chemical Formula C28H40Cu2N12Se6B2F8 C28H40Cu2N12S2Se4B2F8 C28H40Cu2N12S6B2F8 
F.W. (g/mol) 1319.18 1225.38 1037.78 
Space group P-1 
 
P-1 P21/c 
Crystal system Triclinic Triclinic Monoclinic 
a, Å 8.21868(16) 
 
8.1987(16) 9.4763(19) 
b, Å 11.247(2) 11.198(2) 27.970(6) 
c, Å 12.904(3) 12.935(3) 7. 8016(16) 
α, ° 66.67(3) 65.68(3) 90 
β, ° 84.64(3) 84.17(3) 99. 89 (3) 
γ, ° 77.72(3) 77.75(3) 90 
V, Å3 1066.1(4) 1057.5(4) 2037.1(7) 
Z 1 1 2 
Dcal, Mg/m
3 2.055 1.924 1.692 
Indices  (min) [-10, -14, 16] [-12, -21, -24] [-11, -34, -7] 
              (max) [9, 14, 11] [11, 21, 26] [11, 34, 9] 
Parameters 266 267 266 
F(000) 636 600 1056 
μ, mm-1 6.194 4.622 1.429 
2θ range,  3.12-26.75 2.95- 26.35 2.18 - 26.31 
Collected reflections 9066 8161 16881 
Unique reflections 4435 4221 4096 
Final R (obs. Data)a, R1 0.0503 0.0455 0.0440 
                 wR2 0.1120 0.1049 0.0984 
Final R (all data), R1 0.0796 0.0658 0.0591 
                 wR2 0.1319 0.1182 0.1074 
Goodness of fit (S) 1.093 1.100 1.089 
Largest diff.  Peak 1.158 1.097 0.416 
Largest diff.  Hole -0.736 -0.778 -0.424 
Table 6.11. Summary of crystallographic data for complexes 7, 8, and 10. 
 








Figure 6.11. Cyclic voltammetry (CV) scans for A) [Cu2(μ-dmise)(dmise)4][2BF4] 
(1), B)  [Cu2(dmit)5][2BF4] (2), C) [Cu2(μ-mbis)3][2BF4] (3), D) [Cu2(mbit)3][2BF4] 
(4), E) [Cu2(ebis)3][2BF4] (5), F) [Cu2(ebit)3][2BF4] (6). All data collected with 1
 
mM 







Figure 6.11(cont.). Cyclic voltammetry (CV) scans for G) 
[Cu2(μ-mbis)2(dmise)2][2BF4] (7), H)  [Cu2(mbit)2(dmise)2][2BF4] (8), I) 
[Cu2(μ-mbis)2(dmit)2][2BF4] (9), J) [Cu(mbit)(μ-dmit)]n[BF4]n (10), K) dmise, F) dmit. 
All data collected with 1
 










Figure 6.12. Crystal packing diagram of [Cu2(μ-dmise)(dmise)4][2BF4] (1) 
showing 50% probability density ellipsoids displaying H-F and H-Se short contact 









Figure 6.13. Crystal packing diagram of [Cu2(μ-mbis)(mbis)2][2BF4] (3) showing 
50% probability density ellipsoids and displaying H-F short contact interactions 
along the c-axis. The short-contact interaction between the acetonitrile solvent 





Figure 6.14. Crystal packing diagram of [Cu2(μ-mbis)2(dmise)2][2BF4] (7) 
showing 50% probability density ellipsoids and H-Se short-contact interactions 














Figure 6.15. Crystal packing diagram of [Cu2(μ-mbis)2(dmit)2][2BF4] (8) 
showing 50% probability density ellipsoids and the H-F and H-Se short-













Figure 6.16. Crystal packing diagram of [Cu2(ebit)3][2BF4] (6) 
showing 50% probability density ellipsoids and the H-F short contact 








Figure 6.17. Crystal packing diagram of [Cu(mbit)(μ-dmit)]n[BF4]n (10) 
showing 50% probability density ellipsoids and the H-F short-contact 
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